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Abstract 
 
Increasing the proportion of unsaturated fatty acids (UFA) in milk is believed to be 
beneficial in terms of human health, thereby increasing the nutritional quality of milk. The 
proportion of UFA in milk is mainly dependent on the proportion of UFA in the diet, the 
degree of biohydrogenation of UFA in the rumen, and on activity of the stearoyl-CoA 
desaturase (SCD) enzyme in the mammary gland. This thesis focuses on SCD in the 
mammary gland of dairy cows, and how SCD can be influenced by nutrition. In the first 
study it was shown that supplementing the diet of dairy cows with soybean oil significantly 
decreases mammary SCD1 expression compared with rapeseed oil or linseed oil and this 
was partly reflected by the lower desaturase indices in milk. In contrast, mammary SCD5 
expression was much lower (<103) than that of SCD1 and was not affected by dietary plant 
oil supplementation. To study the changes in genome-wide expression of genes in response 
to dietary UFA supplementation, mammary tissue samples of the same experiment were 
used for micro-array analysis. It was found that 972 genes were significantly affected 
through UFA supplementation, indicating that large transcriptional adaptations occurred in 
the mammary gland when diets of dairy cows were supplemented with unprotected dietary 
UFA. Since biopsy of the mammary gland is an invasive and costly method which presents 
a risk of udder infection, the use of milk somatic cells as a non-invasive, alternative source 
of mRNA was investigated in the second experiment. Since there was a significant 
relationship between SCD1 expression in milk somatic cells and mammary tissue, it can be 
concluded that milk somatic cells can be used as a source of mRNA to study SCD1 
expression in dairy cows. To study the effects of acetate (Ac) and β-hydroxybutyrate 
(BHBA) as well as various long-chain fatty acids (LCFA) on mammary SCD expression, a 
bovine mammary epithelial cell line (MAC-T) was used in the third experiment. This study 
showed that Ac up-regulates expression of SCD1 and acetyl-CoA carboxylase in MAC-T 
cells, which indicates that Ac may increase desaturation and de novo synthesis of fatty acids 
in the bovine mammary gland. In addition it was shown that expression of sterol regulatory 
binding protein 1 (SREBP-1) and insulin-induced gene 1 protein (INSIG-1) was related to 
the expression of several lipogenic genes, thereby strengthening the support for the role of 
SREBP-1 and INSIG-1 as central regulators of lipogenesis in the bovine mammary gland. 
Overall, it can be concluded that saturated LCFA have little or no effect on SCD1 
expression in the bovine mammary gland, whereas unsaturated LCFA inhibit mammary 
SCD1 expression. The regulation of SCD1 in the bovine mammary gland by LCFA appears 
to be, at least partly, regulated by the transcription factors SREBP-1 and INSIG-1. Based 
on the in vitro research it appears that short-chain fatty acids, in particular Ac, upregulate 
mammary SCD1 expression, although further research is needed to verify if short-chain 
fatty acids induce SCD1 expression in the bovine mammary gland. The recently discovered 
isoform SCD5 is expressed in bovine mammary tissue, although contribution to ∆9-
desaturation of fatty acids appears to be quite low. 
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General Introduction 
 
Milk fat is one of the most important sources of dietary fatty acids (FA) in the Western 
human diet. In general, about 65-75% of the FA in milk are saturated (Jensen, 2002; Heck 
et al., 2009), mainly due to the extensive biohydrogenation of dietary unsaturated fatty 
acids (UFA) occurring in the rumen of dairy cows (Lock & Bauman, 2004). It is generally 
believed that regular consumption of diets rich in saturated fatty acids (SFA), in particular 
C14:0 and C16:0, raise serum total and low-density lipoprotein cholesterol levels, thereby 
increasing the risk of cardiovascular disease and the development of the metabolic 
syndrome (Mensink et al., 2003; Astrup et al., 2011). In addition, high intake of SFA is 
related to reduced insulin sensitivity and subsequently to increased type 2 diabetes (Parillo 
& Riccardi, 2004). Decreasing the proportion of SFA in milk fat may therefore be 
beneficial for human health. In the Netherlands however, the content of even-chain SFA in 
milk fat of raw bovine milk was higher in 2005 compared with 1992, which was related to 
changes in composition of diets fed to dairy cows (Heck et al., 2009). Furthermore, milk 
and meat of ruminants contains a wide range of conjugated linoleic acids (CLA) which are 
a mixture of positional and geometric isomers of linoleic acid with a conjugated double-
bond system. These CLA originate from the rumen as a result of the biohydrogenation 
process by rumen microbes. However, the majority of cis-9, trans-11 CLA, the major CLA 
isomer found in milk, is endogenously synthesised in the mammary gland by desaturation 
of C18:1 trans-11 (Palmquist et al., 2005). The cis-9, trans-11 CLA isomer has been 
associated with numerous health benefits for consumers including prevention of 
atherosclerosis, different types of cancer and hypertension (Wahle et al., 2004; 
Bhattacharya et al., 2006).  
The proportion of UFA in milk is mainly dependent on the proportion of UFA in the 
diet, the degree of biohydrogenation in the rumen, and on the extent of desaturation of UFA 
in the mammary gland (Figure 1). To reduce the proportion of SFA in milk fat, two major 
strategies can be adopted. One strategy is to increase the supply of UFA to the mammary 
gland, by reducing the extent of biohydrogenation of UFA in the rumen. To this end, 
various rumen lipid protection technologies have been developed and evaluated. Such 
rumen lipid protection technologies involve either modifications of FA structure to resist 
the action of microbial enzymes or encapsulation of UFA inside a microbial-resistant shell 
(Jenkins and Bridges, 2007). The efficacy of these protection technologies to reduce 
biohydrogenation varies widely (Sterk et al., 2010). The second strategy to reduce the 
proportion of SFA in milk fat is to stimulate the desaturation of SFA within the mammary 
gland. The present thesis focuses on the latter. 
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Figure 1. Simplified schematic overview of the flow of saturated fatty acids (SFA) and 
unsaturated fatty acids (UFA) from feed to milk.  
 
 
Stearoyl-CoA Desaturase 
Fatty acids can be desaturated by the ∆9-desaturase enzyme, also known as stearoyl-
CoA desaturase (SCD; EC 1.14.19.1) present in various tissues of animals. Stearoyl-CoA 
desaturase is a membrane-bound, endoplasmic enzyme which introduces a cis-double bond 
between carbons 9 and 10 in a wide range of FA. The preferred substrates of SCD are 
C18:0 and, to a lesser extent, C16:0, which are converted to C18:1 cis-9 and C16:1 cis-9, 
respectively (Ntambi & Miyazaki, 2004). The oxidative reaction catalysed by SCD requires 
the electron acceptor cytochrome b5, NAD(P)-cytochrome b5 reductase and molecular 
oxygen. The electrons flow from NAD(P)H via cytochrome b5 reductase, to cytochrome 
b5, to SCD, and finally to O2, which is reduced to H2O (Figure 2; Paton & Ntambi, 2009). 
SCD catalyses the critical committed step in the biosynthesis of monounsaturated fatty 
acids (MUFA), predominately C18:1 cis-9. These MUFA serve as the main substrates for 
the synthesis of membrane phospholipids, triglycerides, cholesterol esters, wax esters and 
alkyldiacylglycerols (Paton & Ntambi, 2009). In addition, MUFA are thought to serve as 
mediators in signal transduction as well as cellular differentiation (including neuronal 
differentiation) and MUFA may also influence apoptosis and mutagenesis in some tumours. 
Since endogenous synthesised C18:1 cis-9 is crucial for these processes, SCD plays a vital 
role in metabolism and its activity is expected to influence cellular differentiation, insulin 
sensitivity, metabolic rate, adiposity, atherosclerosis, cancer and obesity (Paton & Ntambi, 
2009). 
Bio-
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Figure 2. The pathway of electron transfer in the desaturation of fatty acids by stearoyl-
CoA desaturase (SCD; Paton & Ntambi, 2009). 
 
 
Regulation of SCD in Rodents 
Most of the research on SCD has been conducted using rodents. In mice, four different 
isoforms of SCD have been characterized, i.e. SCD1, SCD2, SCD3 and SCD4, which are 
expressed in different types of tissue. Mouse SCD1 is predominantly expressed in lipogenic 
tissues including adipose tissue and liver, whereas SCD2 is mainly expressed in brain and 
at much lower levels in adipose tissue and liver. The SCD3 isoform is primarily expressed 
in skin, whereas SCD4 is mainly expressed in the heart (Popeijus et al., 2008). In addition 
to the tissue-specific expression, the SCD isoforms also differ in substrate preference. 
Whereas SCD1, SCD2 and SCD4 prefer C18:0, and to a lesser extent C16:0, SCD3 appears 
to only utilize C16:0 as a substrate (Miyazaki et al., 2006). In the mammary gland, all four 
isoforms of SCD are expressed, although relative mRNA abundance is highest for SCD1  
(± 70%) and SCD2 (± 30%), whereas SCD3 and SCD4 are barely detected (<0.01%) (Han 
et al., 2010). This latter indicates that SCD1 and, to a lesser extent, SCD2 are the most 
important isoforms of SCD in the mammary gland of mice.  
SCD1 is a highly regulated enzyme, at both the transcription and protein level, with a 
relative short half-life time of approximately 2 to 4 h, as the N-terminus of SCD1 contains a 
sequence responsible for rapid degradation of the SCD1 protein (Flowers & Ntambi, 2008; 
Popeijus et al., 2008). Mice with a targeted disruption of SCD1 are deficient in 
triglycerides, cholesterol esters, wax esters and alkyldiacylglycerols. In addition, these mice 
have reduced body adiposity, increased insulin sensitivity and are resistant to diet-induced 
obesity (Ntambi & Miyazaki, 2003).  
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The expression of SCD1 is affected by numerous dietary, hormonal and environmental 
factors. Nutrients that have been shown to upregulate SCD1 in rodents include: glucose, 
fructose and cholesterol, whereas polyunsaturated fatty acids (PUFA) downregulate SCD1 
(Ntambi & Miyazaki, 2003). Moreover, insulin (Waters & Ntambi, 1994; Frick et al., 2002) 
and growth hormone are examples of hormones that upregulate SCD1, whereas leptin 
(Cohen et al., 2002) has been shown to downregulate SCD1. Several transcription factors 
are involved in the regulation of SCD1. Liver X receptor (LXR), a member of the nuclear 
receptor family of transcription factors, upregulates SCD1 by binding to the LXR response 
element in the SCD1 promoter, as well as LXR-mediated activation of sterol regulatory-
element binding protein-1 (SREBP-1) transcription, since SCD1 expression is also induced 
by the nuclear fragment of SREBP-1 via the sterol regulatory element in its promoter 
(Flowers & Ntambi, 2008). There are three different isoforms of SREBP, i.e. SREBP-1a, 
SREBP-1c and SREBP-2, which have specific roles in lipid and cholesterol metabolism. 
The SREBP-1c isoform is involved in FA synthesis, whereas SREBP-2 is mainly 
associated with cholesterol synthesis and SREBP-1a appears to be involved in both 
pathways (Eberlé et al., 2004). Inactivated full length SREBP is bound to the endoplasmic 
reticulum coupled with SREBP cleavage-activating protein (SCAP) and associated with 
insulin-induced gene 1 (INSIG-1) or insulin-induced gene 2 (INSIG-2). When activated, 
the SREBP/SCAP complex dissociates from INSIG and translocates to the Golgi apparatus 
where proteases release a nuclear fragment of SREBP (nSREBP). Once translocated to the 
nucleus, nSREBP binds to the sterol regulatory element in the promoter region of target 
genes (including fatty acid synthase (FAS), SCD1 as well as SREBP-1 itself), thereby 
stimulating their expression (Eberlé et al., 2004). After feeding a high carbohydrate meal, 
SCD1 expression is rapidly induced (40-fold over fasting), which is thought to be due to 
insulin-mediated increases in SREBP-1c activation and subsequent activation of the SCD1 
promoter (Paton & Ntambi, 2009). 
Peroxisome proliferator-activated receptors (PPAR) are nuclear receptors that function 
as ligand-activated transcription factors regulating the expression of genes involved in 
metabolism, cellular differentiation and development (Michalik et al., 2006) and can 
interact with LXR (Paton & Ntambi, 2009). Three isoforms of PPAR are known, i.e. 
PPARα, PPARδ and PPARγ. The PPARα isoform is highly expressed in liver and plays a 
key role in FA oxidation (Pyper et al., 2010), whereas PPARδ is mainly involved in FA 
catabolism in skeletal muscle and inflammatory responses (Grimaldi, 2010). The PPARγ 
isoform is mainly expressed in adipose tissue where it regulates adipose cell differentiation 
(Tontonoz & Spiegelman, 2008). When re-feeding mice with a targeted deletion of PPARα 
after fasting, the normal SCD1 induction is completely attenuated, which is likely due to a 
loss of LXR/PPARα dimerization (Paton & Ntambi, 2009). The PPARγ agonist 
rosiglitazone upregulates SCD1 (Way et al., 2001), indicating that SCD1 is a target of 
PPARγ.  
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Regulation of SCD in Dairy Cows 
In bovine, two isoforms of SCD have been characterized, i.e. SCD1 and SCD5. In 
lactating ruminants, SCD1 is abundantly expressed in the mammary gland and plays an 
important role in the production of milk fat (McDonald & Kinsella, 1973; Bernard et al., 
2008; Bionaz & Loor, 2008b). The recently discovered SCD5 appears to be predominantly 
expressed in brain and pancreas (Lengi & Corl, 2007). Contrary to rodents, not much is 
known about the nutritional regulation of bovine SCD. Feeding cows diets high in 
concentrate and low in fibre, which causes milk fat depression (MFD), has been shown to 
inhibit expression of key lipogenic genes, including SCD1, in the mammary gland 
(Peterson et al., 2003; Harvatine & Bauman, 2006). In addition, abomasal infusion of trans-
10, cis-12 CLA, which is the main biohydrogenation intermediate responsible for the 
inhibition of milk fat synthesis, also inhibits lipogenic gene expression, including SCD1 
(Baumgard et al., 2002; Bauman & Harvatine, 2006). This coordinated inhibition of genes 
involved in lipogenesis, has been associated with reduced expression of SREBP-1 and 
proteins involved in the activation and distribution of SREBP-1 towards the nucleus 
(Harvatine & Bauman, 2006), which is a mechanism clearly demonstrated in rodents (Jump 
et al., 2005). However, information regarding SCD and its regulation in the bovine 
mammary gland remains scarce.  
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Aim and Outline of This Thesis 
The main focus of the research described in this thesis was on the SCD enzyme in the 
mammary gland of dairy cows, and how SCD activity can be influenced by nutrition. More 
specifically, the effect of FA on mRNA expression of SCD was investigated in the bovine 
mammary gland. In addition, a non-invasive alternative to mammary tissue for measuring 
SCD expression in the mammary gland of dairy cows was examined. The overall purpose 
of this research was to explore nutritional strategies that could increase the activity of SCD 
in the mammary gland of dairy cows. Increasing SCD activity in the mammary gland could 
lead to increased MUFA as well as cis-9, trans-11 CLA content, thereby improving the 
nutritional quality of milk. In addition, understanding the regulation of SCD in the 
mammary gland could facilitate this process and lead to an improved FA profile of milk. 
This thesis describes various experiments aimed at improved understanding of nutritional 
regulation of SCD in the bovine mammary gland. 
 
Chapter 2 and 3 describe the effect of supplementing the diet of dairy cows with various 
plant oils differing in FA composition, on gene expression in the mammary gland.  
Chapter 2 focuses on the effects on mammary SCD expression and milk FA composition 
while Chapter 3 describes the effects on overall mammary gene expression using micro-
array analysis.  
 
Chapter 4 describes the use of milk somatic cells as a non-invasive, alternative source of 
RNA to mammary tissue for measuring SCD expression in the mammary gland of dairy 
cows.  
 
Chapter 5 describes the effect of acetate and β-hydroxybutyric acid on SCD expression in 
a bovine mammary epithelial cell line (MAC-T). In addition, the effect of several long-
chain fatty acids on SCD expression was investigated. 
 
Chapter 6 contains a general discussion of the results of the various experiments carried 
out in this thesis. This chapter also contains general conclusions and describes areas 
recommended for further research to improve our understanding and optimize mammary 
SCD expression.  
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Abstract 
 
Stearoyl-CoA desaturase (SCD) is an important enzyme in the bovine mammary gland, 
which introduces a double bond at the ∆9 location of primarily myristoyl-, palmitoyl-, and 
stearoyl-CoA. The main objective of this study was to compare the effects of various fatty 
acids (FA) typically present in dairy cow rations, on the expression of SCD1 and SCD5 in 
the mammary gland of dairy cows. Twenty-eight Holstein-Friesian cows were randomly 
assigned to one of the four dietary treatments. The dietary treatments were a basal diet 
supplemented (DM basis) with either 2.7% rapeseed oil as a source of C18:1 cis-9, 2.7% 
soybean oil as a source of C18:2 cis-9,12, 2.7% linseed oil as a source of C18:3 cis-9,12,15 
or 2.7% of a 1:1:1 mixture of the three oils. The oil supplements were included in the 
concentrate, which was fed together with maize silage and grass silage. In addition, cows 
were grazing on pasture, consisting mainly of perennial ryegrass, during daytime. Biopsies 
from the mammary gland were taken and analysed for mRNA expression of SCD1 and 
SCD5 by using quantitative RT-PCR. Milk yield as well as milk protein and fat content did 
not differ between the four dietary treatments. Dietary supplementation with rapeseed oil 
and linseed oil increased proportions of C18:1 cis-9 and C18:3 cis-9,12,15 in blood plasma, 
respectively, compared with the other treatments. Supplementation with soybean oil and 
linseed oil increased milk FA proportions of C18:2 cis-9,12 and C18:3 cis-9,12,15, 
respectively, but supplementation with rapeseed oil did not increase C18:1 cis-9 in milk. 
Mammary SCD1 expression was reduced by supplementation of soybean oil compared 
with rapeseed oil and linseed oil. In contrast, SCD5 expression did not differ amongst the 
four treatments. The C16 and C18 desaturation indices, representing proxies for SCD 
activity, were lower for the soybean oil diet, compared with the diet supplemented with a 
mixture of the three oils. In conclusion, our study shows that mammary SCD1 expression is 
significantly down-regulated in dairy cows by feeding unprotected soybean oil compared 
with rapeseed oil or linseed oil, and this is partially reflected by the lower desaturase 
indices in the milk. Furthermore, mammary SCD5 expression appears to be differently 
regulated than that of SCD1. 
 
 
  
Dietary fatty acids and mammary SCD expression 
 
 
 
11 
Introduction 
 
The relationship between dietary fat type and various chronic diseases in humans, 
including cardiovascular disease, has been extensively investigated. Although various trans 
fatty acids (TFA) have an unfavourable impact on the serum lipoprotein profile, conjugated 
linoleic acids (CLA) have anti-carcinogenic and anti-atherogenic effects (Lock & Bauman, 
2004). Saturated fatty acids (SFA) generally raise serum total and low-density lipoprotein 
cholesterol levels and increase the risk of cardiovascular disease (Mensink et al., 2003). 
Moreover, high intake of SFA is related to reduced insulin sensitivity and subsequently to 
increased type 2 diabetes (Parillo & Riccardi, 2004). Decreasing the proportion of SFA in 
milk fat may therefore be beneficial for human health. In the Netherlands though, the 
content of even-chain SFA in milk fat of raw bovine milk was higher in 2005 compared 
with 1992, which was related to changes in composition of diets fed to dairy cattle (Heck et 
al., 2009). 
Stearoyl-CoA desaturase (SCD) converts SFA into monounsaturated fatty acids 
(MUFA) by introducing a double bond between carbon atoms 9 and 10 in the saturated 
carbon chain, but it can also catalyse the desaturation of a wide spectrum of 
monounsaturated fatty acyl-CoA substrates, including C18:1 trans-11 to generate cis-9, 
trans-11 CLA (Ntambi & Miyazaki, 2004). Increasing SCD activity is therefore of interest 
to increase the content of various beneficial fatty acids (FA) in milk. In lactating ruminants, 
stearoyl-CoA desaturase 1 (SCD1) is abundantly expressed in the mammary gland and 
plays an important role in the production of milk fat (McDonald & Kinsella, 1973; Bernard 
et al., 2008; Bionaz & Loor, 2008b). Recently, a novel isoform of SCD, designated 
stearoyl-CoA desaturase 5 (SCD5), has been identified which appears to be expressed 
predominantly in brain and pancreas (Wang et al., 2005; Lengi & Corl, 2007). SCD5 is also 
expressed in the bovine mammary gland (Gervais et al., 2009), but the contribution of 
SCD5 to mammary SCD activity during lactation and whether its expression can be 
influenced by dietary FA remains obscure.  
Nutritional regulation of SCD1 expression has been extensively studied in rodents, 
primarily in liver and adipose tissue (Ntambi, 1999), and to a smaller degree in the 
mammary gland (Lin et al., 2004; Singh et al., 2004). It is well established that 
polyunsaturated FA (PUFA) supplementation, both n-3 and n-6, results in severe down-
regulation of SCD1 in both liver and adipose tissue of rodents, whereas SFA and MUFA 
have little effect (Ntambi, 1999). In dairy cows, only a few studies have examined the 
effect of nutritional factors on regulation of SCD in the mammary gland (Bernard et al., 
2008). Therefore, knowledge regarding the effect of nutrition on milk fat synthesis in the 
bovine mammary gland and especially the underlying mechanisms, such as regulation of 
key lipogenic genes, is still limited. Most of the studies that examined the effect of 
nutritional factors on mammary SCD in dairy cows, utilized diets that cause milk fat 
depression (MFD). Harvatine & Bauman (2006) and Peterson et al. (2003) both reported a 
tendency towards reduction of mammary SCD1 expression in dairy cows with diet-induced 
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MFD. Addition of fish oil to the diet of dairy cows, which also causes MFD, resulted in a 
significant reduction of SCD1 mRNA in the mammary gland (Ahnadi et al., 2002). 
Nevertheless, the effects of the major unsaturated FA C18:1 cis-9, C18:2 cis-9,12 or C18:3 
cis-9,12,15, which are typically present in dairy cow rations, on mammary SCD1 and 
SCD5 expression is still not clear. Consequently, in the present study we investigated the 
effects of dietary FA supplementation of C18:1 cis-9, C18:2 cis-9,12 or C18:3 cis-9,12,15, 
by feeding unprotected rapeseed oil, soybean oil or linseed oil, respectively, or its mixture, 
on both SCD1 and SCD5 expression in the mammary gland of dairy cows and evaluated 
the effects of these FA on milk desaturation indices, as indicators of mammary SCD 
activity. 
 
Material and Methods 
 
Animals and Diets 
This experiment was conducted at the Cranendonck Research Farm, the Netherlands, 
between 26 September and 14 November 2007. Twenty-eight Holstein-Friesian cows were 
distributed in order to ensure uniform distribution among seven blocks based on parity (2.4 
± 0.63), DIM (153 ± 32.8 days), milk yield (25.7 ± 3.08 kg/d) and milk fat content (4.31 ± 
0.12 %) (values expressed as mean ± SEM). Cows within each block were randomly 
assigned to one of the four dietary treatments (n=7 per dietary treatment). The dietary 
treatments were a basal diet supplemented (DM basis) with either: 2.7% rapeseed oil (RO) 
as a source of C18:1 cis-9, 2.7% soybean oil (SO) as a source of C18:2 cis-9,12, 2.7% 
linseed oil (LO) as a source of C18:3 cis-9,12,15 or 2.7% of a 1:1:1 mixture of the three 
oils (MIX). Oil supplements were not protected against biohydrogenation in the rumen. The 
oil supplements were included in the concentrate, which was fed, together with maize silage 
and grass silage, as a mixed ration (MR). Maize silage, grass silage and concentrates 
comprised 52, 12 and 36% of the MR, respectively, on a DM basis. In addition to the MR, 
the cows received approximately 1 kg of a commercial standard concentrate per day, 
through automatic feeding stations. Cows were milked twice daily at 06:00h and 18:00h 
and were grazing on pasture from 08:00h until 16:00h. At other times, cows were inside a 
free-stall barn and had ad libitum access to the MR. The pasture used for grazing was 
established in September 2006 and consisted primarily of ryegrass (Lolium perenne L.) 
with approximately 20% white clover (Trifolium repens L.). The paddocks were 
approximately 5 hectare in size and the total stocking density was 16 cows/ha. The 
treatment period lasted 23 days and after the treatments ended, cows were fed a post-trial 
diet (POST), without oil supplementation, for a period of 28 days as control. In the post-
trial period there was no concentrate in the MR as all the concentrate was provided through 
automatic feeding stations. Ingredient and chemical composition of the different 
concentrates are presented in Table 1 and chemical and FA composition of the pasture and 
of the different MRs used in this experiment are presented in Table 2. Individual milk 
production and MR intake per treatment group were recorded daily.  
Dietary fatty acids and mammary SCD expression 
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Table 1. Ingredient and chemical composition of the concentrate fed post-trail (POST) and 
the concentrates supplemented with either: rapeseed oil (RO), soybean oil (SO), linseed oil 
(LO) or a mixture of these oils (MIX). 
Item POST RO SO LO MIX 
Ingredient, g/kg 
Triticale -1 333.6 333.6 333.6 333.6 
Rapeseed meal, formaldehyde   
treated 
- 
 
195.0 
 
195.0 
 
195.0 
 
195.0 
 
Soybean meal - 102.0 102.0 102.0 102.0 
Dried brewers grain - 79.0 79.0 79.0 79.0 
Rapeseed oil - 75.0 - - 25.0 
Soybean oil - - 75.0 - 25.0 
Linseed oil - - - 75.0 25.0 
Rapeseed meal 108.1 68.0 68.0 68.0 68.0 
Citrus pulp 370.0 60.0 60.0 60.0 60.0 
Soybean meal, formaldehyde 
treated 
- 
 
47.0 
 
47.0 
 
47.0 
 
47.0 
 
Palm kernel expeller 227.3 - - - - 
Sugar beet molasses 101.0 - - - - 
Coconut expeller 64.8 - - - - 
Wheat gluten feed 45.0 - - - - 
Wheat middlings 31.0 - - - - 
Soybean hulls 29.3 - - - - 
Protapec2 13.7 - - - - 
Calcium carbonate 2.0 16.3 16.3 16.3 16.3 
   Sodium chloride 2.4 10.5 10.5 10.5 10.5 
Magnesium oxide 90% 3.4 4.8 4.8 4.8 4.8 
Urea - 4.5 4.5 4.5 4.5 
Monocalcium phosphate - 2.3 2.3 2.3 2.3 
Vitamin mineral premix 2.0 2.0 2.0 2.0 2.0 
Chemical composition, g/kg DM     
DM, g/kg 911.7 891.1 900.5 904.1 901.0 
Ash 87.6 81.2 79.3 86.1 84.9 
CP 161.2 246.5 296.5 252.3 242.4 
Crude fat 55.6 98.0 89.6 93.8 93.9 
NDF 326.3 179.8 148.4 196.3 185.2 
ADF 249.0 116.8 110.4 122.9 119.3 
Starch 35.6 219.8 151.2 172.4 211.7 
Sugars 120.0 73.0 105.8 87.1 72.3 
1
 Not included; 2 Potato fruit-juice (concentrated) mixed with soybean hulls (Cehave 
Landbouwbelang, Veghel, the Netherlands). 
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Table 2. Chemical composition, fatty acid composition and dry matter intake (DMI) of the 
pasture used for grazing, the mixed ration used as post-trial diet (POST) and the four mixed 
rations supplemented with either: rapeseed oil (RO), soybean oil (SO), linseed oil (LO), or 
a mixture of these three oils (MIX). 
Item  
Pasture 
Mixed rations including the various concentrates1 
POST RO SO LO MIX 
Chemical composition, g/kg DM 
   DM, g/kg 191.7 560.9 589.4 574.5 573.1 593.6 
   Ash 90.9 66.1 66.2 64.3 66.5 67.4 
   CP 229.7 132.2 162.8 180.0 164.9 161.4 
   Crude fat 55.9 40.5 55.8 52.9 54.3 54.4 
   NDF 340.4 356.4 305.9 294.0 310.3 307.7 
   ADF 191.3 227.7 187.0 181.3 185.1 188.0 
   Starch -2 182.4 227.4 214.7 223.4 224.2 
   Sugars 206.4 57.4 48.5 55.7 48.7 48.5 
       
Fatty acid composition,  
g/100g fatty acids 
   C8:0 ND3 1.4 0.3 0.2 0.2 0.3 
   C10:0 ND 1.5 0.3 0.2 0.2 0.3 
   C12:0 ND 16.4 3.5 1.9 1.9 3.7 
   C14:0 ND 6.0 1.6 0.8 0.8 1.5 
   C16:0 13.4 13.2 16.2 13.7 10.2 13.0 
   C16:1 cis(c)-9 ND 0.2 1.1 0.1 0.2 0.5 
   C18:0 1.9 2.6 3.9 3.3 3.1 3.4 
   C18:1 c9 5.3 16.8 29.2 19.9 20.1 23.3 
   C18:1 c11 ND 0.8 2.1 1.2 1.6 1.8 
   C18:2 c9c12 15.0 29.8 31.2 46.4 28.8 34.5 
   C18:3 c9c12c15 57.2 7.5 6.4 9.1 30.2 14.5 
   C20:0 ND 0.4 0.4 0.4 0.3 0.4 
   C22:0 0.7 0.5 0.4 0.5 0.4 0.5 
   C24:0 0.7 0.4 0.3 0.3 0.3 0.3 
   Others 0.7 0.6 0.8 0.5 0.6 0.6 
   Unidentified 5.1 1.9 2.2 1.3 1.3 1.4 
       
DMI, kg/d 5.54 12.8 15.1 14.4 14.5 14.7 
1
 Including concentrate which was supplied through the automatic feeding stations. 
2
 Not determined. 
3
 ND = not detected. 
4
 DMI of pasture was 5.5 kg/d during the four dietary treatments and was 4.8 kg/d during 
POST.  
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Pasture intake was estimated from the difference between grass height measurements made 
before and after grazing, assuming grass growth during the period of grazing is a negligible 
proportion of total grass consumption in view of the short grazing period length and 
stocking density (Penning, 2004). Sward surface height was measured as described in 
Abrahamse et al. (2008a) using 40 sward surface height measurements per averaged height 
observation.  
 
Sampling and Analysis 
A representative sample of individual feedstuffs, including pasture, and of the MR was 
taken during the last 3 days of the treatment and post-trial period. All feed samples were 
freeze-dried, ground to pass a 1-mm screen and analysed for: DM, ash, CP, crude fat, NDF, 
ADF, starch, sugars and FA composition. The DM content was determined by drying at 
103°C (ISO 6496, ISO, 1999a) and ash content was determined by combustion at 550°C 
(ISO 5984, ISO, 2002). Crude protein (6.25 x N) was determined using the Kjeldahl 
method (ISO 5983, ISO, 2005) and the Berntrop method with acid hydrolysis (ISO 6492, 
ISO, 1999b) was used to determine crude fat. Neutral detergent fibre was determined 
according to a modified method of Van Soest et al. (1991) with additional incubations in 
alpha amylase and protease as described by Goelema et al. (1998). Acid detergent fibre was 
determined according to Van Soest (1973). Starch was analysed using enzymatic hydrolysis 
(ISO 15914; ISO, 2004) and sugar analysis was carried out using a 40% ethanol solution as 
described by Abrahamse et al. (2008b).  
For FA analysis of the feedstuffs, fat from freeze-dried samples was extracted with 
chloroform-methanol (2:1 v/v), according to Folch et al. (1957) with minor modifications 
as described by Khan et al. (2009), except no internal standard was added. Methylation of 
FA was done as follows: extracted fat was dissolved in 2 ml hexane and 100 mg of 
anhydrous sodium sulphate was added. Next, 50 µl of a 30% sodium methanolate solution 
in methanol was added to transesterify the glycerides to their corresponding methyl esters 
by vortexing for 2 min. at room temperature. Subsequently, 1 ml hydrochloric acid in 
methanol solution (1.25M) was added to esterify the free FA, followed by heating the 
mixture for 20 min. at 85ºC under constant shaking. The mixture was then cooled down to 
room temperature under a flow of cold water and shaken vigorously and 1 ml of the upper 
layer, which contains the FA methyl esters (FAME), was transferred to a 1.5 ml vial and 
used for gas chromatography (GC) analysis. 
On the last day of the treatment period and of the post-trial period, two consecutive milk 
samples (a.m. and p.m. milking) were obtained, and pooled (1:1 ratio) for analysis. One 
aliquot was stored at 4°C pending fat, protein and lactose analysis using mid infrared 
spectrometry (ISO 9622, ISO, 1999c; Qlip NV, Zutphen, the Netherlands). Another aliquot 
was stored at -20°C pending FA analysis. Milk FA extraction and methylation were 
performed as described by van Knegsel et al. (2007) with some minor adjustments. First, 
the milk samples were heated to 45°C and a representative milk sample of 20 ml was 
centrifuged at 3,000 x g for 10 min. at 4°C. The upper fat layer was then collected with a 
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spatula, dried on filter paper and transferred to 1.5 ml tube, which was stored overnight at   
-20°C. Next, the milk fat samples were heated for 10 min. at 60°C, followed by 
centrifugation at 20,000 x g for 5 min. at 20°C, and the clear fat fraction was transferred to 
a new 1.5 ml tube containing a small amount of anhydrous sodium sulphate. Afterwards, 
the milk fat samples were stored again at -20°C until analysis. Before analysis, the frozen 
samples were heated for 10 min. at 60°C, followed by centrifugation at 20,000 x g for 5 
min. at 20°C. Subsequently, 50 µl of milk fat was added to 5 ml of hexane and the glycerol-
bound FA were transesterified to methyl esters by vortexing with 100 µl sodium 
methanolate in methanol (30%). The solution was neutralized with 1 g sodium hydrogen 
sulphate and dried with anhydrous sodium sulphate. This solution was then transferred to a 
1.5 ml vial and used for GC analysis.  
For plasma FA analysis, blood samples (10 ml) were collected from the jugular vein in 
heparin-containing tubes at the last day of the treatment and the post-trial period. The blood 
samples were centrifuged at 3,000 x g for 15 min. to harvest plasma, which was stored at -
20°C pending FA analysis. Fat was extracted using chloroform:methanol (2:1, v/v) as 
described by Folch et al. (1957). The extracted fat was saponified using methanolic sodium 
hydroxide and the constituent FA were converted into their methyl esters using boron 
trifluoride in methanol according to Metcalfe et al. (1966) with minor modifications as 
described by Khan et al. (2009). 
Methylated FA obtained from feed samples, milk samples and blood plasma samples 
were quantified using a gas chromatograph (TRACE GC Ultra™, Thermo Electron 
Corporation, Waltham MA, USA) equipped with a flame-ionization detector and auto-
sampler. Methylated FA were separated using a fused silica capillary column (100 m x 0.25 
mm and 0.2 µm film thickness; Restek RT-2560, Restek, Bellefonte PA, USA) using 
helium as a carrier gas at a constant flow of 1.5 ml/min. Methylated FA samples of 1 µl 
were injected into the GC with a split ratio of 1:50. The following program was used for the 
GC: starting temperature 140ºC for 4 min., followed by an increase at a rate of 4ºC per min. 
until 240ºC and left for 20 min. at 240ºC. Temperature of the flame-ionization detector was 
280ºC. Peaks were identified by comparing the retention times with those of the 
corresponding FAME standards (S37, Supelco, Poole, Dorset, UK) and, when no 
commercial standard was available, by using published chromatograms obtained via 
comparable analytic conditions (Loor et al., 2004; Shingfield et al., 2006; Cruz-Hernandez 
et al., 2007). Under these conditions, several C18:1-trans isomers were not completely 
resolved and are therefore listed together. Fatty acid desaturation indices in milk, as proxies 
for SCD activity in the mammary gland, were calculated as the ratio between the product 
and the sum of the product and substrate FA (Kelsey et al., 2003). 
 
Biopsy Procedure 
On the last day of the treatment and the post-trial period, approximately 0.7 to 1.0 g of 
mammary tissue was obtained from each cow by surgical biopsy from the midpoint section 
of a rear quarter, according to the method of Farr et al. (1996). Collected tissues were 
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immediately snap-frozen in liquid nitrogen and stored at -80°C until RNA extraction. 
Following biopsy, a single intramammary injection of antibiotics (Avuloxil®; active 
ingredients: amoxicillin and clavulic acid; Pfizer Animal Health, Capelle a/d IJssel, the 
Netherlands) was applied in the affected rear quarter. In addition, cows received an 
intramuscular injection of antibiotics (Excenel®; active ingredient: ceftiofur hydrochloride; 
Pfizer Animal Health, Capelle a/d IJssel, the Netherlands). Cows were subsequently 
machine milked as normal and hand-stripped as needed to remove all intramammary blood 
clots. No mammary infections were observed after biopsy. The biopsy procedure was 
approved by the Animal Care and Ethics Committee of Wageningen UR Livestock 
Research, Lelystad, the Netherlands. 
 
RNA Isolation and Real Time PCR 
Total RNA was extracted from mammary gland biopsies with Trizol® reagent 
(Invitrogen, Breda, the Netherlands). First-strand cDNA synthesis was performed from 1 
µg of total RNA reaction using Superscript III reverse transcriptase (200 units; Invitrogen), 
dNTPs (0.5 mM; Roche Diagnostics, Almere, the Netherlands) and random hexamer 
primers (250 ng; Roche) in a volume of 20-µl at 50 ºC for 1 h. Quantitative RT-PCR was 
performed on a LightCycler 1.2 by using FastStart DNA Master SYBR Green I reagents 
(Roche), according to the manufacturer’s protocol. The following gene-specific primers 
were used: for SCD1, forward primer 5’-GGCGTTCCAGAATGACGTTT-3’ and reverse 
primer 5’-AAAGCCACGTCGGGAATTG -3’; for SCD5, 5’-
GGCACCGGCAGGACATC-3’ (forward) and 5’-GAGCAGTCAGGAGGAAGCAGAA-
3’ (reverse). 18S RNA and beta-actin (ACTB) were measured to correct for the input of 
cDNA. For 18S RNA, we used the forward primer 5’-AGAAACGGCTACCACATCCAA-
3’ and reverse primer 5’-GGGTCGGGAGTGGGTAATTT-3’. For ACTB, 5’-
GCCCTGAGGCTCTCTTCCA-3’ (forward) and 5’-CGGATGTCGACGTCACACTT-3’ 
(reverse). All primer pairs, except for 18S RNA, were designed in such a way that they 
span an intron of their corresponding genomic sequence or that its sense or reverse primer 
anneals on an exon-intron junction. Templates were amplified after a preincubation for 10 
min at 95 ºC, followed by amplification for 40 cycles (10 s at 95 ºC, 5 s at 60 ºC, 5 s at 72 
ºC). PCR efficiencies were established to be 100% for SCD1 and SCD5, and 95% for the 
two reference (18S RNA and ACTB) genes. All reactions revealed a single product as 
determined by melting curve analysis. Specificity of the primer sets were verified by 
sequencing of the generated amplicons. Expression levels of SCD1 and SCD5 were 
normalized using the geometric mean of 18S and ACTB. The relative RNA expression 
levels were calculated using the modified comparative CT method (Pfaffl, 2001). All 
measurements were performed in duplicate.  
 
Statistical Analysis 
Statistical analyses were carried out by ANOVA using the PROC MIXED procedure of 
SAS (version 9.1, SAS Institute Inc.) for a randomized block design. Covariate analysis 
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using the post-trial data did not improve the ability to detect differences due to treatment 
and therefore, post-trial data was not included in the statistical analysis. Treatment effects 
on animal performance, milk FA composition, blood plasma FA composition and mRNA 
abundance of the different genes were analysed and considered significant at a probability 
of P < 0.05, and as a trend at a probability of 0.05 < P < 0.10. To test pair wise 
comparisons, post hoc analyses were carried out on the least square means adjusted for 
multiple comparisons using the Tukey-Kramer test. The regression procedure (PROC REG) 
of SAS was used to analyse correlations between relative abundance of mammary SCD 
mRNA and the various desaturase indices calculated from milk FA during the treatment 
period, and to analyse correlations between milk trans-10, cis-12 CLA and milk fat content 
as well as short- and medium-chain fatty acids (SMCFA) in milk. 
 
Results 
 
Diet Composition, Intake and Milk Yield 
The formulation of the different diets resulted in expected high concentrations of C18:1 
cis-9, C18:2 cis-9,12 and C18:3 cis-9,12,15 in the RO, SO and LO diet, respectively, with 
the MIX diet in between (Table 2). Total DMI was 20.6, 19.9, 20.0 and 20.2 kg/d for diets 
RO, SO, LO and MIX, respectively, but could not be statistically evaluated since intake 
was not determined per individual animal. Average milk yield was 28.8 (SEM 3.0) kg/d 
and did not differ (P = 0.99) among the four dietary treatments. In addition, the four 
treatments did not differ in concentration as well as yield of milk fat (P = 0.19 and P = 
0.42, respectively), protein (P = 0.36 and P = 0.88, respectively) and lactose (P = 0.17 and 
P = 0.96, respectively). Mean milk fat, protein and lactose contents were 3.59 (SEM 0.26), 
3.51 (SEM 0.13) and 4.40 (SEM 0.07) %, respectively. Calculated energy balance was 
positive during days of milk sampling. 
 
Fatty Acid Composition of Blood Plasma 
The main FA identified in blood plasma were C18:2 cis-9,12 (mean 29.4 g/100g FA), 
C18:0 (mean 15.9 g/100g FA), C18:1 cis-9 (mean 9.0 g/100g FA), C16:0 (mean 9.0 g/100g 
FA) and C18:3 cis-9,12,15 (mean 5.6 g/100g FA). Feeding the RO diet resulted in an 
elevated blood plasma fraction of C16:0, C16:1 cis-9 and C18:1 cis-9 (Table 3). Cows fed 
the LO diet had higher plasma proportions of C18:3 cis-9,12,15 compared with the other 
diets, and higher plasma proportions of C18:2 trans-11, cis-15 compared with RO and SO.  
 
Mammary SCD1 and SCD5 Expression 
Figure 1 shows the results from analysis of SCD1 (a) and SCD5 (b) mRNA expression 
in the mammary gland using quantitative RT-PCR. Cows fed the SO diet showed a 
significantly reduced mammary SCD1 expression, expressed as fold change compared to 
the corresponding control (0.45), compared with the RO (1.00) and LO diet (1.12; SEM = 
0.14; P = 0.01). The SCD1 expression of cows fed the MIX diet (0.70) was in between the  
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Table 3. Blood plasma fatty acid composition (g/100 g fatty acids) of cows fed the post-
trial diet (POST) or the treatment diets supplemented with either: rapeseed oil (RO), 
soybean oil (SO), linseed oil (LO), or a mixture of these three oils (MIX). For the four 
dietary treatments n = 7, and for POST n = 28. 
  Dietary treatments   
Fatty acid POST1 RO SO LO MIX SEM P-value2 
C4-C12 ND3 ND ND ND ND - - 
C13:0 0.03 0.04 0.04 0.04 0.05 0.008 0.83 
Iso-C13:0  ND ND ND ND ND - - 
Anteiso-C13:0  0.13 0.07 0.09 0.08 0.05 0.013 0.21 
C14:0 0.68 0.61 0.51 0.57 0.56 0.041 0.29 
Iso-C14:0  0.09 0.09 0.10 0.12 0.12 0.018 0.66 
C14:1 cis(c)-9 ND ND ND ND ND - - 
C15:0 0.49 0.52 0.49 0.53 0.43 0.050 0.52 
Iso-C15:0  0.35 0.33 0.35 0.37 0.33 0.031 0.67 
Anteiso-C15:0  0.59 0.52a 0.40ab 0.52a 0.37b 0.037 0.01 
C16:0 9.38 9.83a 9.04b 8.44b 8.90b 0.188 <0.001 
Iso-C16:0  0.22 0.16 0.20 0.20 0.18 0.013 0.11 
C16:1 c9 1.08 1.29a 0.91b 1.03b 0.98b 0.060 <0.001 
C17:0 0.63 0.67 0.63 0.62 0.64 0.026 0.45 
Iso-C17:0  0.43 0.39a 0.28b 0.31ab 0.25b 0.024   0.002 
Anteiso-C17:0  0.15 0.17 0.12 0.13 0.18 0.022 0.15 
C17:1 c9 0.25 0.27 0.19 0.20 0.20 0.023 0.07 
C18:0 15.36 15.69 16.02 16.00 16.24 0.470 0.86 
C18:1 c9 8.09 11.28a 7.74b 8.69b 8.29b 0.418 <0.001 
C18:1 c11 0.42 0.71a 0.49b 0.54ab 0.66ab 0.053 0.02 
C18:1 c12 0.86 0.71b 1.07a 1.10a 0.86ab 0.086 0.01 
C18:1 c13 0.06 0.07 0.04 0.06 0.09 0.012 0.11 
C18:1 c15 0.17 0.16 0.17 0.20 0.21 0.018 0.24 
C18:1 trans(t)-4 0.04 0.04 0.05 0.04 0.03 0.009 0.47 
C18:1 t5 0.02 0.03 0.04 0.03 0.03 0.005 0.31 
C18:1 t6-8 0.09 0.15 0.15 0.14 0.15 0.019 0.93 
C18:1 t9 0.11 0.18ab 0.17ab 0.16b 0.23a 0.016 0.05 
C18:1 t10+t11 0.63 1.14 1.27 1.16 1.64 0.214 0.33 
C18:1 t12 0.20 0.25 0.30 0.31 0.35 0.032 0.19 
C18:1 t13+t14 0.88 0.88 0.77 1.05 1.01 0.084 0.08 
C18:1 t16+c14 0.29 0.24c 0.26bc 0.35a 0.32ab 0.019 <0.001 
C18:2 c9c12 30.30 28.37 32.59 27.09 29.06 1.667 0.11 
C18:2 t11c15 0.08 0.09b 0.08b 0.20a 0.15ab 0.032 0.03 
C18:2 t9t12 0.03 0.04 0.04 0.03 0.04 0.005 0.31 
C18:2 c9t11 CLA 0.11 0.15 0.14 0.15 0.18 0.019 0.51 
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Table 3. Continued. 
  Dietary treatments   
Fatty acid POST1 RO SO LO MIX SEM P-value2 
C18:2 t10c12 CLA 0.07 0.50 0.49 0.59 0.77 0.162 0.60 
C18:3 c9c12c15 7.59 4.68b 4.55b 8.08a 5.24b 0.376 <0.001 
C18:3 c6c9c12 0.78 0.59 0.56 0.46 0.37 0.060 0.05 
C20:0 0.06 0.07 0.07 0.06 0.07 0.008 0.58 
C20:1 c11 0.07 0.07b 0.07b 0.14a 0.09b 0.009 <0.001 
C20:2 c11c14 0.09 0.11 0.10 0.09 0.10 0.009 0.43 
C20:3 n-3 0.03 0.04 0.05 0.05 0.05 0.007 0.65 
C20:3 n-6 2.10 1.83 1.63 1.67 1.55 0.135 0.48 
C20:4 n-6 1.94 1.87 1.73 1.54 1.56 0.131 0.24 
C20:5 n-3 0.99 0.72 0.72 0.85 0.72 0.050 0.20 
C22:0 0.05 0.07 0.06 0.07 0.05 0.015 0.64 
C22:1 c13 0.04 0.03 0.04 0.03 0.03 0.006 0.90 
C22:2 c13c16 0.03 0.03 0.03 0.03 0.03 0.004 0.48 
C22:4 n-6 0.87 1.59 1.87 1.77 1.77 0.326 0.93 
C22:5 n-3 0.88 0.88 0.79 0.79 0.89 0.076 0.62 
C22:6 n-3 0.59 1.00 1.13 1.12 1.05 0.239 0.97 
C23:0 0.05 0.06 0.06 0.06 0.06 0.010 0.97 
C24:0 0.06 0.06 0.07 0.07 0.06 0.008 0.52 
C24:1 c15 0.03 0.06 0.05 0.04 0.05 0.011 0.76 
Unidentified 11.46 10.62 11.18 12.05 12.72 1.382 0.70 
        
SFA4 28.76 29.35 28.55 28.17 28.53 0.457 0.30 
MUFA5 13.31 17.54a 13.80b 15.28ab 15.22ab 0.641   0.002 
PUFA6 46.47 42.49 46.48 44.50 43.53 1.500 0.22 
        
OBCFA7 3.37 3.23 2.91 3.13 2.80 0.125 0.07 
TFA8 2.53 3.69 3.77 4.21 4.90 0.369 0.10 
a,b,c,d
 Means within a row without common superscript differ (P < 0.05). 
1
 Values are shown for comparison only and were not included in the statistical analysis. 
2
 Effect of treatment. 
3
 ND = not detected. 
4
 Saturated fatty acids ∑ (C13:0, iso-C13:0, anteiso-C13:0, C14:0, iso-C14:0, C15:0, iso-
C15:0, anteiso-C15:0, C16:0, iso-C16:0, C17:0, iso-C17:0, anteiso-C17:0, C18:0, C20:0, 
C22:0, C23:0, C24:0). 
5
 Mono-unsaturated fatty acids ∑ (C16:1 c9, C17:1 c9, C18:1 c9, C18:1 c11, C18:1 c12, 
C18:1 c13, C18:1 c15, C18:1 t4, C18:1 t5, C18:1 t6-8, C18:1 t9, C18:1 t10+t11, C18:1 
t12, C18:1 t13+t14, C18:1 t16+c14, C20:1 c11, C22:1 c13, C24:1 c15). 
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Table 3. Continued. 
6
 Poly-unsaturated fatty acids ∑ (C18:2 c9c12, C18:2 t11c15, C18:2 t9t12, C18:2 c9t11 
CLA, C18:2 t10c12 CLA, C18:3 c9c12c15, C18:3 c6c9c12, C20:2 c11c14, C20:3 n-3, 
C20:3 n-6, C20:4 n-6, C20:5 n-3, C22:2 c13c16, C22:4 n-6, C22:5 n-3, C22:6 n-3). 
7
 Odd- and branched-chain fatty acids ∑ (C13:0, iso-C13:0, anteiso-C13:0, iso-C14:0, 
C15:0, iso-C15:0, anteiso-C15:0, iso-C16:0, C17:0, iso-C17:0, anteiso-C17:0, C17:1 c9). 
8
 Trans fatty acids ∑ (C18:1 t4, C18:1 t5, C18:1 t6-8, C18:1 t9, C18:1 t10+t11, C18:1 t12, 
C18:1 t13+14, C18:1 t16+c14, C18:2 t11c15, C18:2 t9t12, C18:2 c9t11 CLA, C18:2 
t10c12 CLA). 
 
 
other diets and did not differ (P = 0.44) from those diets. Mammary SCD5 expression did 
not differ (P = 0.12) among the four dietary treatments. The average mRNA abundance of 
SCD1 (1686 ± 174 pg/µl) was substantially higher than that of SCD5 (0.766 ± 0.088 pg/µl).  
 
Fatty Acid Composition of Milk 
The effects of diet on milk FA composition are presented in Table 4. Compared with 
LO, cows fed the MIX diet had lower proportions of C6:0 in milk fat. The C16:0 fraction in 
milk fat was higher for RO compared with LO and MIX. Compared with the RO and MIX 
diet, cows fed the SO diet had a higher proportion of C18:0 in milk fat. The RO diet did not 
result in a significantly higher proportion of C18:1 cis-9. The SO treatment did result in 
increased proportions of C18:2 cis-9,12 in milk fat compared with RO and LO. Compared 
with the other treatments, C18:3 cis-9,12,15 was increased for the LO diet. In addition, 
C18:2 trans-11, cis-15 was increased for LO compared with RO and SO.  
The proportion of long-chain FA (LCFA) in milk fat was higher for MIX, compared 
with RO. The SO treatment resulted in less odd- and branched-chain fatty acids (OBCFA) 
in the milk fat compared with RO, primarily due to the lower proportion of C13:0 and 
C15:0 for SO. Total SFA was significantly lower for MIX compared with RO and SO, and 
total PUFA was higher for LO and MIX compared with RO. Total TFA tended to be higher 
for MIX compared with RO (P = 0.09).  
The four calculated desaturation indices from milk FA all showed the same tendency, 
with numerically the lowest values for SO and the highest values for MIX. For the 
desaturation indices of C16 and C18, the values for SO were significantly lower compared 
with the MIX diet. The r2 between the different desaturation indices ranged from 0.66 to 
0.82. 
 
Correlation between Desaturation Indices and SCD1 and SCD5 Expression 
Figure 2a shows the correlation between the C14 desaturation index, calculated from 
milk FA, and mammary SCD1 expression of the cows during the treatment period (C14 
index = 0.086 (± 0.007) + 0.058 (± 0.017) x SCD1 expression; r2 = 0.35; P = 0.002).  
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Table 4. Milk fatty acid composition (g/100 g fatty acids) of cows fed the post-trial diet 
(POST) or the treatment diets supplemented with either: rapeseed oil (RO), soybean oil 
(SO), linseed oil (LO), or a mixture of these three oils (MIX). For the four dietary 
treatments n = 7, and for POST n = 28. 
  Dietary treatments   
Fatty acid POST1 RO SO LO MIX SEM P-value2 
C4:0 2.72 2.52 2.57 2.48 1.94 0.264 0.32 
C6:0 2.13 1.80ab 1.86ab 1.93a 1.33b 0.152 0.04 
C8:0 1.42 1.14 1.12 1.22 0.86 0.103 0.10 
C10:0 3.16 2.49 2.36 2.65 1.96 0.219 0.18 
C11:0 0.45 0.35 0.28 0.35 0.26 0.030 0.08 
C12:0 3.91 3.17 2.84 3.27 2.88 0.213 0.42 
C13:0 0.22 0.20a 0.13b 0.18ab 0.17ab 0.014 0.01 
Iso-C13:0 0.03 0.02b 0.03ab 0.05a 0.02ab 0.007 0.02 
Anteiso-C13:0  0.12 0.09 0.07 0.10 0.09 0.008 0.06 
C14:0 11.43 10.46 10.20 10.54 9.67 0.368 0.36 
Iso-C14:0 0.08 0.06b 0.09a 0.09ab 0.06b 0.007 0.01 
C14:1 cis(c)-9 1.33 1.37 1.02 1.20 1.43 0.124 0.11 
C15:0 1.08 1.15a 0.82b 0.95b 0.95b 0.049 <0.001 
Iso-C15:0 0.22 0.20b 0.23a 0.22ab 0.19b 0.009 0.01 
Anteiso-C15:0  0.50 0.48 0.44 0.47 0.47 0.016 0.32 
C16:0 29.36 27.58a 26.56ab 23.84c 25.11bc 0.584 <0.001 
Iso-C16:0  0.19 0.15b 0.18a 0.16ab 0.18a 0.009 0.01 
C16:1 c9 1.90 2.12 1.64 1.81 2.24 0.183 0.11 
C17:0 0.62 0.61 0.54 0.60 0.57 0.017 0.05 
Iso-C17:0  0.17 0.16 0.15 0.15 0.17 0.012 0.65 
Anteiso-C17:0  0.24 0.08 0.12 0.12 0.10 0.015 0.42 
C17:1 c9 0.19 0.22 0.17 0.19 0.22 0.018 0.13 
C18:0 9.10 8.75b 10.91a 9.71ab 8.90b 0.506 0.02 
C18:1 c9 19.12 21.31 21.21 21.30 22.65 0.951 0.67 
C18:1 c11 0.33 0.71ab 0.46c 0.56bc 0.76a 0.050   0.001 
C18:1 c12 0.36 0.32b 0.62a 0.48ab 0.48ab 0.051   0.004 
C18:1 c13 0.08 0.11 0.09 0.11 0.13 0.009 0.05 
C18:1 c15 0.26 0.25b 0.24b 0.50a 0.35b 0.037 <0.001 
C18:1 trans(t)-4 0.01 0.03 0.04 0.04 0.03 0.004 0.64 
C18:1 t5 0.01 0.03 0.03 0.03 0.03 0.007 0.97 
C18:1 t6-8 0.30 0.57 0.49 0.53 0.64 0.042 0.10 
C18:1 t9 0.18 0.40 0.35 0.36 0.47 0.031 0.06 
C18:1 t10+t11 1.62 3.34 3.54 3.36 4.64 0.491 0.22 
C18:1 t12 0.44 0.53b 0.59ab 0.64a 0.65a 0.025 0.01 
C18:1 t13+t14 0.35 0.95 0.97 1.39 1.35 0.207 0.29 
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Table 4. Continued. 
  Dietary treatments   
Fatty acid POST1 RO SO LO MIX SEM P-value2 
C18:1 t16+c14 0.54 0.46c 0.52c 0.68a 0.60b 0.016 <0.001 
C18:2 c9c12 1.49 1.49b 1.90a 1.47b 1.89a 0.073 <0.001 
C18:2 t11c15 0.21 0.21b 0.20b 0.66a 0.43ab 0.074 <0.001 
C18:2 t9t12 0.01 0.01 0.01 0.04 0.04 0.010 0.11 
C18:2 c9t11 CLA 0.63 0.91 1.07 1.05 1.15 0.095 0.36 
C18:2 t10c12 CLA 0.01 0.02 0.02 0.02 0.03 0.004 0.38 
C18:3 c9c12c15  0.55 0.35c 0.45bc 0.66a 0.54b 0.026 <0.001 
C18:3 c6c9c12  0.02 0.01 0.02 0.02 0.02 0.004 0.45 
C20:0 0.12 0.12 0.14 0.11 0.12 0.007 0.09 
C20:1 c11 0.04 0.06ab 0.04b 0.06ab 0.07a 0.006 0.03 
C20:2 c11c14 0.02 0.02 0.02 0.03 0.02 0.006 0.30 
C20:3 n-3 0.01 0.01 0.01 0.02 0.01 0.005 0.14 
C20:3 n-6  0.07 0.05 0.06 0.06 0.05 0.005 0.79 
C20:4 n-6  0.10 0.09 0.09 0.08 0.08 0.006 0.60 
C20:5 n-3  0.05 0.03 0.04 0.04 0.04 0.005 0.56 
C22:0 0.05 0.05 0.06 0.05 0.05 0.003 0.12 
C22:1 c13 0.01 0.01 0.01 0.02 0.01 0.004 0.49 
C22:2 c13c16 0.05 0.02b 0.03ab 0.04a 0.03b 0.004 0.01 
C22:4 n-6 0.02 0.02 0.02 0.04 0.01 0.006 0.05 
C22:5 n-3 0.08 0.07ab 0.07ab 0.08a 0.06b 0.006 0.04 
C22:6 n-3  0.01 0.01 0.01 0.02 0.01 0.006 0.29 
C23:0 0.02 0.01 0.02 0.03 0.02 0.005 0.16 
C24:0 0.04 0.03b 0.04ab 0.06a 0.03b 0.005   0.001 
C24:1 c15 0.01 0.01 0.01 0.02 0.01 0.005 0.30 
Unidentified 2.24 2.23b 2.17b 3.06a 2.74a 0.101 <0.001 
        
SMCFA3  26.09 22.95 21.99 23.28 20.07 1.081 0.18 
C16 FA4 31.26 29.70a 28.20a 25.65b 27.35ab 0.651   0.002 
LCFA5 36.32 41.35b 44.39ab 44.38ab 46.37a 1.122 0.03 
OBCFA6 4.08 3.78a 3.26b 3.62ab 3.47ab 0.105 0.01 
        
SFA7 67.35 61.68a 61.78a 59.31ab 56.11b 1.493 0.04 
MUFA8 27.09 32.78 32.04 33.29 36.75 1.295 0.08 
PUFA9 3.33 3.31b 4.01ab 4.34a 4.40a 0.201   0.003 
        
TFA10 4.31 7.45 7.82 8.80 10.04 0.735 0.09 
 
 
Chapter 2 
 
24 
Table 4. Continued. 
  Dietary treatments   
Fatty acid POST1 RO SO LO MIX SEM P-value2 
∆9-desaturase indices11 
   C14:1 c9  0.11 0.12 0.09 0.10 0.13 0.012 0.11 
   C16:1 c9  0.07 0.07ab 0.05b 0.07ab 0.08a 0.006 0.02 
   C17:1 c9 0.25 0.26 0.23 0.24 0.28 0.016 0.18 
   C18:1 c9 0.69 0.71ab 0.66b 0.69ab 0.72a 0.014 0.04 
a,b,c,d
 Means within a row without common superscript differ (P < 0.05). 
1
 Values are shown for comparison only and were not included in the statistical analysis. 
2
 Effect of treatment. 
3
 Short- and medium-chain fatty acids ∑ (C4:0, C6:0, C8:0, C10:0, C12:0, C14:0, C14:1 
c9). 
4
 C16 fatty acids ∑ (C16:0, C16:1 c9). 
5
 Long-chain fatty acids ∑ (fatty acids with 18 carbons or more). 
6
 Odd- and branched-chain fatty acids ∑ (C11:0, C13:0, iso-C13:0, anteiso-C13:0, iso-
C14:0, C15:0, iso-C15:0, anteiso-C15:0, iso-C16:0, C17:0, iso-C17:0, anteiso-C17:0, 
C17:1 c9). 
7
 Saturated fatty acids ∑ (C4:0, C6:0, C8:0, C10:0, C11:0, C12:0, C13:0, iso-C13:0, 
anteiso-C13:0, C14:0, iso-C14:0, C15:0, iso-C15:0, anteiso-C15:0, C16:0, iso-C16:0, 
C17:0, iso-C17:0, anteiso-C17:0, C18:0, C20:0, C22:0, C23:0, C24:0). 
8
 Mono-unsaturated fatty acids ∑ (C14:1 c9, C16:1 c9, C17:1 c9, C18:1 c9, C18:1 c11, 
C18:1 c12, C18:1 c13, C18:1 c15, C18:1 t4, C18:1 t5, C18:1 t6-8, C18:1 t9, C18:1 
t10+t11, C18:1 t12, C18:1 t13+t14, C18:1 t16+c14, C20:1 c11, C22:1 c13, C24:1 c15). 
9
 Poly-unsaturated fatty acids ∑ (C18:2 c9c12, C18:2 t11c15, C18:2 t9t12, C18:2 c9t11 
CLA, C18:2 t10c12 CLA, C18:3 c9c12c15, C18:3 c6c9c12, C20:2 c11c14, C20:3 n-3, 
C20:3 n-6, C20:4 n-6, C20:5 n-3, C22:2 c13c16, C22:4 n-6, C22:5 n-3, C22:6 n-3). 
10
 Trans fatty acids ∑ (C18:1 t4, C18:1 t5, C18:1 t6-8, C18:1 t9, C18:1 t10+t11, C18:1 t12, 
C18:1 t13+14, C18:1 t16+c14, C18:2 t11c15, C18:2 t9t12, C18:2 c9t11 CLA, C18:2 
t10c12 CLA). 
11
 ∆9-desaturase indices are calculated as: ∆9-desaturase product divided by the sum of the 
∆9-desaturase product and substrate. 
 
The r2 values of the correlation between mammary SCD1 expression and the other three 
desaturation indices were: 0.35 (P = 0.002), 0.25 (P = 0.01) and 0.39 (P = 0.001) for the 
C16, C17 and C18 index, respectively. Figure 2b shows the correlation between the C14 
desaturation index and mammary SCD5 expression of the cows during the treatment period 
(C14 index = 0.102 (± 0.009) + 0.016 (± 0.028) x SCD5 expression; r2 = 0.02; P = 0.57). 
The r2 values of the correlation between mammary SCD5 expression and the other three 
desaturation indices were: 0.01 (P = 0.69), 0.02 (P = 0.56) and 0.01 (P = 0.57) for the C16, 
C17 and C18 index, respectively. 
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Discussion 
 
The aim of this study was to compare the effects of different unprotected dietary 
unsaturated FA on the expression of SCD1 and SCD5 in the mammary gland of dairy cows. 
Therefore, we supplemented the diets of lactating cows with either rapeseed oil, soybean oil 
or linseed oil for a period of 3 weeks in order to increase the flow of C18:1 cis-9, C18:2 cis-
9,12 and C18:3 cis-9,12,15 to the mammary gland, respectively. The blood plasma 
proportion of these three FA was indeed primarily related to their supply with the diet. 
Addition of unprotected rapeseed oil and linseed oil resulted in a significant higher blood 
plasma proportion of C18:1 cis-9 and C18:3 cis-9,12,15, respectively. Supplementation 
with unprotected soybean oil did not significantly increase the proportion of C18:2 cis-9,12 
in blood plasma. This is probably due to the fact that C18:2 cis-9,12 is the most abundant 
FA in blood plasma (approximately 30% of total FA) and shows considerable variation. 
Although the proportion of C18:2 cis-9,12 in blood plasma for SO was not significantly 
different, the proportion of C18:2 cis-9,12 in milk fat was significantly higher for SO 
compared with RO and LO. This indicates that the uptake of C18:2 cis-9,12 by the 
mammary gland was higher for SO compared with RO and LO. Differential uptake of FA 
by the mammary gland could be the result of changes in the FA composition of the 
different lipid fractions present in blood plasma. In this study, the total lipid fraction in 
blood plasma was analysed, which includes cholesterol esters, phospholipids, 
triacylglycerols and non-esterified FA. Since C18:2 cis-9,12 and C18:3 cis-9,12,15 are 
preferably incorporated in plasma cholesterol esters and phospholipids whereas the bovine 
mammary gland primarily extracts FA from the triacylglycerols and non-esterified FA 
fractions in blood plasma (Loor et al., 2002), the transfer efficiency of these PUFAs from 
diet to milk is generally low in dairy cows.  
Since the different unsaturated FA sources were added to the diet as unprotected oils, 
there was most likely an increase in ruminal biohydrogenation intermediates, as indicated 
by the rather high TFA isomer levels in milk. Some of these TFA can affect expression of 
several genes involved in lipid metabolism in the mammary gland. The trans-10, cis-12 
CLA isomer has been identified as one of the major ruminal biohydrogenation 
intermediates, responsible for the inhibition of milk fat synthesis in dairy cows (Baumgard 
et al., 2002). Studies on the mechanisms involved in the inhibition of milk fat synthesis 
revealed a coordinated down-regulation of mammary gene expression of rate-limiting 
lipogenic enzymes, including lipoprotein lipase (LPL), acetyl-CoA carboxylase (ACC), 
fatty acid synthase (FAS) and SCD, following abomasal trans-10, cis-12 CLA infusion 
(Baumgard et al., 2002; Harvatine & Bauman, 2006) or diet-induced MFD (Peterson et al., 
2003; Harvatine & Bauman, 2006). This inhibitory effect has been linked to a reduced 
expression of transcription factor SREBP-1 and proteins involved in the activation and 
distribution of SREBP-1 towards the nucleus (Harvatine & Bauman, 2006). Indeed, milk 
trans-10, cis-12 CLA in our study was negatively correlated with milk fat content (r2 = 
0.54; P < 0.001) and proportion of milk SMCFA (r2 = 0.43; P < 0.001). However, the 
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amount of trans-10, cis-12 CLA in milk fat did not correlate with SCD1 mRNA expression 
(r2 = 0.001; P = 0.88) or with that of SCD5 (r2 = 0.009; P = 0.48). Abomasal infusion with 
high doses of trans-10, cis-12 CLA, causing severe MFD, generally reduces desaturation 
indices serving as a proxy for SCD activity (Baumgard et al., 2001) and SCD expression 
(Baumgard et al., 2002). However, lower doses of trans-10, cis-12 CLA, causing mild 
MFD, typically do not affect the proxies for SCD activity (Peterson et al., 2002a; de Veth et 
al., 2004; Kay et al., 2007). Taken together, it is likely that in our study the unprotected 
dietary oil supplements did increase trans-10, cis-12 CLA production in the rumen which 
probably inhibited milk fat synthesis to some extent, but this amount was not sufficient to 
significantly affect SCD expression. 
The higher blood plasma proportion of C16:0 and C16:1 cis-9 for the RO diet, most 
likely reflected the higher concentrations of these FA in the RO diet. The higher proportion 
of C18:2 trans-11, cis-15 in blood plasma observed in cows fed the LO diet is in agreement 
with previous studies, demonstrating that C18:2 trans-11, cis-15 is the primary 
biohydrogenation intermediate produced in the rumen from C18:3 cis-9,12,15 (Harfoot & 
Hazlewood, 1988; Loor et al., 2005).  
In our study, cows on the SO diet showed a significant lower SCD1 expression (55% 
reduction) in the mammary gland, compared to the cows that received the RO or LO diet. 
In rodents, PUFA supplementation, especially of the n-3 and n-6 series, results in 
suppression of hepatic SCD1 expression, while SFA and MUFA have no or little effect 
(Ntambi, 1999). Moreover, Singh et al. (2004) found that dietary supplementation of 
safflower oil, high in C18:2 cis-9,12, decreased both SCD1 mRNA levels and total SCD 
activity in the mammary gland of lactating mice. In goats however, Bernard et al. (2005b) 
reported that dietary soybean supplementation (± 23 g C18:2 cis-9,12 /kg DM) decreased 
SCD1 expression in subcutaneous adipose tissue, but not in the mammary gland, indicating 
that the mammary gland might be less sensitive to dietary manipulation by PUFA 
compared to subcutaneous adipose tissue. In addition, it was shown by Murrieta et al. 
(2006) that feeding high-linoleate safflower seeds (± 18 g C18:2 cis-9,12 /kg DM) to 
lactating beef cows did not affect SCD1 mRNA abundance in the mammary gland.  
Contrary to SO, we found no differences in mammary SCD1 mRNA levels between 
cows receiving the RO, LO or MIX diet. This is in agreement with Delbecchi et al. (2001), 
who found no differences in mammary SCD1 expression in dairy cows in response to 
dietary supplementation of protected or unprotected canola oil (± 38 g C18:1 cis-9 /kg 
DM). Moreover, data from Enjalbert et al. (1998) showed no significant effect on 
mammary gland desaturation rate of C18:0 in lactating Holstein cows, when C18:1 cis-9 
was duodenally infused. In goats however, dietary supplementation with oleic sunflower oil 
or formaldehyde-treated linseed both reduced SCD1 expression in the mammary gland (P = 
0.07 and P < 0.05 respectively; Bernard et al., 2005a). These inconsistent results could be 
due to species-specific differences in the regulation of SCD1 gene expression, or because 
we used a lower level of FA supplementation (12 g C18:1 cis-9 /kg DM or 12 g C18:3 cis-
9,12,15 /kg DM in our study versus 30 g C18:1 cis-9 /kg DM or 25 g C18:3 cis-9,12,15 /kg 
DM in the study of Bernard et al. (2005a)).  
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a) 
 
b) 
 
 
Figure 1. Patterns of mammary SCD1 (a) as well as SCD5 (b) mRNA expression in cows 
fed diets supplemented with either: rapeseed oil (RO), soybean oil (SO), linseed oil (LO), 
or a mixture of these three oils (MIX). Mammary gene expression was determined with 
Real Time PCR and expressed as fold change compared to the corresponding control 
values. Vertical lines represent the standard error of the mean and treatments without 
common superscript differ (P < 0.05). For SO and LO n=7, and for RO and MIX n=6. 
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a) 
 
b) 
 
 
Figure 2. Correlation between the C14 desaturation index and the relative abundance of 
mammary SCD1 mRNA (a) or SCD5 mRNA (b) of cows in the treatment period (n=24). 
The desaturation indices were calculated from milk fatty acids as: C14:1 cis-9 / (C14:1 cis-
9 + C14:0). For SCD1: the C14 index = 0.086 (± 0.007) + 0.058 (± 0.017) x SCD1 
expression; r2 = 0.35; P = 0.002 and for SDC5 the C14 index = 0.102 (± 0.009) + 0.016 (± 
0.028) x SCD5 expression; r2 = 0.02; P = 0.57.  
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Mammary SCD5 expression did not differ between the four dietary treatments, 
indicating that SCD5 and SCD1 are differently regulated. In line with this, it was 
demonstrated recently that mammary SCD1 mRNA expression tended to be reduced in 
dairy cows by intravenous infusion of trans-10, cis-12 CLA, while there was no effect on 
the expression of mammary SCD5 (Gervais et al., 2009). The knowledge that SCD5 lacks 
N-terminal PEST sequences typically found in SCD1 (Lengi & Corl, 2007), which are 
considered to be a signal for protein degradation (Rechsteiner & Rogers, 1996), may 
suggest that SCD5 exhibits a higher protein stability than SCD1, and that SCD5 might be 
less sensitive to nutritional regulation at the mRNA level than SCD1. This is in accordance 
with our observation that the mRNA abundance for SCD1 was much higher (>103) than 
that for SCD5 in the mammary tissue biopsies. In addition, the fact that SCD5 is 
abundantly expressed in brain, a tissue enriched in PUFA, may suggest that the expression 
of transcripts for SCD5 is less sensitive to PUFA than that for SCD1 (Lengi & Corl, 2007). 
Further studies are needed to provide compelling evidence that SCD1 and SCD5 are 
differentially regulated at their transcriptional and/or protein level in the bovine mammary 
gland.  
The higher proportion of C16:0 in milk fat for the RO diet was most likely caused by 
the somewhat higher proportion of C16:0 in the RO diet. In contrast to our expectations, the 
proportion of C18:1 cis-9 in milk fat was not higher for the RO diet, although the 
proportion of C18:1 cis-9 in blood plasma was significantly higher for RO compared with 
the other diets. A lower SCD activity is not supported by our findings, because mRNA 
levels of SCD1 and SCD5 as well as desaturation indices in milk for the RO diet did not 
differ compared with LO and MIX. Therefore, we suggest that the uptake of C18:1 cis-9 by 
the mammary gland is somewhat low or that the absorbed C18:1 cis-9 is utilized for 
processes other than milk fat synthesis.  
Several pairs of FA that represent a product/substrate relationship for SCD are present 
in milk fat, and are frequently used to estimate in vivo SCD activity within the mammary 
gland. The desaturase indices which are typically used are the C14, C16, C17 and C18 
indices and the cis-9, trans-11 CLA index. The C14 index is considered the best indicator 
of SCD activity, since generally most of the C14:0 present in milk originates from de novo 
FA synthesis in the mammary gland and desaturation of C14:0 is the major source of C14:1 
cis-9 (Peterson et al., 2002b; Lock & Garnsworthy, 2003; Bernard et al., 2008). Indeed, 
blood plasma levels of C14:0 were low (0.6 ± 0.04 g/100 g FA) and C14:1 cis-9 was not 
detected. In contrast, the absorption of various C16 and C18 FA from the duodenum and 
from mobilized adipose tissue can be significant (Glasser et al., 2008), and proportions of 
C16:1 cis-9, C17:1 cis-9, and in particular C18:1 cis-9 in blood plasma FA were 
substantial. Since no distinction between C18:1 trans-10 and trans-11 could be made in our 
study, the cis-9, trans-11 CLA index was not calculated. The SO diet in our study, which 
caused a down-regulation of SCD1 mRNA compared with the other unprotected oil 
supplements, indeed resulted in the lowest values for the C16 and C18 desaturation indices. 
This suggests that the lower SCD1 expression for the SO diet caused a reduction in SCD1 
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activity in the mammary gland. There were positive, although not strong, relationships 
between SCD1 mRNA levels and the four different desaturase indices. Feng et al. (2007) 
reported a significant relationship between the C14 desaturase index and relative abundance 
of SCD mRNA in milk somatic cells from dairy cows, indicating that both produce similar 
estimates of relative SCD activity in the mammary gland. Also in goats, moderate 
relationships were found among SCD mRNA levels, in vitro SCD activity and milk proxy 
ratios for SCD activity (Bernard et al., 2005a). However, there are also some indications 
that desaturase indices do not always reflect actual SCD activity in bovine adipose tissue 
(Archibeque et al., 2005) or in the bovine mammary gland (Bionaz & Loor, 2008b). 
Differences between the mammary SCD mRNA levels and the desaturase indices 
calculated from milk FA could be due to effects at the protein level of SCD, or because 
SCD1 has additional physiological functions like the synthesis of phospholipids (Scaglia & 
Igal, 2005). 
Contrary to SCD1, we found no relationship between SCD5 mRNA abundance and the 
four desaturase indices. Together with the relative low mRNA levels of SCD5, our data 
suggest that the contribution of mammary SCD5 to generate milk ∆9 unsaturated FA is 
relatively small. However, further research on SCD5 is necessary to determine its role in 
∆9 desaturation of milk FA in the bovine mammary gland.  
 
Conclusions 
 
This study showed that mammary SCD1 mRNA expression was significantly down-
regulated in dairy cows by feeding unprotected soybean oil compared with rapeseed oil or 
linseed oil. In addition, SCD5 expression was not significantly affected by the four dietary 
treatments. This inhibitory effect on mammary SCD1 expression by feeding unprotected 
soybean oil was partially reflected by the lower desaturase indices calculated from milk FA. 
Mammary expression of SCD1 transcripts appears to be more sensitive to dietary supply of 
C18:2 cis-9,12 than to C18:1 cis-9 or C18:3 cis-9,12,15. Our data also support the idea that 
SCD1 and SCD5 expression in the bovine mammary gland respond differentially to dietary 
FA. 
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Abstract 
 
The aim of this study was to determine the effects of supplementing unprotected dietary 
unsaturated fatty acids (UFAs) from different plant oils on gene expression in the 
mammary gland of grazing dairy cows. A total of 28 Holstein–Friesian dairy cows in mid-
lactation were blocked according to parity, days in milk, milk yield and fat percentage. The 
cows were then randomly assigned to four UFA sources based on rapeseed, soybean, 
linseed or a mixture of the three oils for 23 days, after which, all 28 cows were switched to 
a control diet for an additional 28 days. On the last day of both periods, mammary gland 
biopsies were taken to study genome-wide differences in gene expression on Affymetrix 
GeneChip® Bovine Genome Arrays (no. 900493) by ServiceXS (Leiden, the Netherlands). 
Supplementation with UFAs resulted in increased milk yield but decreased milk fat and 
protein percentages. Furthermore, the proportion of de novo fatty acids (FAs) in the milk 
was reduced, whereas that of long-chain FAs increased. Applying a statistical cut-off of 
false discovery rate of q-values < 0.05 together with an absolute fold change of 1.3, a total 
of 972 genes were found to be significantly affected through UFA supplementation, 
indicating that large transcriptional adaptations occurred in the mammary gland when 
grazing dairy cows were supplemented with unprotected dietary UFA. Gene sets related to 
cell development and remodelling, apoptosis, nutrient metabolic process, as well as 
immune system response were predominantly downregulated during UFA supplementation. 
Such molecular knowledge on the physiology of the mammary gland might provide the 
basis for further functional research on dairy cows. 
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Introduction 
 
The growing awareness over the last decade of the association between diet and health 
has led nutritional quality to become a relevant factor in consumers’ food choices. A major 
development has been the recognition that certain lipids in dairy milk, such as oleic acid, 
some isomers of the conjugated linoleic acid (CLA) and a-linolenic acid (ALA), can 
improve human health status and prevent diseases (Bauman et al., 2006). Supplementing 
the diet of lactating dairy cows with different unsaturated fatty acids (UFA) is a significant 
attempt to improve milk fat composition for human consumption (Mansbridge & Blake, 
1997; Harvatine & Bauman, 2006). Recently functional genomics studies, based on 
quantitative real-time polymerase chain reaction (qRT-PCR), have described the effects of 
dietary UFA on the expression of a number of candidate genes in the mammary gland 
involved in lipid metabolism (Harvatine & Bauman, 2006; Bauman et al., 2008; Bionaz & 
Loor, 2008a and 2008b; Harvatine et al., 2009; Kadegowda et al., 2009b). There is 
significant evidence that feeding cows with UFA-rich diets reduces the mammary mRNA 
abundance of acetylcoenzyme A (CoA) carboxylase (ACACA), fatty acid synthase 
(FASN), and stearoyl-CoA desaturase 1 (SCD1), as well as the transcription factor sterol 
regulatory element binding factor 1 (SREBP1) and peroxisome proliferator-activated 
receptor-g (PPARG; Bauman et al., 2006; Thering et al., 2009). However, information on 
the genome-wide expression of genes in the mammary gland tissue of dairy cows 
supplemented with different dietary unprotected UFA is still lacking. Therefore, it is not 
known yet whether dietary unprotected UFA supplementation also affects processes not 
related to lipid metabolism and the expression of less obvious genes.  
Although qRT-PCR is a powerful approach to obtain a quantitative and highly precise 
estimates of gene expression; interest in microarray technologies for measuring gene 
expression has exploded in recent years (Sinicropi et al., 2007). The biggest advantage of 
microarray technology is its unbiased approach and the large number of transcripts that can 
be quantified in a single experiment. Microarray studies provide the ability to monitor the 
genome-wide expression of genes and to discover target genes that would not have been 
detected by other more focussed methods (Sinicropi et al., 2007). In addition, they provide 
a holistic view of the molecular events that occur when the mammary gland adapts to 
changes in the supply of dietary lipids, and consequent changes in the milk yield and 
composition through feeding strategies. Therefore, the recent development of microarray 
platforms for bovines in combination with bioinformatics has gained much attention in 
dairy science to discover genes and molecular pathways related to changes in the 
environment and/or phenotypic characteristics. Here, these developments have been used to 
determine the effects of unprotected dietary UFA from different plant oils on the global 
expression pattern of genes in the mammary gland tissue of grazing dairy cows in order to 
improve our understanding of mammary gland physiology.  
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Material and Methods 
 
Animals and Diets 
A total of 28 Holstein-Friesian dairy cows in mid-lactation were blocked according to 
parity (2.4 ± 0.63 births), days in milk (153 ± 32.8 days), milk yield (25.7 ± 1.08 kg/day) 
and milk fat percentage (4.3% ± 0.12%). Cows were then randomly assigned to treatment 
groups based on one of the four dietary treatments (n = 7 per dietary treatment). The dietary 
treatments consisted of a basal diet supplemented with either 2.7% of rapeseed oil, 2.7% of 
soybean oil, 2.7% of linseed oil or 2.7% of a proportional mixture of the three oils on a dry 
matter (DM) basis (Table 1). Rapeseed oil was chosen because it is an oil rich in c9-18:1 
(oleic acid), whereas soybean oil was chosen as an oil rich in c9,c12-18:2 (linoleic acid) 
and the linseed oil as an oil rich in ALA. Overall, the concentration and the different oil 
sources used in the experiment are typically present in dairy cows rations. The oil 
supplements were included in the concentrate, which was fed, together with maize silage 
and grass silage, as a mixed ration (MR; Table 1). Maize silage, grass silage and 
concentrates represented 52%, 12% and 36% of the MR (DM basis). In addition to the MR, 
each cow received 1 kg of a commercial standard concentrate per day through automatic 
feeders in the milking parlor. Cows were fed the MR indoors at night, and were grazed on 
pasture composed of ryegrass (Lolium perenne L.), with approximately 20% white clover 
(Trifolium repens L.) during the day (from 0800 h to 1600 h). The average paddock size 
was 5 ha and the stocking rate was 16 cows/ha. Cows were fed the MR at a level of about 
14.5 kg of DM/cow per day, and grazed at a daily herbage intake of approximately 5.5 kg 
of DM/cow. After the first 23 days (experimental period I), all cows were switched to a 
control diet without oil supplementation for an additional 28 days (experimental period II; 
Tables 1 and 2). This design, in which, each cow got both of the intervention in sequence, 
was chosen because it reduces variability of gene expression between cows due to 
heterogeneity in genetic background, and increases the statistical power to detect 
differential gene expression to a specified Type I error rate. A disadvantage of this design is 
that the effects attributed to UFA supplementation may be confounded with effects due to 
difference (of 28 days) in lactation stage (see Discussion). Cows were milked twice a day in 
the milking parlor at the facility. Each of the four groups of cows was kept indoors in 
separated pens. Individual milk production and MR intake per treatment group were 
recorded daily during both experimental periods. The pasture intake estimation was limited 
by the variation in the sward heights before grazing (at 0800 h) and after grazing (1600 h) 
on the last 3 days of each period, using a rising plate meter (weight: 350 g, diameter: 0.5 m, 
standing pressure ca. 17.5 N/m2; Eijkelkamp, Giesbeek, the Netherlands). Samples of 
individual feedstuffs, including pasture and MR were taken during the last 3 days of the 
experimental periods, and were then analysed for nutrient composition and fatty acid (FA) 
profile. Ingredients of the concentrates and MR are presented in Table 1, whereas chemical 
composition of concentrates and the chemical and FA composition of the MR are presented 
in Table 2. The chemical and FA composition of the pasture are presented in Table S1.  
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Table 1. Ingredients of the experimental diets and the concentrates offered in the mixed 
ration. 
  UFA-enriched treatment 
Item Control 
treatment 
Rapeseed 
oil 
Soybean 
oil 
Linseed 
oil 
Mixture 
1:1:1 
Ingredients in the mixed rations, g/kg 
Maize silage 520.0 520.0 520.0 520.0 520.0 
Grass silage 120.0 120.0 120.0 120.0 120.0 
Concentrate1 360.0 360.0 360.0 360.0 360.0 
Ingredients in the concentrates, g/kg 
Triticale - 333.6 333.6 333.6 333.6 
Rapeseed meal, 
formaldehyde   treated 
- 
 
195.0 
 
195.0 
 
195.0 
 
195.0 
 
Soybean meal - 102.0 102.0 102.0 120.0 
Dried brewers grain - 79.0 79.0 79.0 79.0 
Rapeseed oil - 75.0 - - 25.0 
Soybean oil - - 75.0 - 25.0 
Linseed oil - - - 75.0 25.0 
Rapeseed meal 108.1 68.0 68.0 68.0 68.0 
Citrus pulp 370.0 60.0 60.0 60.0 60.0 
Soybean meal, 
formaldehyde treated 
- 
 
47.0 
 
47.0 
 
47.0 
 
47.0 
 
Palm kernel expeller 227.3 - - - - 
Sugar beet molasses 101.0 - - - - 
Coconut expeller 64.8 - - - - 
Wheat gluten feed 45.0 - - - - 
Wheat middlings 31.0 - - - - 
Soybean hulls 29.3 - - - - 
Protapec2 13.7 - - - - 
Calcium carbonate 2.0 16.3 16.3 16.3 16.3 
   Sodium chloride 2.4 10.5 10.5 10.5 10.5 
Magnesium oxide 90% 3.4 4.8 4.8 4.8 4.8 
Urea - 4.5 4.5 4.5 4.5 
Monocalcium phosphate - 2.3 2.3 2.3 2.3 
Vitamin mineral premix 2.0 2.0 2.0 2.0 2.0 
UFA = unsaturated fatty acids. 
1 Including the concentrate supplied through the automatic feeding station. 
2
 Concentrated potato fruit juice mixed with soybean hulls (Cehave Landbouwbelang, 
Veghel, the Netherlands).  
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Table 2. Chemical composition of the concentrates and chemical and FA composition of 
the mixed rations (MR). 
  UFA-enriched treatment 
Item Control 
treatment 
Rapeseed 
oil 
Soybean 
oil 
Linseed 
oil 
Mixture 
1:1:1 
Chemical composition of  
concentrates (g/kg DM) 
   DM (g/kg) 911.7 891.1 900.5 904.1 901.0 
   Ash 87.6 81.2 79.3 86.1 84.9 
   CP 161.2 246.5 296.5 252.3 242.4 
   Crude fat 55.6 98.0 89.6 93.8 93.9 
   NDF 326.3 179.8 148.4 196.3 185.2 
   ADF 249.0 116.8 110.4 122.9 119.3 
   Starch 35.6 219.8 151.2 172.4 211.7 
   Sugars 120.0 73.0 105.8 87.1 72.3 
Chemical composition of  
MR (g/kg DM) 
     
   DM (g/kg) 560.9 589.4 574.5 573.1 593.6 
   Ash 66.1 66.2 64.3 66.5 67.4 
   CP 132.2 162.8 180.0 164.9 161.4 
   Crude fat 40.5 55.8 52.9 54.3 54.4 
   NDF 356.4 305.9 294.0 310.3 307.7 
   ADF 227.7 187.0 181.3 185.1 188.0 
   Starch 182.4 227.4 214.7 223.4 224.2 
   Sugars 57.4 48.5 55.7 48.7 48.5 
FA composition of MR (g/100g FA)   
   C8:0 1.5 0.3 0.2 0.2 0.3 
   C10:0 1.5 0.3 0.2 0.2 0.3 
   C12:0 16.8 3.6 2.0 1.9 3.8 
   C14:0 6.1 1.7 0.8 0.8 1.5 
   C16:0 13.5 16.7 13.9 10.3 13.3 
   C16:1 cis(c)-9 0.2 1.1 0.2 0.2 0.5 
   C18:0 2.7 4.0 3.3 3.2 3.5 
   C18:1 c9 17.3 30.1 20.3 20.5 23.8 
   C18:1 c11 0.9 2.2 1.3 1.6 1.8 
   C18:2 c9c12 30.6 32.2 47.2 29.3 35.2 
   C18:3 c9c12c15 7.7 6.6 9.3 30.7 14.8 
   C20:0 0.5 0.4 0.5 0.3 0.4 
   C22:0 0.5 0.5 0.5 0.4 0.5 
   C24:0 0.4 0.3 0.3 0.3 0.3 
FA = fatty acid; UFA = unsaturated fatty acids; DM = dry matter.  
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In addition, on the last day of experimental periods I and II, two consecutive milk samples 
(0700 h and 1700 h milking) were obtained and pooled (0.6 : 0.4 ratio). One aliquot was 
stored at 4°C until analysis of fat, protein and lactose percentage, and another aliquot was 
frozen at -20°C until analysis for FA composition by gas chromatography. Fat, protein and 
lactose percentage was determined using mid-infrared spectrometry (International 
Standard Organisation (ISO) 9622, 1999c; Qlip NV, Zutphen, the Netherlands). 
On the last day of both experimental periods, biopsies were carried out before the 
afternoon milking. A core of secretory tissue (750 to 1000 mg) of mammary tissue from 
each cow was obtained by surgical biopsy from the midpoint section of a rear quarter 
according to the method of Farr et al. (1996). The capsular end of the core was deleted to 
reduce the gene expression heterogeneity as a result of its greater amount of connective 
tissue (Farr et al., 1996). Tissue biopsies were snap-frozen in liquid nitrogen and stored at   
-80°C until RNA extraction. 
To prevent local infection, a single intramammary injection of amoxicillin and clavulic 
acid (Avuloxil®; Pfizer Animal Health, Capelle a/d IJssel, the Netherlands) was applied in 
the affected rear quarter. Furthermore, a single intramuscular dose of ceftiofur 
hydrochloride (Excenel®; Pfizer Animal Health, Capelle a/d IJssel, the Netherlands) was 
given immediately after the biopsy. Within 2 h of the biopsy, cows were machine-milked 
and hand-stripped as needed to remove all intramammary blood clots, according to the 
method of Farr et al. (1996). This experiment was conducted at the Cranendonck Research 
Farm, the Netherlands, between September 26 and November 14, 2007, and procedures 
were approved by the Animal Care and Ethics Committee of Wageningen UR Livestock 
Research, Lelystad, the Netherlands. 
 
Chemical Analysis 
Composite samples of feeds from the last 3 days of each experimental period were 
analysed for DM content (ISO 6496, 1999a), ash (ISO 5984, 2002), Kjeldahl N (ISO 5983, 
2005), ADF (Van Soest, 1973) and NDF according to a modified method of Van Soest et 
al. (1991) with additional incubations in a-amylase and protease as described by Goelema 
et al. (1998). Crude fat was determined by Berntrop method with acid hydrolysis (ISO 
6492, 1999b). 
 
Fatty Acid Analysis 
The FA of milk and feedstuffs were extracted with chloroform–methanol (2 : 1, v/v) and 
transesterified to fatty acid methyl esters (FAME) by vortexing with sodium methanolate in 
methanol (30%). Then, FAME were used for gas chromatography analysis (Trace GC 
Ultra,Waltham, MA, USA). Specific details with regard to the analysis of FA in milk and 
feedstuffs are presented in the Supplementary materials. The proportion of de novo 
synthesis of FA was estimated based on the assumption that all FAs from 4-carbon to 14-
carbon and 50% of 16-carbon FAs were synthesised by the mammary gland (Delamaire & 
Guinard-Flament, 2006). In addition, the proportion of long-chain fatty acid (LCFA) was 
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calculated by the sum of 50% 16-carbon and all the 18- to 24-carbon FA (Delamaire & 
Guinard-Flament, 2006).  
 
RNA Isolation, Processing and Microarray Analysis  
Total RNA from mammary gland tissue (50 to 100 mg) was isolated using TRIzol® 
reagent (Invitrogen, Breda, the Netherlands), following the manufacturer’s instructions. The 
RNA purity and concentrations were determined using a NanoDrop ND-1000 
spectrophotometer (Isogen, Maarssen, the Netherlands), and the RNA quality was assessed 
using the BioAnalyzer 2100 (Agilent Technologies, Amsterdam, the Netherlands). The 
RNA was judged as suitable for array hybridization because they showed intact bands 
corresponding to the 18S and 28S ribosomal RNA subunits, displayed no RNA degradation 
products, and presented an average RNA integrity number of 8.32 ± 0.05. The RNA of each 
biopsy was amplified, biotinlabeled and hybridized to single dye Affymetrix GeneChip® 
Bovine Genome Array (no. 900493) by ServiceXS (Leiden, the Netherlands), as described 
in the users’ manual (Affymetrix GeneChip® Expression Analysis Technical Manual, Santa 
Clara, CA, USA). As the factorial design and analysis of the microarray experiment is a 
reliable method to identify the influence of multiple factors on the expression profiles of the 
probe sets in the microarray (Xu & Faisal, 2010), a total of 56 one-color arrays were 
prepared, one array per RNA sample. Briefly, total RNA (2 mg per sample) was reverse 
transcribed to cDNA using a T7-oligo(dT) primer. Following second strand cDNA 
synthesis, the double-stranded cDNA was purified as a template for the subsequent in vitro 
transcription reaction. Linearly amplified biotin-labeled cRNA was synthesised in the 
presence of a biotin-labeled nucleotide analog/RNA mix. The labeled cRNA was purified, 
fragmented and hybridized to the arrays at 45°C for 16 h with constant rotational mixing at 
60 r.p.m. Washing and staining of the arrays was carried out using the Affymetrix 
GeneChip® Fluidics Station 450 (Santa Clara, CA, USA). The arrays were scanned using an 
Affymetrix GeneChip® Scanner 7G (Santa Clara, CA, USA) and Affymetrix GeneChip® 
Operating Software version 1.4, following the GeneChip’s specifications. After scanning, 
the Affymetrix GeneChip Command Console Software automatically acquired and 
analysed image data and computed an intensity value for each probe cell. A number of 
quality control parameters associated with assay and hybridization performance were 
closely monitored. Specific details with regard to these quality control parameters are 
presented in the Supplementary materials. 
 
Validation of Differential Gene Expression by qRT-PCR 
In order to validate microarray analysis, the following four genes measured by 
microarray analysis were confirmed by qRT-PCR: FASN, fatty acid desaturase 1 (FADS1), 
fatty acid desaturase 3 (FADS3) and SCD1. Briefly, reverse transcription of 1 mg of the 
isolated total RNA (see section ‘RNA isolation, processing and microarray analysis’) was 
performed in a 20-ml reaction using Superscript III reverse transcriptase (Invitrogen, Breda, 
the Netherlands), deoxynucleosides (Roche Diagnostics, Almere, the Netherlands) and 
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random hexamer primers (Roche Diagnostics, Almere, the Netherlands) for 1 h at 50°C 
according to the manufacturer’s protocol (Invitrogen, Breda, the Netherlands). Templates 
were amplified after a preincubation for 10 min at 95°C, followed by amplification for 40 
cycles (10 s at 95°C, 5 s at 60°C and 5s at 72°C) on a LightCycler 1.2 Real-Time PCR 
System by using FastStart DNA Master SYBR Green I reagents (Roche Diagnostics, 
Almere, the Netherlands). All reactions revealed a single product as determined by melting 
curve analysis. Quantitative measurement was taken by establishing a linear amplification 
curve from serial dilutions of cDNAs for corresponding genes, and efficiencies of the used 
sets of primers were calculated to be at least 95%. Values were calculated according to the 
comparative threshold cycle method using 18SRNA as the endogenous reference gene. 
 
Microarray Data Analysis 
All microarray analysis including preprocessing, normalization and statistical analysis 
was carried out using Bioconductor packages (version 2.5) in R programming language 
(version 2.11). Data were quality assessed before and after normalization using a number of 
built-in quality control methods implemented in the Bioconductor affycoretools and 
associated packages to identify eventual irregularities of array hybridization, RNA 
degradation and data normalization.  
Arrays were considered to be of sufficient quality when they showed not more than 
10% of specks in Bioconductor’s Fitting Probe Level Model (fitPLM) images, were not 
deviating in RNA degradation and density plots, and were not significantly deviating in 
Normalized Unscaled Standard Errors Plot and in Relative Log Expression plots (data not 
shown). Upon rigorous examination of the resulting diagnostic plots, all 56 microarrays 
were included in further analysis. Affymetrix GeneChip® uses a set of 11 to 20 
oligonucleotide probes, each 25 bases long, to represent a single gene (Gautier et al., 2004). 
The expression level for a single gene is the summary of the data from the entire probe set 
(Gautier et al., 2004). In this study, the expression levels of probe sets were summarized 
using the library GeneChip content-corrected robust multichip average algorithm ( Wu et 
al., 2004), employing the empirical Bayes approach for background correction followed by 
quantile normalization. As many of the original annotations for the Affymetrix GeneChip® 
Bovine have been found to be erroneous (Gautier et al., 2004), a custom chip definition file 
(CDF; Bovine_Bt_REFSEQ version 12.0.0), available at 
http://brainarray.mbni.med.umich.edu/Brainarray/Database/ CustomCDF/12.0.0/refseq.asp 
was used to re-annotate the probes to new probe sets. Therefore, the original probe set 
definitions were discarded and all probes were recomposed into new probe sets by mapping 
each probe via their sequence to unique genes available in Refseq genomics resources. As 
these custom CDFs are based on the latest genomic knowledge, the newly defined probe 
sets perform better, and allow for more reliable comparison of gene expression. In addition, 
as genes are uniquely represented in a custom CDF, bias toward genes represented by 
multiple probe sets is avoided in gene-set enrichment (de Leeuw et al., 2008). This resulted 
in gene expression values for 11,495 known genes with unique identifiers from 24,128 
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transcripts. All microarray experiment data are MIAME (Minimum Information About a 
Microarray Experiment) compliant and has been deposited in gene expression omnibus 
(GEO; http://www.ncbi.nlm.nih.gov/geo/; accession numbers GSE20909). 
 
Statistical Analyses 
Milk yield and composition, as well as FA composition, were analysed using a mixed-
effects ANOVA (release 9.1; Statistical Analysis Software Institute Inc. Cary, NC, USA). 
The model included UFA sources, UFA supplementation (experimental periods), and the 
interaction between UFA sources and UFA supplementation (experimental periods), as 
fixed effects and cow within pen as a random effect. When differences between UFA 
sources were significant (P < 0.05), Tukey’s test was used to compare means. The same 
model was used to analyse gene expression. The mixed-effects ANOVA was chosen 
because when there are more than two conditions to compare, the application of ANOVA 
F-test is much powerful than a t-test (Cui & Churchill, 2003). ANOVA considers the 
variability of the expression levels within and among treatments. If the variability of the 
expression of a gene among treatments is substantially greater than the variability within 
treatments, this indicates that the gene is differentially expressed. Lastly, the mixed-effects 
ANOVA allows to treat the cow as a random effect, which captures variability between 
individual cows within the same condition (Churchill, 2004). Ollier et al. (2009) also 
analysed genome-wide expression in the mammary gland of goats fed with diets differing 
in forage-to-concentrate ratio supplemented or not with lipids by ANOVA, including diet, 
period and animal group effects. However, in our study, the expression of genes in 
mammary gland was not significantly affected by the different dietary unprotected UFA 
sources. Therefore, this statistically insignificant variable and the interaction between UFA 
sources and UFA supplementation (experimental periods) were removed from the model. 
The final statistical model included UFA supplementation (experimental periods) as fixed 
effect and cow as a random effect. The P-values were corrected for multiple testing using a 
false discovery rate (FDR) method, which provides an estimate of the fraction of false 
discoveries among the significant terms (Bunger et al., 2007). The list of differentially 
expressed genes was generated using a FDR < 5% (q-value < 0.05) together with an 
absolute fold change (FC) threshold of 1.3. In addition, three complementary methods were 
applied to relate changes in gene expression to functional changes. One method, provided 
via the ErmineJ software program, was based on overrepresentation of gene ontology (GO) 
terms (Lee et al., 2005). Another approach was the gene-set enrichment analysis (GSEA). 
The GSEA derives its power by focusing on gene sets, that is, groups of genes that share 
common biological functions (e.g. biochemical, metabolic or signal transduction routes), 
chromosomal location or regulation. The GSEA method first calculates an enrichment score 
(ES) that reflects the degree to which a set of genes is overrepresented at the extremes (top 
or bottom) of the entire list of genes. Then after, it estimates the significance level of ES by 
using an empirical phenotype-based permutation test procedure that preserves the complex 
correlation structure of the gene expression data, and lastly there is an adjustment for 
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multiple hypothesis testing (Subramanian et al., 2005). Gene set size filter considered a 
minimum of 15 and a maximum of 500 genes, and the number of permutation was set to 
1000. Gene sets were considered significantly enriched at a FDR < 5%. Normalized 
enriched scores of significantly enriched pathways were calculated. Both applied methods 
have the advantage that it is unbiased, because no gene selection step is used, and a score is 
computed based on all genes in a GO term or gene set. The last method used the Ingenuity 
Pathways Analysis (IPA; version 5.5, Ingenuity Systems, Redwood City, CA, USA) to 
identify the relevant molecular and cellular functions, canonical pathways, biological 
functions and the biological interaction networks among significant genes. For IPA 
analysis, the data set containing gene identifiers and corresponding to an absolute threshold 
of FC of 1.3 and FDR q-values < 0.05 was uploaded into the application. Each identifier 
was mapped to its corresponding gene object in the Ingenuity knowledge base. To study the 
biological interaction networks, genes were overlaid onto a global molecular network 
developed from information contained in the Ingenuity Pathways Knowledge Base. 
Networks of these genes were then algorithmically generated based on their connectivity. 
Network analysis returns a score that ranks networks according to their degree of relevance 
to the network eligible molecules in the data set (Calvano et al., 2005). The network score 
is based on the hypergeometric distribution and is calculated with the right-tailed Fisher’s 
exact test. The score is the negative log of this P-value. A score of 1.3 thus indicates a P-
value of 0.05 and is considered statistically significant. Only those molecules that show 
relationships to other genes, proteins or endogenous chemicals were integrated into the 
analysis. 
 
Results 
 
DM Intake, Milk Production and Composition 
Total estimated MR intake was 12.5 ± 1.50 kg/day when cows were fed with control 
diet and 14.7 ± 1.50 kg/day when cows were supplemented with UFA. Total DM intake 
(DMI) was 15.1, 14.4, 14.5 and 14.7 kg/day for diets enriched with rapeseed oil, soybean 
oil, linseed oil and a proportional mix of them all, respectively, but the differences in DMI 
could not be statistically evaluated as intake was not determined per individual animal. 
Average pasture intake was 5.80 ± 0.5 kg/day for cows fed on control diet and 5.52 ± 0.5 
kg/day for cows fed on UFA-enriched diet. The milk yield was 15% greater (P < 0.05) 
when supplementing dairy cows with UFA (27.6 ± 1.26 kg/day) relative to the same cows 
fed the control diet (23.4 ± 1.26 kg/day), irrespective of the UFA source (P < 0.10). Milk 
fat and protein yield did not differ between treatments (1.00 ± 0.05 and 0.91 ± 0.05 kg/day, 
respectively). Although lactose yield was greater (P < 0.01) for cows fed on UFA-enriched 
diet (1.21 ± 0.04 kg/day) compared with cows fed on control diet (1.02 ± 0.04 kg/day), the 
total milk fat percentage was lower by over 20% (3.59% v. 4.30% ± 0.60%; P < 0.05) and 
protein percentage was lower by over 6% (3.51% v. 3.75% ± 0.41%; P < 0.05) for the same 
comparison. Lactose content was not different among treatments (4.37% ± 0.05%).  
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Table 3. FA profile of milk when comparing dairy cows supplemented with UFA relative 
to the same cows fed a control diet. 
Item (n = 28 cows) Control diet UFA-enriched 
diet 
     s.e P-value1 
De novo FAs (%)2        41.2         35.6     1.03 *** 
LCFA (%)3        50.0         56.1     0.98 *** 
Total trans–FAs (%)           3.33           7.53     0.56 *** 
c9,t11-CLA           0.57           0.99     0.093 *** 
t10,c12-CLA           0.01           0.02     0.003 *** 
FA = fatty acid; UFA = unsaturated fatty acids; LCFA = Long Chain Fatty Acid; CLA = 
Conjugated Linoleic Acid. 
1 P-value = effect of UFA supplementation; *** levels of significance indicate P < 0.001. 
2 De novo FA include all FA from C4 to C14 and 50% of C16 FA. 
3 Long Chain Fatty Acids include all FA with 18 carbon atoms or more. 
 
 
In addition, throughout supplementation of dietary UFA, the proportion of de novo FA 
decreased (P < 0.001), and the proportion of LCFAs and trans-18 FA in the milk increased 
(P < 0.001; Table 3). Further information of dietary effects on milk FA profiles are given in 
the Supplementary materials (Table S2 and Table S3). 
 
Differential Expression of Genes in the Mammary Gland 
We identified a total of 972 genes differentially expressed in the mammary gland tissue 
of cows fed on a diet supplemented with UFA compared with the same cows receiving the 
control diet. The list of differentially expressed genes was generated using a cut-off of FDR 
q-values < 0.05 together with an absolute FC threshold of 1.3 and further refined by 
selecting those probe sets mapping to unique Entrez Gene identifiers. The gene 
identification, symbol and description of these genes are shown in Supplementary material 
(Table S4). Within these 972 genes, 312 upregulated and 660 downregulated genes were 
found when cows were supplemented with UFA compared with when cows were fed the 
control diet. As gene expression was not significantly affected in mammary gland of cows 
fed on diets differing in the sources of dietary unprotected UFA sources, we focused on the 
effect of UFA supplementation (experimental period) on gene expression in the mammary 
gland tissue, instead of the effect of different UFA sources. To validate the microarray gene 
expression data, mammary gland tissue RNA samples were analysed by qRT-PCR for the 
genes FASN, FADS1, FADS3 and SCD1. The qRT-PCR results confirmed the microarray 
expression levels for the selected genes (Supplementary material, Table S5). In addition, 
correlations between qRT-PCR and microarray gene expressions was consistently high, 
with most genes having r2 values > 0.70. 
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Figure 1. Ingenuity Pathways Analysis (IPA) networks detected when comparing dairy 
cows supplemented with unsaturated fatty acid relative to the same cows fed a control diet. 
(a) IPA network 1 included genes involved in cell cycle, cancer, cellular assembly and 
organization and presented a score of 46 and 33 focus genes; (b) IPA network 2 included 
genes involved in cell-mediated immune response, cellular development and amino acid 
metabolism, with a score of 43 and 30 focus genes. The network displayed graphically as 
nodes (gene/gene products) and edges (the biological relationship between nodes). The 
node colour intensity indicates the expression of genes: red upregulated, green 
downregulated in animals supplemented with UFA relative to the same cows fed a control 
diet. The shapes of nodes indicate the functional class of the gene product. The fold value 
and false discovery rate q-values are indicated under each node. 
a) 
b) 
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Figure 1. Ingenuity Pathways Analysis (IPA) networks detected when comparing dairy 
cows supplemented with unsaturated fatty acid relative to the same cows fed a control diet. 
(c) IPA network 3 included genes involved in skeletal and muscular disorders, cell death, 
dermatological disease, with a score of 40 and 28 focus genes; and (d) IPA network 4 
included genes involved in connective tissue development and function, as well as tissue 
morphology and antigen presentation, with a score of 35 and 24 focus genes. The network 
displayed graphically as nodes (gene/gene products) and edges (the biological relationship 
between nodes). The node colour intensity indicates the expression of genes: red 
upregulated, green downregulated in animals supplemented with UFA relative to the same 
cows fed a control diet. The shapes of nodes indicate the functional class of the gene 
product. The fold value and false discovery rate q-values are indicated under each node. 
c) 
d) 
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Functional Clustering of Differential Expressed Genes in the Mammary 
Gland 
To gain insight into the mammary gland tissue processes that were altered during UFA 
supplementation, we tested the list of differentially expressed genes using GO term 
enrichment analysis (Supplementary material; Table S6), GSEA (Supplementary material; 
Table S7) and IPA (Figure 1). One major finding of all these approaches was that UFA 
supplementation mainly reduces expressions of genes involved in cellular growth and 
proliferation, cytoskeleton organization and cellular homeostasis, apoptosis, nutrient 
metabolism, as well as molecular transport and defence response (Figure 2a). Most of the 
genes included in these molecular and cellular functions were downregulated during UFA 
supplementation (Figure 2b). A specific examination of the lipid metabolism IPA molecular 
and cellular function revealed that the SREBP-1 was downregulated during UFA 
supplementation (Table 4). Consequently, the expression of gene sets regulated by SREBP-
1 were also downregulated (Table 4). Interestingly, the canonical signalling pathways 
significantly modulated in the mammary gland tissue of dairy cows fed on diets 
supplemented with UFA relative to the same cows fed on control diet were mainly involved 
in cellular growth, proliferation and development or immune system response 
(Supplementary material; Figure S1). Those pathways associated with cellular growth, 
proliferation and development, included the mammalian target rapamycin (mTOR) 
signalling pathways, the Janus kinases and signal transfers and activators of transcription 
(JAK/STAT) signalling pathways, as well as the granulocyte-macrophage colony-
stimulating factor (GM-CSF) pathway (Supplementary material; Figure S2a). Most of the 
genes included in these canonical pathways were downregulated during UFA 
supplementation (Supplementary material; Figure S2b). In addition, the main canonical 
pathways involved in immune response were related to interleukin (IL) IL-2, IL-3, IL-8 and 
IL-6 signalling, as well as natural killer cell signalling (Supplementary material; Figure 
S3a). Remarkably, most of these canonical pathways included downregulated genes when 
cows were supplemented with UFA compared with when cows were fed with control diet 
(Supplementary material; Figure S3b). The IPA networks with the highest significance 
score (network score >35) are represented in Figure 1a to d. The first network (Figure 1a) 
presented a score of 46 and 33 focus genes. The major node that was identified during UFA 
supplementation: tumor protein P53 (P53), is a key transcription factor associated with 
mammary development in ruminants (Piantoni et al., 2008). The second network (Figure 
1b), having a score of 43 and 30 focus genes, indicated gene clusters centred on the 
serine/threonine-protein phosphatase 2A, and peptidylprolylisomerase. This network 
presents functions related to immune response, cellular development and amino acid 
metabolism. The third IPA network (Figure 1c), having a score of 40 and 28 focus genes, 
centred on Ras. Members of the Ras family of small GTPases function downstream of 
mitogenic growth factor receptors and interact with a number of effectors to regulate cell 
proliferation and survival (Swarbrick et al., 2008). The last network (Figure 1d) involved 
genes associated with connective tissue development and function, as well as tissue  
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Figure 2. (a) Molecular and cellular functions significantly modulated in the mammary 
gland tissue when comparing dairy cows supplemented with unprotected unsaturated fatty 
acids (UFAs) relative to the same cows fed control diet. Statistical significance of pathway 
modulation was calculated via a right-tailed Fisher’s Exact test in Ingenuity Pathway and 
represented as –log (P-value): 2log values exceeding 1.30 were significant false discovery 
rate q-values < 0.05. (b) The downregulated and upregulated genes for each molecular 
pathway are presented. The colour intensity indicates the expression of genes: red 
upregulated, green downregulated in animals supplemented with UFA relative to the same 
cows fed a control diet. 
a) 
b) 
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Table 4. Lipid metabolism genes in mammary gland when comparing dairy cows 
supplemented with UFA relative to the same cows fed a control diet. Lipid metabolism 
genes were identified by Ingenuity Pathways Analysis and they presented an absolute FC 
threshold of 1.3 and a FDR < 5%. 
Enrez ID Symbol Gene title FC1 FDR q-value2 
NM_001046190 ABCD1 ATP-binding cassette, sub-family D, 
member 1 
-1.43 *** 
NM_001034319 ACAA1 acetyl-Coenzyme A acyltransferase 1 -1.31 *** 
NM_174224 ACACA acetyl-coenzyme A carboxylase alpha -2.10 *** 
XM_590080 ACOT4 acyl-CoA thioesterase 1.32 *** 
XM_613318 ACSM3 acyl-CoA synthetase medium-chain 
family member 3 
1.62 ** 
NM_174746 ACSS1 acyl-CoA synthetase short-chain 
family member 1 
-1.37 *** 
NM_001105339 ACSS2 acyl-CoA synthetase short-chain 
family member 2 
-1.48 ** 
NM_001034055 ADIPOR1 Adiponectin receptor 1 -1.36 *** 
NM_177518 AGPAT1 1-acylglycerol-3-phosphate O-
acyltransferase 1  
-1.96 *** 
NM_174233 AGTR1 angiotensin II receptor, type 1 1.36 *** 
NM_173986 AKT1 v-akt murine thymoma viral oncogene 
homolog 1 
-1.99 *** 
NM_001076293 ALOX5AP 5-lipoxygenase activating protein 1.45 *** 
NM_001034523 AP2M1 adaptor-related protein complex 2, 
mu 1 subunit 
-1.64 *** 
NM_174242 APOA1 apolipoprotein A-I 1.37 *** 
NM_173991 APOE apolipoprotein E -1.65 ** 
NM_001040469 C3 Complement 3 -1.72 *** 
NM_174008 CD14 CD14 -1.65 *** 
NM_001001601 CDH5 cadherin 5, type 2  -1.37 *** 
NM_173902 CLU Clusterin -1.49 ** 
XM_876020 CNTFR cystic fibrosis transmembrane 
conductance regulator 
-1.78 *** 
NM_174035 CYBB cytochrome b-245, beta polypeptid 1.39 *** 
NM_001014927 DHCR7 7-dehydrocholesterol reductase -1.36 *** 
NM_174308 EDNRA endothelin receptor type A 1.40 *** 
NM_174537 FCER1G Fc fragment of IgE, high affinity I -1.49 *** 
NM_001076014 FIG4 SAC1 lipid phosphatase domain  1.45 *** 
NM_001034322 FKBP4 FK506 binding protein 4 -1.33 *** 
NM_176608 GHR Growth hormone 1.45 *** 
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Table 4. Continued. 
Enrez ID Symbol Gene title FC1 FDR q-value2 
NM_001034627 GSN Gelsolin (amyloidosis, finnish type) -1.45 *** 
NM_174087 IGF2 insulin-like growth factor 2 -1.31 ** 
XM_869739 IL18BP interleukin [IL]–18–binding protein -1.39 ** 
NM_001077909 INSIG1 insulin induced gene 1 -1.49 *** 
NM_175782 LGALS1 lectin, galactoside-binding, soluble, 1 1.36 *** 
NM_001034768 LGALS4 lectin, galactoside-binding, soluble, 4 -1.62 *** 
NM_001103323 LIPA Lipase A 1.31 ** 
NM_174103_at LIPF lipase, gastric 1.31 *** 
XM_586851 LIPG Lipase G -1.79 *** 
XM_865119 LPIN1 Lipin 1.59 *** 
XM_614220 LRP5 low density lipoprotein receptor-
related protein 5 
-1.76 *** 
NM_180998 LTF lactotransferrin -1.46 *** 
NM_001080362 LYPLA2 lysophospholipase II -1.35 *** 
NM_175793 MAPK1 Mitogen-activated protein kinase 1 -1.59 *** 
XM_001255254 MAPKAPK2 mitogen-activated protein kinase-
activated protein kinase 2 
-1.33 *** 
NM_001033608 MIF Macrophage migration inhibiting 
factor 
-3.61 *** 
NM_001081605 MTMR3 Homo sapiens myotubularin related 
protein 3 
-1.31 *** 
NM_174119 NCF1 Neutrophil Cytosol Factor 1 -1.33 *** 
NM_001014883 NR1H2 nuclear receptor subfamily 1, group 
H, member 2 
-1.57 *** 
NM_001083509 PCCA propionyl Coenzyme A carboxylase, 1.35 *** 
NM_001017953 PDGFB platelet-derived growth factor beta 
polypeptide 
-1.48 *** 
NM_174577 PI4KA phosphatidylinositol 4-kinase -1.53 *** 
NM_174783 PI4KB phosphatidylinositol 4-kinase -1.31 *** 
NM_174560_at PLA2G15 phospholipase A2, group XV 1.31 *** 
NM_001035390 POR P50 cytochrome oxidoreductase -1.36 *** 
NM_001046005 PNPLA2 patatin-like phospholipase domain 
containing protein 2 
-1.52 *** 
NM_174161 PSAP sphingolipid activator protein-1 -1.63 *** 
NM_174791 PTGDS prostaglandin D2 synthase -1.51 ** 
NM_174443 PTGES prostaglandin E synthase -1.67 *** 
NM_001034310 PTTG1 pituitary tumor-transforming 1 1.35 *** 
NM_001100348 PXMP3 peroxisomal membrane protein 3 1.37 *** 
NM_001035081 RAB7A member RAS oncogene family -1.67 *** 
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Table 4. Continued. 
Enrez ID Symbol Gene title FC1 FDR q-value2 
NM_174161 PSAP sphingolipid activator protein-1 -1.63 *** 
NM_174791 PTGDS prostaglandin D2 synthase -1.51 ** 
NM_174443 PTGES prostaglandin E synthase -1.67 *** 
NM_001034310 PTTG1 pituitary tumor-transforming 1 1.35 *** 
NM_001100348 PXMP3 peroxisomal membrane protein 3 1.37 *** 
NM_001035081 RAB7A member RAS oncogene family -1.67 *** 
NM_001076945 SCD5 stearoyl-CoA desaturase 5 1.30 *** 
NM_174598 SCNN1A Socidum channel -2.84 *** 
NM_173882 SERPINA1 serpin peptidase inhibitor, clade A  -1.63 *** 
NM_174821 SERPING1 serpin peptidase inhibitor, clade G  -1.51 *** 
NM_001082443 SIGIRR single immunoglobulin and toll-
interleukin 1 receptor (TIR) domain 
-1.54 *** 
NM_174782 SLC12A2 solute carrier family 12 1.35 *** 
NM_001034041 SNCA synuclein, alpha 1.52 *** 
XM_870939 SPHK1 sphingosine Kinase -1.35 *** 
NM_001099137 SRD5A1 steroid-5-alpha-reductase, alpha 
polypeptide 1 (3-oxo-5 alpha-steroid 
delta 4-dehydrogenase alpha 1) 
-1.48 *** 
NM_001113302 SREBP1 sterol regulatory element binding 
transcription factor 1 
-1.48 *** 
NM_173960 SST somatostatin 1.38 *** 
NM_174617 STAT5B signal transducer and activator of 
transcription 5 
-1.58 *** 
NM_174674 TNFRSF1A tumor necrosis factor receptor 
superfamily, member 1A 
-1.52 *** 
XM_583785 TNFSF10 tumor necrosis factor (ligand) 
superfamily, member 10 
-1.82 *** 
NM_174703 TNXB tenascin XB -1.41 ** 
NM_174201 TP53 tumor protein p53 -1.48 *** 
NM_175776 TSPO translocator protein -1.38 *** 
UFA = unsaturated fatty acid; FC = fold change; FDR = false discovery rate; CoA = 
coenzyme A. 
1 FCs were calculated considering gene expression when cows were fed with UFA-enriched 
diet compared with the same cows fed control diet. 
2 FDR q-value = effect of UFA supplementation. 
**, *** levels of significance indicate P < 0.01 and P < 0.001, respectively.  
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morphology and antigen presentation, with a score of 35 and 24 focus genes. Figure 1d 
shows how UFA supplementation could be related to genes that modulate the nuclear factor 
kappa-light-chain-enhancer of activated B cells (NFkB), which is a transcription regulator 
of genes encoding cytokines, cytokine receptors and cell adhesion molecules that drive 
immune and inflammatory responses (Sigal, 2006). 
 
Discussion 
 
Milk Production and Composition 
Our study suggests that supplementing grazing dairy cows with different unprotected 
UFA sources increases the milk yield by 15%. This is in agreement with the study of Bu et 
al. (2007), who reported that supplementing basal diet with either 4.0% soybean oil, 4.0% 
linseed oil or 2.0% soybean oil and 2.0% linseed oil, resulted in a milk yield increase of 
16.7% compared with the control treatment. The greater energy density, protein content and 
starch content in the enriched-UFA diet could have increased the availability of glucose 
precursors for lactose synthesis in the mammary gland. This, followed by the reduced NDF 
content, probably stimulated milk production. However, because the control period was 
conducted 28 days after UFA supplementation, the effects attributed to diet supplemented 
with UFA may be confounded with effects due to a difference of 28 days in lactation stage. 
Therefore, isolation of the specific effects of UFA supplementation on milk production and 
composition may be complex and challenging to draw clear conclusions.  
The reduction in milk fat and protein percentage in cows fed with UFA supplementation 
most likely resulted from a dilution effect. However, the decreased milk fat and protein 
contents, without modifications in lactose content, were coupled with the decreased 
expression of genes associated with the transport processes of nutrients, and with the 
reduction of fat, and protein metabolism (see section ‘Effects of UFA supplementation on 
nutrient metabolism’). Therefore, these results suggested that the modification of milk 
components cannot be only accounted for the increase in milk production but also for the 
decreased activities per cell. Interestingly, the performance of cows fed on different plant 
oil treatments were the same, suggesting that oils rich in oleic (rapeseed oil), linoleic 
(soybean oil), ALA (linseed oil) affected the performance of animals in a similar way. 
Furthermore, cows fed on diets supplemented with different unprotected UFA sources had 
increased proportion of LCFA and c9,t11-CLA in milk but reduced de novo FA synthesis, 
which in turn, improved the nutrition quality aspects of their milk (Table 3, S2 and S3). It is 
well established that feeding dairy cows with plant oils results in a reduction in the de novo 
FA, and increases LCFA (Bauman & Griinari, 2003; Bernard et al., 2008; Thering et al., 
2009). Altered fermentation of these plant oils results in rumen outflow of unique 
biohydrogenation intermediates, some of which reduce lipid synthesis in the mammary 
gland (Bauman & Griinari, 2003; Bauman et al., 2008). In particular, the trans-18:2 FA has 
emerged as an important factor associated with the inhibition of de novo FA synthesis 
(Bauman et al., 2006; Harvatine et al., 2009).This study found similar results. Therefore, it 
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is likely that in our study the different unprotected UFA sources had undergone ruminal 
biohydrogenation, increasing the trans-FA and CLA isomers reaching the mammary gland, 
which could be considered as an important factor in the inhibition of the milk synthesis of 
de novo FA proportion in milk. These observations, together with several gene expression 
effects (see section ‘Effects of UFA supplementation on nutrient metabolism’) are the 
major factors in leading us to believe that the dietary UFA supplementation, together with 
the higher energy and protein content, was indeed the main factor affecting milk yield and 
composition, rather than the lactation stage. 
 
Differential Gene Expression of Genes in the Mammary Gland 
A total of 972 genes were differentially expressed in the mammary gland tissue when 
supplementing grazing dairy cows with UFA compared with when cows were fed with a 
control diet, suggesting a large degree of transcriptomic adaptation to the dietary UFAs. 
Similar to the milk production and composition variables, we acknowledge that the effects 
of UFA supplementation on gene expression might be confounded by lactation stage, but 
also by the different amount of dietary protein and energy that was utilized by the cow. 
There are no studies that report the effects of varying dietary protein and energy levels on 
the genome-wide expression in the mammary gland of dairy cows. Further, there are no 
studies that describe the genome-wide expression in the mammary gland of mid-lactation 
cows. However, Bionaz & Loor (2008b) observed that the expression of 45 genes 
associated with lipid synthesis and with well-defined roles in mammary lipid metabolism 
peaked at 60 days post-partum, and thereafter, their mRNA abundance decreased following 
the lactation curve. As the mRNA expression of most of the genes in our study presented 
different pattern from the so-called lactation curve, it may be assumed that there is an effect 
of enriched-UFA diet on their expression. Surprisingly, expressions of genes in the 
mammary gland were not significantly different between UFA sources. A possible 
explanation for these results might be that the variability in the FA profile among the 
dietary treatments was not sufficient because the unprotected UFA sources had undergone 
extensive biohydrogenation by rumen microorganisms (Chilliard et al., 2007); and 
therefore, the contrast in absorbed FA composition between supplements was probably too 
small to cause large differences in mammary gland tissue gene expression. In agreement, 
Ollier et al. (2009) supplementing mid-lactation multiparous goats with oil from whole 
intact rapeseed or sunflower did not find significant changes in the expression of 8,382 
genes in the mammary gland, despite changes in milk composition. However, the lack of 
differently expressed genes between UFA sources could also be the result of a high 
variability in the expression levels of genes in the mammary gland within groups of 
treatments, as biological variation is intrinsic to all organisms (Churchill, 2002). 
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Functional Clustering of Differential Expressed Genes in the Mammary 
Gland 
The functional clustering of differentially expressed genes by GO analysis, GSEA and 
IPA showed that supplementation of UFA leads to downregulation of hundreds of genes 
that modulate cellular growth proliferation and development cell death, connections 
between cells and morphology (cytoskeleton organization), apoptosis, cell cycle, nutrient 
metabolism, as well as immune system response. 
 
Effects of UFA Supplementation on Cellular Growth Proliferation and 
Development, Cellular Death, Cytoskeleton Organization and Apoptosis  
The downregulation of the expression of key genes (P53, PPP2R1A and Ras) associated 
with cellular growth, cell cycle, remodelling and apoptosis, as well as canonical pathways 
such as mTOR and JAK/STAT signalling, suggested changes in mammary gland tissue 
integrity and cell adhesion when cows were supplemented with UFA-enriched diets. The 
mTOR controls cellular metabolism, growth and proliferation (Panasyuk et al., 2009), and 
the JAK/STAT pathway is the principal signalling mechanism for a wide array of cytokines 
and growth factors resulting in cell proliferation, differentiation, cell migration and 
apoptosis (Rawlings et al., 2004). These cellular events are critical to mammary gland 
lactation (Rawlings et al., 2004). The information with regard to the effect of UFA 
supplementation on regulation of genes functioning in remodelling of the mammary gland 
in dairy cows is lacking. However, Connor et al. (2008) studying the specific mechanisms 
controlling the increase in milk production in dairy cows during the first few weeks of 
lactation, reported a downregulation of genes functioning in remodelling of the mammary 
gland. Therefore, it can be suggested that inhibition related to cell proliferation and 
remodelling could be mainly occurring in response to UFA-enriched diet that promoted an 
increase in milk synthesis. 
 
Effects of UFA Supplementation on Immune System Response 
We present some of the first data in the bovine that reveal changes in the expression of 
defence, inflammatory and immune-related genes in response to UFA supplementation. 
Cows fed with UFA-enriched diet revealed downregulation of many key genes known to be 
involved in cellular and humoral immune responses, as well as pathogen-induced signalling 
and cellular stress and injury (Supplementary,material; Figure S3). It featured a number of 
genes involved in cytokine and IL signalling, which exert potent chemokinetic and 
chemotactic activity on leukocytes and enhance the bactericidal activity of phagocytes in 
dairy cows (Pfaffl et al., 2003), as well as T and B cell receptors, natural killer cell 
signalling, GM-CSF signalling, C-C chemokine receptor type 3 (CCR3) signalling in 
eosinophils, CXC chemokine receptor 4 (CXCR4) signalling and integrin signalling. 
Lessard et al. (2003) suggested that cellular immunity of the dairy cows was affected by 
dietary supplementation of UFA. They observed that 5 days after calving, the lymphocyte 
proliferative response of cows allocated to linseed treatment was reduced. Connor et al. 
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(2008) reported that increasing milk yield through milking frequency resulted in a 
downregulation of several genes that function in innate immune response and 
inflammation. Furthermore, one major finding of our study was the downregulation of 
genes associated with NFkB response after UFA supplementation (Figure 1d). In 
agreement, Lessard et al. (2003) reported that dietary UFA can affect the regulation of 
cytokine gene expression by modulating the activation of transcription nuclear factors such 
as NFkB. Though little is known about the expression of defence, inflammatory and 
immune-related genes in response to dietary UFA supplementation in dairy cows, the 
results presented here suggest that enriched-UFA diets may affect immune functions of the 
mammary gland and thus may modify the susceptibility to mastitis in lactating cows and 
the resulting quality of milk. However, experiments specifically designed to test these 
hypothesis are warranted to verify the roles of UFA on genes involved in immune system 
response pathways and networks, together with cell cycle, cell growth and certain apoptotic 
pathways. 
 
Effects of UFA Supplementation on Nutrient Metabolism  
Our microarray data provide insight into the nutrient metabolism adaptations in the 
mammary gland as a result of UFA supplementation. Our finding suggested that through 
feeding UFA-enriched diets, the mammary gland reduced overall fat and protein metabolic 
activity, but increased carbohydrate metabolism. Most of the transcripts involved with 
biological process related to carbohydrate metabolism (glycolysis and gluconeogenesis, and 
pentose phosphate pathway) were upregulated (Figure 2b). Glucose is the major precursor 
for synthesis of lactose, which controls milk volume by maintaining the osmolarity of milk 
(Finucane et al., 2008). Consistent to increased expression of genes associated with 
carbohydrate metabolism, lactose and milk yield of cows fed with enriched-UFA diet was 
greater relative to cows fed with control diet. Under the conditions of this experiment, 
increasing the fermentable energy content of the diet, by reducing NDF and increasing 
starch was also likely to stimulate the carbohydrate metabolism. In contrast, supplementing 
basal diet of dairy cows with unprotected UFA was characterized by substantial 
downregulation of the mRNA expression of genes in the mammary gland involved in 
protein synthesis, protein trafficking, protein folding and the regulatory pathways 
controlling these processes, as well as lipid, and transport processes of nutrients. These 
changes may explain the reduction of fat and protein percentages in milk of these dairy 
cows. The most prominent functional characteristic of lipid metabolism category was the 
downregulation of the transcription factor SREBP-1, when cows were supplemented with 
dietary unprotected UFA. Therefore, these results suggested that increasing the LCFA and 
trans-FA reaching mammary gland from blood may affect expression of key transcription 
regulator genes and their response genes. Together with the downregulation of SREBP-1, 
ACACA, which catalyses the carboxylation of acetyl-CoA to produce malonyl-CoA 
(Bernard et al., 2008), was found to be downregulated during supplementation of UFA 
(Table 4). These results support the hypothesis that regulation of genes involved in de novo 
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synthesis of FA is under control of SREBP-1 (Bionaz & Loor, 2008b). However, the 
observed downregulation of de novo lipid biosynthesis in bovine mammary gland could 
also be influenced by the downregulation of the insulin-induced gene (INSIG-1; Raghow et 
al., 2008). When cells have sufficient sterol levels, INSIG-1 retains the SREBP-1 cleavage-
activating protein (SCAP)-SREBP-1 in the endoplasmic reticulum and consequently 
inhibits SREBP-1-mediated gene expression. On the basis of the above observations, it is 
tempting to speculate that UFA reaching the mammary gland addresses the expression of 
both SREBP-1 and INSIG-1 to inhibit SREBP-1-mediated gene expression and 
consequently, at least partially, reduce lipogenic activity in the mammary gland. This is in 
agreement with Harvatine & Bauman (2006), who reported that dietary treatments causing 
milk fat depression decreased expression of SREBP-1 and the INSIG-1, consistent with 
decreased abundance of active SREBP-1. Similarly, our findings underscore that 
supplementation of dietary UFA decreased the expression of gene sets regulated by 
PPARG, including those associated with FA import (e.g. acetyl-CoA acyltransferase 1 
(ACAA1)), activation and intracellular channeling of FA (e.g. acyl-CoA synthetase short-
chain family member 1 and 2 (ACSS1 and ACSS2)) and de novo FA synthesis (e.g. 
ACACA). Furthermore, the genes related to the formation of triglyceride (TG) such as the 
acylglycerol phosphate acyl-transferase (AGPAT1), thought to be involved in catalyzing 
the initial step in the synthesis of TG, were downregulated (Table 4). But on the contrary, 
our data indicated that supplementation of dietary unprotected UFA upregulated the 
expression of stearoyl-CoA desaturase 5 (SCD5), an isoform of the ∆-9 desaturase family 
(Lengi & Corl, 2007). The role of SCD5 in the mammary tissue remains elusive, although 
Gervais et al. (2009) reported important differences between SCD1 and SCD5 regulation 
and physiological roles when Holstein cows were infused with a lipid emulsion enriched 
with t10,c12-CLA. However, no effects on the expression of SCD1 were found in this 
study (Supplementary material; Table S8). This is in agreement with Delbecchi et al. 
(2001), who reported no differences in the expression levels of SCD1 in the mammary 
gland when mid-lactation Holstein cows were fed a total MR supplemented with either 
4.8% canola meal, 3.3% unprotected canola seeds plus 1.5% canola meal or 4.8% 
formaldehyde-protected canola seeds. Furthermore, Murrieta et al. (2006) also did not 
report differences on SCD1 mRNA expression in the mammary gland of crossbred beef 
cows supplemented with cracked safflower seed supplements. However, most of the studies 
that examined the effect of milk fat depressing diets on SCD1 expression in the mammary 
gland, reported a tendency toward reduction of mammary expression of SCD1 (Harvatine 
& Bauman, 2006; Gervais et al., 2009). 
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Conclusions 
 
The results of our study suggest that supplementing the diets of grazing dairy cows with 
different unprotected UFAs decreases milk fat and protein percentage, and increases milk 
yield. Due to the UFA supplementation, the proportion of LCFAs in milk increases, 
whereas de novo FA synthesis decreases, which in turn, improves the nutrition quality 
aspects of dairy milk. The UFA supplementation led to robust transcriptional adaptations 
with 972 genes affected, suggesting a strong impact on metabolism and other cellular 
functions in the mammary gland. In particular, the functional analysis on these genes 
indicated that inclusion of dietary UFAs not only reduces the expression of genes 
associated with lipid and protein metabolism, but unexpectedly also of genes involved in 
cell–cell interactions, cells morphology (cytoskeleton organization), cell death and immune 
response. The large-scale transcriptional adaptations occurring in mammary tissue in 
response to dietary lipids might provide the basis for more detailed functional studies for 
future research. 
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Supplementary Material 
 
Fatty Acid Analysis 
For fatty acid (FA) analysis of the feedstuffs, fat from freeze dried samples was 
extracted with chloroform-methanol (2:1 v/v), according to Folch et al. (1957). The 
homogenized extracts were filtered (595½, 125 mm diameter, Whatman Sleicher and 
Schuell, Dassel, Germany), and water was added for a clear separation. The upper phase 
was completely removed by repeated washing (3 times) with a solution containing 30 mL 
chloroform, 480 mL methanol and 470 mL sodium chloride solution (7.3 g/L water). 
Approximately 3 mL of the lower fat containing phase was collected and solvents were 
evaporated by vacuum centrifugation. The residual fat was dissolved in 2 mL hexane and 
100 mg of anhydrous sodium sulphate was added. Fatty acids were transesterified using 
both acid and base catalysed methods. For basic methylation, 50 µL sodium methanolate in 
absolute methanol (2 mol L-1) was added. Subsequently, 1 mL hydrochloric acid 
methanolic solution was added for acid methylation and the mixture was heated for 20 
minutes at 85ºC under constant shaking. The mixture was then cooled down to room 
temperature under a flow of cold water and shaken vigorously. After that, 1 mL of the 
upper layer, which contains the fatty acid methyl esters (FAME), was transferred to a 1.5 
mL vial and used for gas chromatography analysis. For milk FA analysis, milk samples 
were heated to 45ºC and directly centrifuged at 3,000 x g for 10 min at 4°C. The upper 
layer (fat and cream) was collected, filtered on folded filter paper, and stored overnight at -
20ºC. Then, the mixture was heated for 10 min at 60ºC. The oil substance was centrifuged 
twice at room temperature (5 min at 20,000 x g), and the fat fraction was transferred to a 
tube containing a small amount of anhydrous sodium sulphate. Subsequently, 50 µL of milk 
fat was added to 5 mL of hexane and the glycerol bounds FA were transesterified to FAME 
by vortexing for 1 min with 100 µL of sodium methanolate in absolute methanol (2 mol    
L-1). The solution was neutralized with 1 g of sodium hydrogen sulphate and dried with 
anhydrous sodium sulphate. The FAME from feedstuff and milk were injected into a gas 
chromatograph (TRACE GC ULTRA, Thermo Electron Corporation, Waltham, MA, USA) 
equipped with a flame-ionization detector and auto-sampler. The carrier gas was helium. 
Samples (1 µL) were injected by split injection (split ratio 1:50). Separation of FAME was 
performed with a fused silica capillary column (100 m x 0.25 mm x 0.2 µm film thickness; 
Restek RT-2560, Restek, Bellefonte, PA, USA). The oven temperature was programmed 
from 140ºC for 4 min, followed by an increase of 4ºC per min to 240ºC, and held for 20 
min. The FAME concentrations were measured by using the Supelco FAME standards 
(S37, Supelco, Poole, Dorset, UK).  
 
Quality Control Analysis of Affymetrix GeneChip® Bovine Genome Array  
All array images were inspected for the presence of artefacts visible without 
magnification of the image (i.e., high/low intensity spots, scratches, high regional, or 
overall background, etc.). Subsequently, the boundaries of the probe area were checked for 
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fluorescent presence of B2 oligo, which was spiked into each hybridization cocktail. The 
B2 Oligo serves as a positive hybridization control and is used to place a grid over the 
image. Furthermore, Noise Values were compared between chips. Noise (Raw Q) was a 
measure of the pixel-to-pixel variation of probe cells on a GeneChip array. Additionally, 
Poly-A RNA controls were used to monitor the entire target labelling process. Further, to 
monitor the hybridization process, Affymetrix 20x Eukaryotic Hybridization Controls were 
used, composed of a mixture of biotin-labelled cRNA transcripts of E.coli genes prepared 
in staggered concentrations (BioB, bioC and bioD) and cre, the recombinase gene from P1 
bacteriophage. The hybridization controls were spiked into the hybridisation cocktail, 
independent of RNA sample preparation, and were thus used to evaluate sample 
hybridization efficiency on eukaryotic gene expression arrays. Lastly, the β-actin and 
GAPDH were used to assess RNA sample and assay quality. The Signal values of the 3’ 
probe sets for actin and GAPDH were compared to the Signal values of the corresponding 
5’ probe sets. The ratio of the 3’ probe set to the 5’ probe set were generally no more than 
3. 
 
References 
Folch, J., M. Lees, and G. H. S. Stanley. 1957. A simple method for the isolation and 
purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509. 
 
 
Table S1. Chemical analyses and fatty acid composition of the pasture. 
Item Pasture 
Chemical composition, (g/kg DM)  
   DM (g/kg) 191.7 
   Ash 90.9 
   CP 229.7 
   Crude fat 55.9 
   NDF 340.4 
   ADF 191.3 
   Sugars 206.4 
FA composition, (g/100g FA)  
   C16:0 13.4 
   C18:0 1.9 
   C18:1 c9 5.3 
   C18:2 c9c12 15.0 
   C18:3 c9c12c15 57.2 
   C22:0 0.7 
   C24:0 0.7 
 
  
  
Table S2. Fatty acid profile of milk when comparing dairy cows fed with unprotected unsaturated fatty acid (UFA) relative to the same cows 
fed a control diet. 
1
 Within UFA-enriched diet, A = rapeseed oil; B = soybean oil; C = linseed oil; and D = proportional mix of them all. Within control diet, group 
A, B, C and D were fed with the same control diet. 
2
 UFAS = effect of UFA-sources, UFAL = effect of UFA level; *, **, *** levels of significance indicate P < 0.05, P < 0.01 and P < 0.001, 
respectively. 
3
 Included n = 28 cows; 4  a,b,c Within rows, mean values not bearing a common superscript differ (P < 0.05), and A,B,C within rows, mean values 
not bearing a common superscript differ (P < 0.01); 5 Only the most relevant fatty acids (FA) are presented. Information related to the 
complete milk FA profile can be found in Chapter 2. 
6
 De novo FA include all FA from C4 to C14 and 50% of C16 FA. 
7
 Long Chain Fatty Acids include all FA with 18 carbon atoms or more.  
8
 CLA = Conjugated Linoleic Acid. 
 Control diet  UFA-enriched diet  
 UFA sources1 P- value2 
Fatty acid3,4,5 A B C D  A B C D s.e. UFAS UFAL 
UFAS x 
UFAL 
 g/100 g total fatty acids     
De novo FA6 41.57 41.53 41.41 40.42  37.34 35.87 35.78 33.06   1.03 0.13  *** 0.48 
LCFA7 49.46 50.38 49.66 50.57  54.07 56.70 55.32 58.14   0.98 0.09  *** 0.46 
18:0 8.65b 9.83a 9.13ab 8.74b  8.74b 10.90a 9.71ab 8.90b 0.576 * 0.26 0.80 
c9-18:1 18.56 18.98 19.19 19.75  21.3 21.21 21.3 22.64 0.863 0.46  *** 0.96 
c9,c12-18:2 1.35B 1.38A 1.33B 1.47A  1.36B 1.78A 1.35B 1.81A 0.075 ***  *** ** 
18:3n3 0.51C 0.5bC 0.50A 0.56B  0.31C 0.42BC 0.63A 0.52B 0.027 *** 0.004 *** 
Total trans-FA 3.05 2.88 3.43 4.05  6.31 6.75 7.74 9.32   0.56 0.12  *** 0.38 
c9,t11 CLA8 0.58 0.49 0.55 0.68  0.85 1.02 0.99 1.11   0.09 0.148  *** 0.43 
t10,c12 CLA 0.008 0.001 0.01 0.01  0.01 0.01 0.02 0.02 0.003 0.09  *** 0.77 
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Table S3. Fatty acids concentration of milk (mg/L) when comparing dairy cows fed with 
unprotected unsaturated fatty acid (UFA) relative to the same cows fed a control diet. 
   P < 0.001, respectively. 
  2
 Included n = 28 cows. 
  3
 De novo FA include all FA from C4 to C14 and 50% of C16 FA. 
  4
 Long Chain Fatty Acids include all FA with 18 carbon atoms or more. 
  5
 CLA = Conjugated Linoleic Acid. 
 
  
Item2 Control diet   
UFA-
enriched diet  P- value
1
 
  s.e.  
De novo FA3, mg/L 11,343  
  8,035 418.5 *** 
C16, mg/L 13,200  
  9,780 416.7 *** 
LCFA4, mg/L 15,282  15,412 467.9 0.84 
Unsaturated Fatty Acids, mg/L 12,023  12,397 349.6 0.45 
Saturated Fatty Acids, mg/L 28,393  21,160 938.6 *** 
Polyunsaturated Fatty Acids, mg/L   1,393  
  1,388   43.1 0.93 
n-3 Fatty Acids, mg/L      269.3  
     201.7     9.28 *** 
n-6 Fatty Acids, mg/L      721.1  
      652.46   20.01 ** 
Trans-octadecenoic Fatty Acids, mg/L   1,798  
   2,900   72.5 *** 
cis-9, trans-11-CLA5, mg/L       263.9  
      368.8   18.80 *** 
trans-10,cis-12-CLA, mg/L           3.56  
          6.4     0.46 *** 
1
 Effect of UFA level; *, **, *** levels of significance indicate P < 0.05, P < 0.01 and 
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Table S4. Gene identification, symbol, description, and fold change of the 972 genes 
differentially expressed in the mammary gland tissue when supplementing grazing dairy 
cows with unprotected unsaturated fatty acid (UFA) compared with when cows were fed 
with a control diet. The differentially expressed genes were identified applying a statistical 
cut-off of false discovery rate (FDR) q-values <0.05 together with an absolute Fold Change 
(FC) of 1.3. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001034271 ARPC3 actin related protein 2/3 complex, subunit 3, 
21kDa 
2.70 *** 
NM_001100373 LOC515994 hypothetical LOC515994 2.03 ** 
NM_001075370 CCBL2 cysteine conjugate-beta lyase 2 1.89 *** 
XM_001250172 SFRS12IP1 SFRS12-interacting protein 1 1.80 *** 
NM_205786 LOC404103 spleen trypsin inhibitor 1.79 *** 
NM_001076109 TIA1 TIA1 cytotoxic granule-associated RNA 
binding protein 
1.75 *** 
XM_864367 SFRS12IP1 SFRS12-interacting protein 1 1.74 *** 
NM_001014386 RNASE1 ribonuclease 1.74 ** 
NM_001098875 MUTED muted homolog (mouse) 1.72 *** 
NM_001034488 BDH2 3-hydroxybutyrate dehydrogenase, type 2 1.71 *** 
NM_001046164 FBP2 fructose-1,6-bisphosphatase 2 1.64 *** 
NM_001102165 IYD iodotyrosine deiodinase 1.63 *** 
NM_001075225 NTRK2 neurotrophic tyrosine kinase, receptor, type 
2 
1.63 ** 
NM_001101265 SHISA2 shisa homolog 2 (Xenopus laevis) 1.63 * 
XM_613318 ACSM3 acyl-CoA synthetase medium-chain family 
member 3 
1.62 ** 
XM_584098 FIGNL1 fidgetin-like 1 1.62 *** 
XM_598984 MED1 mediator complex subunit 1 1.61 *** 
NM_001102017 CCDC88C coiled-coil domain containing 88C 1.61 *** 
NM_001033619 RPL18A ribosomal protein L18a 1.61 *** 
NM_001024499 POLR3D polymerase (RNA) III (DNA directed) 
polypeptide D, 44kDa 
1.61 *** 
XM_865119 LPIN1 lipin 1 1.59 ** 
NM_173936 MIA melanoma inhibitory activity 1.59 ** 
XR_028430 LOC524776 similar to chromodomain helicase DNA 
binding protein 6 
1.57 *** 
NM_001109962 DCLK1 doublecortin-like kinase 1 1.57 ** 
NM_175801 FST follistatin 1.56 * 
NM_001024500 MRPS17 mitochondrial ribosomal protein S17 1.55 ** 
NM_001003902 MRPS14 mitochondrial ribosomal protein S14 1.54 *** 
XM_592516 CLDN23 claudin 23 1.54 ** 
XM_588956 NA NA 1.54 *** 
NM_176649 ATP5G1 ATP synthase, H+ transporting, 
mitochondrial F0 complex, subunit C1 
(subunit 9) 
1.54 *** 
XM_001252404 NA NA 1.53 *** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001105485 NT5DC1 5'-nucleotidase domain containing 1 1.53 *** 
XR_027421 NA NA 1.52 *** 
NM_174079 HAS2 hyaluronan synthase 2 1.52 *** 
XM_867376 ENPP1 ectonucleotide 
pyrophosphatase/phosphodiesterase 1 
1.52 ** 
NM_001034041 SNCA synuclein, alpha (non A4 component of 
amyloid precursor) 
1.52 *** 
NM_001075992 TSC1 tuberous sclerosis 1 1.52 *** 
NM_001076133 PDE12 phosphodiesterase 12 1.51 *** 
NM_001038054 HMG20B high-mobility group 20B 1.51 *** 
NM_175800 NDUFS4 NADH dehydrogenase (ubiquinone) Fe-S 
protein 4, 18kDa (NADH-coenzyme Q 
reductase) 
1.51 *** 
AFFX-r2-Ec-
bioB-3 
NA NA 1.50 ** 
NM_001040472 CD3G CD3g molecule, gamma (CD3-TCR 
complex) 
1.50 ** 
NM_001046120 C2H1orf14
4 
chromosome 1 open reading frame 144 
ortholog 
1.50 *** 
NM_001114608 C2H1orf14
4 
chromosome 1 open reading frame 144 
ortholog 
1.50 *** 
XM_586239 LOC509304 hypothetical LOC509304 1.50 *** 
NM_001038192 THEX1 three prime histone mRNA exonuclease 1 1.49 ** 
NM_001045995 MCEE methylmalonyl CoA epimerase 1.49 *** 
XM_001256926 MCEE methylmalonyl CoA epimerase 1.49 *** 
NM_001079798 PHYHIPL phytanoyl-CoA 2-hydroxylase interacting 
protein-like 
1.49 * 
NM_001076092 DZIP3 DAZ interacting protein 3, zinc finger 1.49 ** 
XM_582415 NA NA 1.48 ** 
XM_001251905 LOC783266 similar to holocarboxylase synthetase 1.48 *** 
XR_027629 NA NA 1.48 *** 
NM_001099139 MGC15737
2 
hypothetical LOC614796 1.48 *** 
XM_593333 MYO9A myosin IXA 1.48 *** 
NM_001110001 KRAS v-Ki-ras2 Kirsten rat sarcoma viral 
oncogene homolog 
1.47 *** 
NM_001099030 KLHL28 kelch-like 28 (Drosophila) 1.47 *** 
NM_001034596 PSMB3 proteasome (prosome, macropain) subunit, 
beta type, 3 
1.47 *** 
XM_583018 PB1 polybromo 1 1.47 *** 
NM_174672 SLC25A16 solute carrier family 25 (mitochondrial 
carrier ///  Graves disease autoantigen), 
member 16 
1.47 *** 
XM_593524 LRP10 low density lipoprotein receptor-related 
protein 10 
1.46 *** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001024490 CDC45L CDC45 cell division cycle 45-like (S. 
cerevisiae) 
1.46 *** 
NM_173985 AIF1 allograft inflammatory factor 1 1.46 ** 
NM_001079801 GGPS1 geranylgeranyl diphosphate synthase 1 1.46 *** 
NM_001098024 AKAP10 A kinase (PRKA) anchor protein 10 1.46 *** 
XM_612699 LOC533324 similar to Protein FAM126B 1.45 *** 
NM_001075618 PPIH peptidylprolyl isomerase H (cyclophilin H) 1.45 *** 
NM_174635 CSNK2A1 casein kinase 2, alpha 1 polypeptide 1.45 ** 
XM_001256068 LOC789682 similar to Mast cell antigen 32 precursor 
(Mast cell Ag-32) (MCA-32) 
1.45 *** 
NM_001076014 FIG4 FIG4 homolog (S. cerevisiae) 1.45 *** 
NM_176608 GHR growth hormone receptor 1.45 ** 
NM_001076293 ALOX5AP arachidonate 5-lipoxygenase-activating 
protein 
1.45 ** 
NM_001001156 ADAM12 ADAM metallopeptidase domain 12 1.45 *** 
NM_001075259 PDCD10 programmed cell death 10 1.44 ** 
NM_001046333 CAMK2D calcium/calmodulin-dependent protein 
kinase II delta 
1.44 *** 
NM_001079774 LOC514330 MMP37-like protein, mitochondrial 1.44 *** 
XR_028714 LOC788997 similar to LOC785621 protein 1.44 ** 
XM_868564 LOC616529 similar to TRD@ protein 1.44 *** 
NM_001076878 SLC39A12 solute carrier family 39 (zinc transporter), 
member 12 
1.44 ** 
XM_581573 NA NA 1.43 ** 
NM_001076997 FMC1 formation of mitochondrial complexes 1 
homolog (S. cerevisiae) 
1.43 *** 
XM_001249856 RNASE12 ribonuclease, RNase A family, 12 (non-
active) 
1.43 * 
XM_001251339 NA NA 1.43 * 
XR_028227 LOC785233 similar to postmeiotic segregation 1 1.43 *** 
XM_591634 SRBD1 S1 RNA binding domain 1 1.43 *** 
NM_001037469 H2B histone H2B-like 1.43 * 
NM_001046257 NOSTRIN nitric oxide synthase trafficker 1.43 * 
NM_001038034 UBE2T ubiquitin-conjugating enzyme E2T 
(putative) 
1.43 *** 
NM_001075531 TPMT thiopurine S-methyltransferase 1.43 *** 
XR_027447 LOC782348 similar to Frizzled-3 precursor (Fz-3) 
(hFz3) 
1.43 *** 
XM_601152 LOC522864 similar to KIAA1370 1.42 *** 
NM_176659 NDUFA3 NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex, 3, 9kDa 
1.42 *** 
NM_001076107 C13H10OR
F97 
chromosome 10 open reading frame 97 
ortholog 
1.42 *** 
NM_001079582 SLC15A2 solute carrier family 15 (H+/peptide 
transporter), member 2 
1.42 ** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001081535 ENPP4 ectonucleotide 
pyrophosphatase/phosphodiesterase 4 
(putative function) 
1.42 ** 
NM_001104975 LOC512150 similar to Myeloid-associated 
differentiation marker 
1.42 ** 
NM_001034453 CCDC104 coiled-coil domain containing 104 1.41 ** 
NM_175816 ATPIF1 ATPase inhibitory factor 1 1.41 *** 
XM_001252335 BLOC1S2 biogenesis of lysosomal organelles 
complex-1, subunit 2 
1.41 *** 
XM_597385 BLOC1S2 biogenesis of lysosomal organelles 
complex-1, subunit 2 
1.41 *** 
NM_001100330 FKBP7 FK506 binding protein 7 1.41 * 
XM_580552 MERTK c-mer proto-oncogene tyrosine kinase 1.41 *** 
NM_001098079 RPE ribulose-5-phosphate-3-epimerase 1.41 *** 
NM_001080353 PI3 peptidase inhibitor 3, skin-derived 
(SKALP) 
1.41 ** 
NM_001037600 FAM82B family with sequence similarity 82, member 
B 
1.41 *** 
NM_001113723 UCRC ubiquinol-cytochrome c reductase complex 
7.2 kDa protein 
1.41 *** 
XM_001251797 LOC783161 similar to LOC152217 protein 1.40 *** 
NM_001037597 NT5C3 5'-nucleotidase, cytosolic III 1.40 ** 
XM_591447 NA NA 1.40 ** 
XM_867971 LOC616011 similar to zinc finger, CCHC domain 
containing 17 
1.40 ** 
NM_174308 EDNRA endothelin receptor type A 1.40 ** 
XR_028112 LOC784517 similar to cationic amino acid transporter 5 1.40 ** 
NM_001024573 PPAPDC2 phosphatidic acid phosphatase type 2 
domain containing 2 
1.40 ** 
NM_001101161 CNOT6 CCR4-NOT transcription complex, subunit 
6 
1.40 *** 
XR_027516 LOC782395 similar to malignant fibrous histiocytoma 
amplified sequence 1 
1.40 *** 
XR_028193 NA NA 1.39 *** 
NM_001038056 TM2D2 TM2 domain containing 2 1.39 *** 
NM_001077834 SNW1 SNW domain containing 1 1.39 *** 
XM_001252075 NA NA 1.39 *** 
NM_001034754 TAF12 TAF12 RNA polymerase II, TATA box 
binding protein (TBP)-associated factor, 
20kDa 
1.39 *** 
NM_001101858 FOLH1 folate hydrolase (prostate-specific 
membrane antigen) 1 
1.39 ** 
NM_001034247 GADD45A growth arrest and DNA-damage-inducible, 
alpha 
1.39 ** 
NM_174035 CYBB cytochrome b-245, beta polypeptide 1.39 ** 
NM_001109807 PPIG peptidylprolyl isomerase G (cyclophilin G) 1.39 ** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001080313 CCDC53 coiled-coil domain containing 53 1.39 *** 
NM_173960 SST somatostatin 1.38 * 
NM_177502 GOT1 glutamic-oxaloacetic transaminase 1, 
soluble (aspartate aminotransferase 1) 
1.38 *** 
NM_001077002 GPR171 G protein-coupled receptor 171 1.38 ** 
NM_001101934 PDK3 pyruvate dehydrogenase kinase, isozyme 3 1.38 ** 
XM_614941 ATP8B1 ATPase, class I, type 8B, member 1 1.38 ** 
XM_603355 TRD@ T-cell receptor delta chain 1.38 * 
XM_593269 LOC515280 similar to hepatocellular carcinoma antigen 
gene 520 
1.38 ** 
NM_001046266 GLT8D2 glycosyltransferase 8 domain containing 2 1.38 ** 
XM_581642 WFDC1 WAP four-disulfide core domain 1 1.38 ** 
XM_603252 PIBF1 progesterone immunomodulatory binding 
factor 1 
1.38 *** 
XM_001256260 NA NA 1.38 *** 
NM_001076113 RIMKLB ribosomal modification protein rimK-like 
family member B 
1.38 ** 
NM_001075566 FRG1 FSHD region gene 1 1.38 *** 
XM_583699 LOC507141 CE5 protein-like 1.37 ** 
XM_001249876 MRPL23 mitochondrial ribosomal protein L23 1.37 ** 
NM_174242 APOA1 apolipoprotein A-I 1.37 ** 
NM_001025350 SF3B5 splicing factor 3b, subunit 5, 10kDa 1.37 *** 
NM_001013601 BOLA-
DQA1 
histocompatibility complex, class II, DQ 
alpha, type 1 
1.37 ** 
XM_595995 SNX7 sorting nexin 7 1.37 *** 
XM_865687 NA NA 1.37 *** 
XM_001251264 SETD1A SET domain containing 1A 1.37 *** 
XM_595033 IPCEF1 interaction protein for cytohesin exchange 
factors 1 
1.37 ** 
NM_001077924 RPP14 ribonuclease P/MRP 14kDa subunit 1.37 ** 
NM_001100348 PXMP3 peroxisomal membrane protein 3, 35kDa 1.37 *** 
XM_001250900 NA NA 1.37 ** 
XM_586922 NA NA 1.37 ** 
NM_001077981 PMS1 PMS1 postmeiotic segregation increased 1 
(S. cerevisiae) 
1.37 *** 
XM_001250072 NA NA 1.37 *** 
NM_001101887 ADHFE1 alcohol dehydrogenase, iron containing, 1 1.37 *** 
XM_587832 SRRM2 serine/arginine repetitive matrix 2 1.37 ** 
XM_581525 LOC505265 similar to tripartite motif protein 5 alpha 1.36 ** 
XM_583884 HEATR5A HEAT repeat containing 5A 1.36 *** 
NM_174233 AGTR1 angiotensin II receptor, type 1 1.36 ** 
XM_581489 FGD4 FYVE, RhoGEF and PH domain containing 
4 
1.36 ** 
XM_001249764 NA NA 1.36 *** 
XM_001249812 NA NA 1.36 *** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
XM_614337 BRWD3 bromodomain and WD repeat domain 
containing 3 
1.36 *** 
NM_001046563 MRPL48 mitochondrial ribosomal protein L48 1.36 *** 
XM_606442 CRLF3 cytokine receptor-like factor 3 1.36 ** 
NM_001040514 THOC7 THO complex 7 homolog (Drosophila) 1.36 *** 
XM_001249315 LOC780994 hypothetical LOC780994 1.36 *** 
XM_866139 FAM96B family with sequence similarity 96, member 
B 
1.36 *** 
XR_028190 LOC514474 similar to tumor protein p53 binding 
protein, 2 
1.36 *** 
XM_868233 NA NA 1.36 *** 
NM_001034615 TPD52L2 tumor protein D52-like 2 1.36 *** 
XM_001251369 NA NA 1.36 *** 
NM_001034517 HBXIP hepatitis B virus x interacting protein 1.36 *** 
NM_001034805 MRPL13 mitochondrial ribosomal protein L13 1.36 ** 
NM_001080317 MRPL3 mitochondrial ribosomal protein L3 1.36 *** 
NM_175782 LGALS1 lectin, galactoside-binding, soluble, 1 1.36 ** 
NM_001034338 CNIH4 cornichon homolog 4 (Drosophila) 1.36 *** 
XM_863865 LOC613274 hypothetical protein LOC613274 1.36 *** 
NM_001038515 CETN2 centrin, EF-hand protein, 2 1.36 ** 
NM_001101256 LOC616371 hypothetical LOC616371 1.36 ** 
NM_001082448 COPG2 coatomer protein complex, subunit gamma 
2 
1.36 ** 
XM_866738 NA NA 1.36 ** 
XM_866635 EML4 echinoderm microtubule associated protein 
like 4 
1.36 ** 
NM_001076213 ZNF45 zinc finger protein 45 1.36 *** 
NM_001102365 HSD17B1 hydroxysteroid (17-beta) dehydrogenase 1 1.36 *** 
XM_001253407 LOC785989 similar to Hydroxysteroid (17-beta) 
dehydrogenase 1 
1.36 *** 
NM_001076909 CUL2 cullin 2 1.36 *** 
NM_001076103 TRIB3 tribbles homolog 3 (Drosophila) 1.35 ** 
XM_001252263 NA NA 1.35 *** 
XM_603768 LOC525415 similar to C-C motif chemokine 3-like 1 
precursor (Small-inducible cytokine A3-
like 1) (Tonsillar lymphocyte LD78 beta 
protein) (LD78-beta(1-70)) (G0/G1 switch 
regulatory protein 19-2) (G0S19-2 protein) 
(PAT 464.2) 
1.35 *** 
NM_001083509 PCCA propionyl Coenzyme A carboxylase, alpha 
polypeptide 
1.35 *** 
XM_586889 CCDC112 coiled-coil domain containing 112 1.35 ** 
XM_581267 NA NA 1.35 ** 
XM_582278 C9H6ORF1
15 
chromosome 6 open reading frame 115 
ortholog 
1.35 *** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
XM_001255988 C29H11orf
10 
chromosome 11 open reading frame 10 
ortholog 
1.35 *** 
NM_174455 RPL24 ribosomal protein L24 1.35 *** 
XM_610489 FAM86A hypothetical protein LOC531984 1.35 ** 
NM_174320 FXYD2 FXYD domain containing ion transport 
regulator 2 
1.35 *** 
NM_001034310 PTTG1 pituitary tumor-transforming 1 1.35 ** 
XM_584118 NA NA 1.35 *** 
XM_001253146 NA NA 1.35 ** 
NM_174782 SLC12A2 solute carrier family 12 
(sodium/potassium/chloride transporters), 
member 2 
1.35 ** 
XM_001251104 PARP14 poly (ADP-ribose) polymerase family, 
member 14 
1.35 ** 
XM_613140 NA NA 1.35 ** 
NM_001101845 THEM2 thioesterase superfamily member 2 1.34 *** 
NM_001034582 WARS2 tryptophanyl tRNA synthetase 2, 
mitochondrial 
1.34 *** 
NM_001076849 OBFC1 oligonucleotide/oligosaccharide-binding 
fold containing 1 
1.34 *** 
NM_001034218 FETUB fetuin B 1.34 *** 
XM_001250957 BNIP3L BCL2/adenovirus E1B 19kDa interacting 
protein 3-like 
1.34 *** 
XM_001252613 NA NA 1.34 ** 
XM_001252642 TAOK3 TAO kinase 3 1.34 ** 
XM_614451 TAOK3 TAO kinase 3 1.34 ** 
NM_001076048 C11H9ORF
78 
chromosome 9 open reading frame 78 
ortholog 
1.34 *** 
XM_616395 MTHFD2L methylenetetrahydrofolate dehydrogenase 
(NADP+ dependent) 2-like 
1.34 ** 
NM_001014931 ORMDL2 ORM1-like 2 (S. cerevisiae) 1.34 *** 
NM_001103173 NBEAL1 neurobeachin-like 1 1.34 ** 
XR_028137 NA NA 1.34 *** 
XM_001256659 MEGF8 multiple EGF-like-domains 8 1.34 *** 
XR_028792 LOC615688 similar to multiple EGF-like-domains 8 1.34 *** 
NM_174594 RNASE6 ribonuclease, RNase A family, k6 1.34 * 
NM_174323 GNA14 guanine nucleotide binding protein (G 
protein), alpha 14 
1.33 *** 
NM_001014875 DUSP11 dual specificity phosphatase 11 1.33 *** 
NM_001034273 GTSF1 gametocyte specific factor 1 1.33 ** 
XM_588490 HLTF helicase-like transcription factor 1.33 *** 
XM_600747 UBR1 ubiquitin protein ligase E3 component n-
recognin 1 
1.33 ** 
NM_001003905 C16orf80 chromosome 16 open reading frame 80 1.33 ** 
XM_584692 NA NA 1.33 *** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
XR_027545 LOC781969 similar to BCL2/adenovirus E1B 19kDa 
interacting protein 3-like 
1.33 *** 
XM_864087 NA NA 1.33 *** 
XM_588295 ELP2 elongation protein 2 homolog (S. 
cerevisiae) 
1.33 *** 
NM_001076015 MRPS31 mitochondrial ribosomal protein S31 1.33 ** 
NM_001080903 RFC2 replication factor C (activator 1) 2, 40kDa 1.33 *** 
NM_001035055 CLDN11 claudin 11 1.33 * 
NM_001075447 SP140 SP140 nuclear body protein 1.33 ** 
NM_001034801 CEBPG CCAAT/enhancer binding protein (C/EBP), 
gamma 
1.33 *** 
NM_001015656 NME7 non-metastatic cells 7, protein expressed in 
(nucleoside-diphosphate kinase) 
1.32 * 
XM_001251303 MGC12798
9 
hypothetical protein MGC127989 1.32 *** 
NM_001075525 C5H12ORF
57 
chromosome 12 open reading frame 57 
ortholog 
1.32 *** 
XM_584232 LOC539014 hypothetical LOC539014 1.32 *** 
NM_176626 PAG18 pregnancy-associated glycoprotein 18 1.32 *** 
NM_001035439 METTL7A methyltransferase like 7A 1.32 *** 
XM_001249762 METTL7A methyltransferase like 7A 1.32 *** 
XM_001249805 NA NA 1.32 *** 
NM_001034529 BXDC2 brix domain containing 2 1.32 ** 
XM_590080 ACOT4 acyl-CoA thioesterase 4 1.32 *** 
NM_001034764 POLB polymerase (DNA directed), beta 1.32 * 
NM_001035458 SUMO1 SMT3 suppressor of mif two 3 homolog 1 
(S. cerevisiae) 
1.32 *** 
XM_001253763 SUMO1 SMT3 suppressor of mif two 3 homolog 1 
(S. cerevisiae) 
1.32 *** 
NM_001045899 BLZF1 basic leucine zipper nuclear factor 1 1.32 * 
NM_001076072 NCK1 NCK adaptor protein 1 1.32 *** 
XM_870116 NA NA 1.32 * 
NM_177508 UMPS uridine monophosphate synthetase 1.32 ** 
NM_001077936 SLC25A20 solute carrier family 25 
(carnitine/acylcarnitine translocase), 
member 20 
1.32 *** 
NM_001015620 TYW3 tRNA-yW synthesizing protein 3 homolog 
(S. cerevisiae) 
1.32 ** 
NM_001113319 CKS2 CDC28 protein kinase regulatory subunit 2 1.32 ** 
NM_001046361 PAPD4 PAP associated domain containing 4 1.32 *** 
NM_001075964 ZADH2 zinc binding alcohol dehydrogenase domain 
containing 2 
1.32 *** 
XR_027926 NA NA 1.32 ** 
NM_001098867 NARS2 asparaginyl-tRNA synthetase 2, 
mitochondrial (putative) 
1.32 ** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001075162 FMO2 flavin containing monooxygenase 2 (non-
functional) 
1.32 *** 
NM_205813 PAICS phosphoribosylaminoimidazole 
carboxylase, 
phosphoribosylaminoimidazole 
succinocarboxamide synthetase 
1.32 ** 
XM_001250433 NA NA 1.32 ** 
NM_001102137 ACSS3 acyl-CoA synthetase short-chain family 
member 3 
1.32 ** 
NM_001046321 MRPL44 mitochondrial ribosomal protein L44 1.32 ** 
NM_001034239 CCT2 chaperonin containing TCP1, subunit 2 
(beta) 
1.32 ** 
NM_175798 CD38 CD38 molecule 1.32 ** 
XR_027415 LOC781730 similar to ecto-NAD+ glycohydrolase 1.32 ** 
NM_001102358 PIR pirin (iron-binding nuclear protein) 1.31 ** 
XM_001250844 SOX6 SRY (sex determining region Y)-box 6 1.31 *** 
XM_614052 SOX6 SRY (sex determining region Y)-box 6 1.31 *** 
XM_611708 DEPDC7 DEP domain containing 7 1.31 ** 
XM_001253587 NA NA 1.31 *** 
XM_865849 IL23R interleukin 23 receptor 1.31 ** 
NM_001076154 CFL2 cofilin 2 (muscle) 1.31 ** 
XM_001251110 RC3H2 ring finger and CCCH-type zinc finger 
domains 2 
1.31 ** 
XM_582844 NA NA 1.31 ** 
NM_001102153 SCARB2 scavenger receptor class B, member 2 1.31 *** 
NM_001076038 STXBP6 syntaxin binding protein 6 (amisyn) 1.31 *** 
NM_001081615 XRCC4 X-ray repair complementing defective 
repair in Chinese hamster cells 4 
1.31 *** 
NM_001038558 CADM1 cell adhesion molecule 1 1.31 ** 
NM_001035033 OMA1 OMA1 homolog, zinc metallopeptidase (S. 
cerevisiae) 
1.31 *** 
XM_594106 LOC540449 similar to Uncharacterized protein 
C14orf152 
1.31 ** 
NM_001034476 SNRPD2 small nuclear ribonucleoprotein D2 
polypeptide 16.5kDa 
1.31 *** 
NM_001033121 ZNF148 zinc finger protein 148 1.31 ** 
NM_001014965 ANKRD49 ankyrin repeat domain 49 1.31 *** 
NM_001079618 MED30 mediator complex subunit 30 1.31 ** 
XM_001251745 NA NA 1.31 ** 
XM_001251778 NA NA 1.31 ** 
NM_001083474 EIF2B3 eukaryotic translation initiation factor 2B, 
subunit 3 gamma, 58kDa 
1.31 *** 
XM_001252878 MTERF mitochondrial transcription termination 
factor 
1.31 *** 
NM_001046003 MCTS1 malignant T cell amplified sequence 1 1.31 *** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
XM_001252845 NA NA 1.31 ** 
XM_867336 CCDC88A coiled-coil domain containing 88A 1.31 *** 
NM_001083389 CCDC58 coiled-coil domain containing 58 1.31 *** 
NM_001034641 MRPL16 mitochondrial ribosomal protein L16 1.31 *** 
NM_001034722 BTG3 BTG family, member 3 1.31 ** 
NM_001046364 BUD31 BUD31 homolog (S. cerevisiae) 1.31 *** 
XM_586184 RNASEH2B ribonuclease H2, subunit B 1.31 *** 
NM_001034341 FHL1 four and a half LIM domains 1 1.31 * 
NM_001076210 COQ3 coenzyme Q3 homolog, methyltransferase 
(S. cerevisiae) 
1.31 *** 
NM_001015626 NHP2 NHP2 ribonucleoprotein homolog (yeast) 1.31 ** 
NM_001034258 OCIAD2 OCIA domain containing 2 1.30 ** 
NM_001075280 PLA2G16 phospholipase A2, group XVI 1.30 ** 
XM_597427 PIGV phosphatidylinositol glycan anchor 
biosynthesis, class V 
1.30 * 
NM_001075389 C4H7ORF1
1 
chromosome 7 open reading frame 11 
ortholog 
1.30 *** 
NM_001075563 ERGIC2 ERGIC and golgi 2 1.30 *** 
NM_177519 GALNT1 UDP-N-acetyl-alpha-D-
galactosamine:polypeptide N-
acetylgalactosaminyltransferase 1 
(GalNAc-T1) 
1.30 * 
NM_001046286 HSD17B11 hydroxysteroid (17-beta) dehydrogenase 11 1.30 * 
NM_001098120 DTWD1 DTW domain containing 1 1.30 * 
NM_001038546 SNUPN snurportin 1 1.30 *** 
NM_001046148 PSMD11 proteasome (prosome, macropain) 26S 
subunit, non-ATPase, 11 
1.30 *** 
NM_001012764 CST6 cystatin E/M 1.30 ** 
XM_592333 ATRX alpha thalassemia/mental retardation 
syndrome X-linked (RAD54 homolog, S. 
cerevisiae) 
1.30 ** 
NM_001045885 TAPBP TAP binding protein (tapasin) -1.30 *** 
NM_001077925 SMCR7 Smith-Magenis syndrome chromosome 
region, candidate 7 
-1.30 *** 
XM_001249838 NA NA -1.30 *** 
NM_001102353 WHSC2 Wolf-Hirschhorn syndrome candidate 2 -1.30 ** 
NM_001035486 SHISA5 shisa homolog 5 (Xenopus laevis) -1.30 * 
NM_001113763 NA NA -1.30 *** 
NM_174720 CPSF1 cleavage and polyadenylation specific 
factor 1, 160kDa 
-1.30 ** 
XM_592881 TH1L TH1-like (Drosophila) -1.30 *** 
XM_001250861 TLN1 talin 1 -1.30 ** 
NM_001035411 GBL G protein beta subunit-like -1.30 *** 
XM_582266 PRKCQ protein kinase C, theta -1.30 * 
XM_587369 PPP5C protein phosphatase 5, catalytic subunit -1.30 ** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001075577 ADAL adenosine deaminase-like -1.30 ** 
NM_001034703 ELOVL1 elongation of very long chain fatty acids 
(FEN1/Elo2, SUR4/Elo3, yeast)-like 1 
-1.30 ** 
XM_587853 BSPRY B-box and SPRY domain containing -1.30 *** 
NM_001045971 SPINT2 serine peptidase inhibitor, Kunitz type, 2 -1.30 ** 
XM_608202 SPATA2 spermatogenesis associated 2 -1.30 ** 
NM_001038634 DNASE1L1 deoxyribonuclease I-like 1 -1.30 ** 
NM_001098465 THAP7 THAP domain containing 7 -1.30 ** 
NM_001046147 PDDC1 Parkinson disease 7 domain containing 1 -1.31 *** 
XM_582280 SRM spermidine synthase -1.31 ** 
NM_001102074 QSOX1 quiescin Q6 sulfhydryl oxidase 1 -1.31 *** 
NM_001076046 SNRNP70 small nuclear ribonucleoprotein 70kDa 
(U1) 
-1.31 ** 
XR_027508 LOC504986 similar to polycystin 1 -1.31 *** 
NM_001099108 PPP4C protein phosphatase 4 (formerly X), 
catalytic subunit 
-1.31 ** 
NM_001035307 EDF1 endothelial differentiation-related factor 1 -1.31 *** 
NM_001110180 MRPL52 mitochondrial ribosomal protein L52 -1.31 ** 
NM_001077046 M6PRBP1 mannose-6-phosphate receptor binding 
protein 1 
-1.31 ** 
NM_001077883 DHFR dihydrofolate reductase -1.31 ** 
XM_001250637 NA NA -1.31 ** 
XM_587493 AGFG2 ArfGAP with FG repeats 2 -1.31 *** 
NM_001081605 MTMR3 myotubularin related protein 3 -1.31 *** 
NM_001035497 UBE2V1 ubiquitin-conjugating enzyme E2 variant 1 -1.31 *** 
NM_001035028 EIF4B eukaryotic translation initiation factor 4B -1.31 *** 
NM_001037607 ARFRP1 ADP-ribosylation factor related protein 1 -1.31 *** 
NM_001076811 KLHL21 kelch-like 21 (Drosophila) -1.31 *** 
XM_877976 NFAT5 nuclear factor of activated T-cells 5, 
tonicity-responsive 
-1.31 ** 
NM_001034518 CYB5R1 cytochrome b5 reductase 1 -1.31 ** 
NM_174218 WARS tryptophanyl-tRNA synthetase -1.31 * 
NM_001075620 BANP BTG3 associated nuclear protein -1.31 *** 
XM_599314 ANKRD52 ankyrin repeat domain 52 -1.31 * 
NM_001076445 RABL4 RAB, member of RAS oncogene family-
like 4 
-1.31 *** 
NM_001046316 LGALS3BP lectin, galactoside-binding, soluble, 3 
binding protein 
-1.31 ** 
XM_865144 DYM dymeclin -1.31 ** 
NM_001098909 ELF3 E74-like factor 3 (ets domain transcription 
factor, epithelial-specific ) 
-1.31 *** 
NM_001035320 CDK2AP2 cyclin-dependent kinase 2 associated 
protein 2 
-1.31 *** 
NM_001075784 CLCC1 chloride channel CLIC-like 1 -1.31 *** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
XM_001250371 LOC785188 similar to transcriptional adaptor 2 (ADA2 
homolog, yeast)-beta 
-1.31 *** 
XM_616212 PTPRM protein tyrosine phosphatase, receptor type, 
M 
-1.31 *** 
XM_869282 LOC617094 similar to phosphoglucomutase 5 -1.31 * 
NM_001035459 BAD BCL2-associated agonist of cell death -1.31 *** 
NM_174783 PI4KB phosphatidylinositol 4-kinase, catalytic, 
beta 
-1.31 *** 
NM_001015578 EHD1 EH-domain containing 1 -1.31 *** 
NM_001076919 KIAA1949 KIAA1949 -1.31 ** 
NM_001102477 UBA1 ubiquitin-like modifier activating enzyme 1 -1.31 *** 
NM_001034319 ACAA1 acetyl-Coenzyme A acyltransferase 1 -1.31 *** 
NM_001104994 THAP11 THAP domain containing 11 -1.31 * 
NM_001046324 HSD17B8 hydroxysteroid (17-beta) dehydrogenase 8 -1.31 *** 
XM_592945 LOC515009 similar to I-1 receptor candidate protein -1.31 ** 
NM_001040475 RBP4 retinol binding protein 4, plasma -1.31 * 
NM_001046346 WDR1 WD repeat domain 1 -1.31 * 
NM_001101210 SLC35C1 solute carrier family 35, member C1 -1.32 ** 
NM_001082608 HNRNPR heterogeneous nuclear ribonucleoprotein R -1.32 *** 
NM_001100355 SLC38A7 solute carrier family 38, member 7 -1.32 ** 
NM_001015570 LGALS9 lectin, galactoside-binding, soluble, 9 -1.32 * 
NM_001039177 LGALS9 lectin, galactoside-binding, soluble, 9 -1.32 * 
XR_027939 LOC783548 similar to tankyrase 1-binding protein 1 -1.32 * 
XM_608640 RNF215 ring finger protein 215 -1.32 *** 
NM_001040583 BRI3 brain protein I3 -1.32 ** 
NM_001075752 EIF4H eukaryotic translation initiation factor 4H -1.32 ** 
NM_001015555 AUP1 ancient ubiquitous protein 1 -1.32 ** 
NM_001024562 EMP3 epithelial membrane protein 3 -1.32 *** 
NM_001104969 LOC509540 hypothetical LOC509540 -1.32 ** 
XM_879421 ACTR1A ARP1 actin-related protein 1 homolog A, 
centractin alpha (yeast) 
-1.32 *** 
NM_001046620 VISA virus-induced signaling adapter -1.32 ** 
XM_001253451 CD320 CD320 molecule -1.32 * 
XR_027898 LOC784355 similar to KLC4 protein -1.32 *** 
NM_001034491 PDLIM4 PDZ and LIM domain 4 -1.32 * 
NM_001075371 BSG basigin -1.32 *** 
XM_877864 MPPE1 metallophosphoesterase 1 -1.32 *** 
NM_174246 AVPR2 arginine vasopressin receptor 2 -1.32 *** 
XM_001250147 IER5L immediate early response 5-like -1.32 ** 
NM_001035080 MTF1 metal-regulatory transcription factor 1 -1.32 *** 
XR_027575 LOC515924 similar to ret proto-oncogene -1.32 *** 
NM_001103183 POLDIP3 polymerase (DNA-directed), delta 
interacting protein 3 
-1.32 ** 
NM_174487 VEGFB vascular endothelial growth factor B -1.32 ** 
XM_001254185 NA NA -1.32 ** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001100315 TMEM189 transmembrane protein 189 -1.32 *** 
NM_001040568 N-PAC cytokine-like nuclear factor n-pac -1.32 *** 
NM_001076889 NRBP1 nuclear receptor binding protein 1 -1.32 ** 
NM_174777 NDST2 N-deacetylase/N-sulfotransferase (heparan 
glucosaminyl) 2 
-1.32 *** 
XM_001254956 NA NA -1.32 *** 
XR_028724 CHD3 chromodomain helicase DNA binding 
protein 3 
-1.33 *** 
NM_001076924 C19H17OR
F28 
chromosome 17 open reading frame 28 
ortholog 
-1.33 ** 
NM_001034387 NUP85 nucleoporin 85kDa -1.33 *** 
XM_585307 NPLOC4 nuclear protein localization 4 homolog (S. 
cerevisiae) 
-1.33 ** 
NM_001103224 ANXA6 annexin A6 -1.33 ** 
NM_001113724 ANAPC11 anaphase promoting complex subunit 11 -1.33 *** 
NM_001098953 MAPK12 mitogen-activated protein kinase 12 -1.33 *** 
NM_001076931 PRSS8 protease, serine, 8 -1.33 *** 
NM_001099192 ADSSL1 adenylosuccinate synthase like 1 -1.33 *** 
XM_001257227 NA NA -1.33 *** 
NM_001075850 WDR13 WD repeat domain 13 -1.33 *** 
XM_589271 FBLN2 fibulin 2 -1.33 ** 
XM_001255254 MAPKAPK
2 
mitogen-activated protein kinase-activated 
protein kinase 2 
-1.33 ** 
NM_001075211 SNF8 SNF8, ESCRT-II complex subunit, 
homolog (S. cerevisiae) 
-1.33 *** 
NM_001102268 CCNY cyclin Y -1.33 ** 
XM_599356 LOC521099 similar to family with sequence similarity 
20, member A 
-1.33 *** 
NM_001035026 BSDC1 BSD domain containing 1 -1.33 *** 
XM_592304 FLII flightless I homolog (Drosophila) -1.33 *** 
NM_174834 MYH10 myosin, heavy chain 10, non-muscle -1.33 *** 
NM_001034322 FKBP4 FK506 binding protein 4, 59kDa -1.33 ** 
NM_174119 NCF1 neutrophil cytosolic factor 1 -1.33 ** 
NM_001081510 SF3A1 splicing factor 3a, subunit 1, 120kDa -1.33 ** 
NM_001076538 ST14 suppression of tumorigenicity 14 (colon 
carcinoma) 
-1.33 ** 
NM_001046133 PUF60 poly-U binding splicing factor 60KDa -1.34 *** 
NM_205788 CEACAM8 carcinoembryonic antigen-related cell 
adhesion molecule 8 
-1.34 *** 
NM_001075154 RGL2 ral guanine nucleotide dissociation 
stimulator-like 2 
-1.34 ** 
NM_001105480 BLES03 basophilic leukemia expressed protein 
BLES03 
-1.34 *** 
NM_001034315 AHCY S-adenosylhomocysteine hydrolase -1.34 ** 
XM_585239 EIF4GI eIF4GI protein -1.34 *** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001035375 SDF4 stromal cell derived factor 4 -1.34 *** 
NM_001014901 RBM14 RNA binding motif protein 14 -1.34 *** 
XM_869552 YIF1B Yip1 interacting factor homolog B (S. 
cerevisiae) 
-1.34 *** 
NM_001038523 CCDC124 coiled-coil domain containing 124 -1.34 *** 
NM_001038030 SGTA small glutamine-rich tetratricopeptide 
repeat (TPR)-containing, alpha 
-1.34 ** 
XM_870523 SDC3 syndecan 3 -1.34 *** 
XM_001249718 LOC783159 similar to v-rel reticuloendotheliosis viral 
oncogene homolog A, nuclear factor of 
kappa light polypeptide gene enhancer in B-
cells 3, p65 
-1.34 *** 
NM_001076372 CCND2 cyclin D2 -1.34 ** 
AFFX-
Bt_GST_5 
NA NA -1.34 ** 
NM_001035489 MRPL38 mitochondrial ribosomal protein L38 -1.34 *** 
NM_001098003 TMCO3 transmembrane and coiled-coil domains 3 -1.34 *** 
NM_001075444 STX5 syntaxin 5 -1.34 *** 
NM_001098967 TMEM138 transmembrane protein 138 -1.34 *** 
XM_880923 NA NA -1.34 *** 
NM_001076487 H1F0 H1 histone family, member 0 -1.34 * 
XM_867588 INTS3 integrator complex subunit 3 -1.34 *** 
NM_001081545 RAB40C RAB40C, member RAS oncogene family -1.34 *** 
NM_001046048 SELENBP1 selenium binding protein 1 -1.34 * 
NM_001102505 RAF1 v-raf-1 murine leukemia viral oncogene 
homolog 1 
-1.34 ** 
NM_001046548 C7H19orf2
2 
chromosome 19 open reading frame 22 
ortholog 
-1.35 *** 
NM_001081711 SAE1 SUMO1 activating enzyme subunit 1 -1.35 ** 
XM_001251013 AQP5 aquaporin 5 -1.35 ** 
NM_001040557 SMARCB1 SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, 
subfamily b, member 1 
-1.35 ** 
XM_870269 CUL4A cullin 4A -1.35 *** 
NM_001075218 S100A16 S100 calcium binding protein A16 -1.35 *** 
NM_001035426 SCAMP3 secretory carrier membrane protein 3 -1.35 *** 
NM_001080362 LYPLA2 lysophospholipase II -1.35 ** 
NM_001098856 S100A11 S100 calcium binding protein A11 
(calgizzarin) 
-1.35 ** 
NM_001035035 PDXP pyridoxal (pyridoxine, vitamin B6) 
phosphatase 
-1.35 *** 
NM_001101852 TSPAN4 tetraspanin 4 -1.35 *** 
NM_001075305 SHC1 SHC (Src homology 2 domain containing) 
transforming protein 1 
-1.35 *** 
XM_590012 GRK4 G protein-coupled receptor kinase 4 -1.35 ** 
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XM_001251271 NA NA -1.35 ** 
NM_001077922 RHOB ras homolog gene family, member B -1.35 *** 
XM_001251998 NA NA -1.35 *** 
NM_174509 CACNB3 calcium channel, voltage-dependent, beta 3 
subunit 
-1.35 *** 
NM_001098093 ST5 suppression of tumorigenicity 5 -1.35 *** 
NM_001046470 TMEM109 transmembrane protein 109 -1.35 *** 
XM_870939 SPHK1 sphingosine kinase 1 -1.35 *** 
NM_001075649 NAT15 N-acetyltransferase 15 (GCN5-related, 
putative) 
-1.35 *** 
NM_001024546 LPCAT3 lysophosphatidylcholine acyltransferase 3 -1.35 ** 
NM_001075811 TFE3 transcription factor binding to IGHM 
enhancer 3 
-1.35 *** 
NM_001014927 DHCR7 7-dehydrocholesterol reductase -1.36 ** 
NM_001077094 CYTH2 cytohesin 2 -1.36 ** 
NM_001038160 BBS2 Bardet-Biedl syndrome 2 -1.36 * 
NM_174195 TCN2 transcobalamin II ///  macrocytic anemia -1.36 *** 
XM_591526 FMNL3 formin-like 3 -1.36 *** 
XM_594391 GPSM3 G-protein signaling modulator 3 (AGS3-
like, C. elegans) 
-1.36 ** 
XR_028354 LOC614048 similar to bromodomain-containing protein 
4 
-1.36 ** 
XM_864659 TMEM195 transmembrane protein 195 -1.36 ** 
NM_174660 SLC25A6 solute carrier family 25 (mitochondrial 
carrier ///  adenine nucleotide translocator), 
member 6 
-1.36 ** 
XM_593945 LOC540422 similar to tigger transposable element 
derived 5 
-1.36 *** 
XM_864245 GOLGA1 golgi autoantigen, golgin subfamily a, 1 -1.36 *** 
NM_001015589 BSCL2 Bernardinelli-Seip congenital lipodystrophy 
2 (seipin) 
-1.36 *** 
NM_001024574 NFIC nuclear factor I/C (CCAAT-binding 
transcription factor) 
-1.36 *** 
NM_001083388 COL18A1 collagen, type XVIII, alpha 1 -1.36 ** 
NM_001083703 RNF185 ring finger protein 185 -1.36 *** 
NM_001035429 TPST2 tyrosylprotein sulfotransferase 2 -1.36 * 
NM_001034055 ADIPOR1 adiponectin receptor 1 -1.36 *** 
NM_001076214 DRAP1 DR1-associated protein 1 (negative cofactor 
2 alpha) 
-1.36 *** 
NM_001038585 PCID2 PCI domain containing 2 -1.36 *** 
XM_584231 DBNDD2 dysbindin (dystrobrevin binding protein 1) 
domain containing 2 
-1.36 *** 
NM_001076535 DHX30 DEAH (Asp-Glu-Ala-His) box polypeptide 
30 
-1.37 *** 
 
Supplementary material 
 
 
 
75 
Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_176788 CEBPB CCAAT/enhancer binding protein (C/EBP), 
beta 
-1.37 * 
XM_602222 TXNDC15 thioredoxin domain containing 15 -1.37 *** 
XM_001252640 LOC512397 similar to Uncharacterized protein 
KIAA0552 
-1.37 *** 
XM_589910 NA NA -1.37 *** 
NM_001076151 WDR45 WD repeat domain 45 -1.37 *** 
NM_001046511 ARD1A ARD1 homolog A, N-acetyltransferase -1.37 *** 
NM_001035390 POR cytochrome P450 reductase -1.37 * 
NM_001101204 DGCR8 DiGeorge syndrome critical region gene 8 -1.37 *** 
XM_865427 OSBPL11 oxysterol binding protein-like 11 -1.37 ** 
NM_001101949 AKR7A2 aldo-keto reductase family 7, member A2 
(aflatoxin aldehyde reductase) 
-1.37 ** 
NM_001083774 CHCHD10 coiled-coil-helix-coiled-coil-helix domain 
containing 10 
-1.37 *** 
NM_174789 SERPINB6 serpin peptidase inhibitor, clade B 
(ovalbumin), member 6 
-1.37 ** 
NM_001001601 CDH5 cadherin 5, type 2 (vascular endothelium) -1.37 *** 
NM_001076383 MID1IP1 MID1 interacting protein 1 (gastrulation 
specific G12 homolog (zebrafish)) 
-1.37 *** 
NM_001046123 MRPS5 mitochondrial ribosomal protein S5 -1.37 * 
NM_001034344 ETHE1 ethylmalonic encephalopathy 1 -1.37 ** 
NM_174584 PRKACA protein kinase, cAMP-dependent, catalytic, 
alpha 
-1.37 ** 
NM_174746 ACSS1 acyl-CoA synthetase short-chain family 
member 1 
-1.37 ** 
NM_001075380 C7H19orf2
5 
chromosome 19 open reading frame 25 
ortholog 
-1.37 *** 
NM_001075440 SEMA4A sema domain, immunoglobulin domain (Ig), 
transmembrane domain (TM) and short 
cytoplasmic domain, (semaphorin) 4A 
-1.37 *** 
XM_586037 ZBED1 zinc finger, BED-type containing 1 -1.37 ** 
NM_001046198 PHB2 prohibitin 2 -1.37 *** 
XM_001256027 NA NA -1.37 ** 
XM_001256033 SMARCD2 SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, 
subfamily d, member 2 
-1.37 ** 
NM_001035338 CDC37 cell division cycle 37 homolog (S. 
cerevisiae) 
-1.38 ** 
NM_175776 TSPO translocator protein (18kDa) -1.38 ** 
NM_001102149 MGC15995
4 
hypothetical LOC533041 -1.38 ** 
XM_865548 LOC614166 similar to Uncharacterized protein C8orf42 
homolog 
-1.38 *** 
NM_174505 ATP6V0D1 ATPase, H+ transporting, lysosomal 
38kDa, V0 subunit d1 
-1.38 *** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001035099 CD81 CD81 molecule -1.38 *** 
XM_615408 TUBB1 tubulin, beta 1 -1.38 *** 
NM_001046089 HGS hepatocyte growth factor-regulated tyrosine 
kinase substrate 
-1.38 *** 
NM_001037589 331879680
0 
membrane-associated ring finger (C3HC4) 
2 
-1.38 *** 
NM_174552 IFNAR1 interferon, alpha ///  receptor -1.38 ** 
NM_001083436 GUSB glucuronidase, beta -1.38 *** 
XM_582199 AACS acetoacetyl-CoA synthetase -1.38 *** 
NM_001075592 MANSC1 MANSC domain containing 1 -1.38 ** 
NM_174220 YARS tyrosyl-tRNA synthetase -1.38 *** 
XM_589879 ANO9 anoctamin 9 -1.38 *** 
NM_001035409 STIM1 stromal interaction molecule 1 -1.38 * 
NM_001076951 MGC14281
1 
hypothetical protein LOC618672 -1.38 *** 
NM_001075799 TRIM27 tripartite motif-containing 27 -1.38 *** 
NM_001075922 DDIT4 DNA-damage-inducible transcript 4 -1.38 ** 
NM_001075124 LAMP1 lysosomal-associated membrane protein 1 -1.38 *** 
NM_001076027 HSPB6 heat shock protein, alpha-crystallin-related, 
B6 
-1.38 ** 
NM_001080244 PFKL phosphofructokinase, liver -1.38 *** 
NM_001075997 NUDCD3 NudC domain containing 3 -1.38 *** 
XM_868381 GRAMD1A GRAM domain containing 1A -1.38 *** 
XM_001256238 NA NA -1.38 * 
NM_001038169 TEX264 testis expressed 264 -1.38 *** 
XM_001252095 NA NA -1.38 *** 
XM_001252121 TEX264 testis expressed 264 -1.38 *** 
NM_001102093 FFR Protein fat-free homolog -1.38 *** 
NM_001075415 SLC25A39 solute carrier family 25, member 39 -1.38 *** 
NM_174801 PPM1G protein phosphatase 1G (formerly 2C), 
magnesium-dependent, gamma isoform 
-1.39 *** 
XM_594051 NA NA -1.39 *** 
XR_028564 LOC787736 similar to Selenoprotein M precursor 
(Protein SelM) 
-1.39 ** 
NM_001075832 EFHD1 EF-hand domain family, member D1 -1.39 *** 
XM_868906 SUPT6H suppressor of Ty 6 homolog (S. cerevisiae) -1.39 *** 
XM_589440 GNAI2 guanine nucleotide binding protein (G 
protein), alpha inhibiting activity 
polypeptide 2 
-1.39 *** 
NM_174428 POLD2 polymerase (DNA directed), delta 2, 
regulatory subunit 50kDa 
-1.39 *** 
NM_001014964 ARAF v-raf murine sarcoma 3611 viral oncogene 
homolog 
-1.39 *** 
NM_001040537 GTF2H5 general transcription factor IIH, polypeptide 
5 
-1.39 *** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001037456 GIYD GIY-YIG domain containing -1.39 *** 
XR_027423 LOC539690 similar to Complement component C1q 
receptor precursor (Complement 
component 1 q subcomponent receptor 1) 
(C1qR) (C1qRp) (C1qR(p)) 
(C1q/MBL/SPA receptor) (Matrix-
remodeling-associated protein 4) (CD93 
antigen) (CDw93) 
-1.39 ** 
NM_001079600 TMEM120A transmembrane protein 120A -1.39 *** 
XM_001252004 NA NA -1.39 *** 
NM_001098149 TUBGCP2 tubulin, gamma complex associated protein 
2 
-1.39 *** 
NM_001102136 NXN nucleoredoxin -1.39 *** 
XM_613708 CRTAP cartilage associated protein -1.39 ** 
NM_001034522 AMBRA1 autophagy/beclin-1 regulator 1 -1.39 *** 
NM_001046191 CRELD2 cysteine-rich with EGF-like domains 2 -1.39 ** 
XM_591339 RFWD3 ring finger and WD repeat domain 3 -1.40 ** 
NM_001040602 RHOF ras homolog gene family, member F (in 
filopodia) 
-1.40 *** 
NM_001012287 BREH1 retinyl ester hydrolase type 1 -1.40 *** 
XM_580317 COL4A1 collagen, type IV, alpha 1 -1.40 ** 
NM_174511 CCL3 chemokine (C-C motif) ligand 3 -1.40 *** 
NM_001046140 SDCCAG3 serologically defined colon cancer antigen 3 -1.40 *** 
NM_001035316 PPP1CA protein phosphatase 1, catalytic subunit, 
alpha isoform 
-1.40 *** 
NM_001038156 LRRC28 leucine rich repeat containing 28 -1.40 *** 
NM_205798 TMBIM1 transmembrane BAX inhibitor motif 
containing 1 
-1.40 *** 
XM_001257081 NA NA -1.40 *** 
XR_028890 NA NA -1.40 *** 
NM_001046478 RHBDD2 rhomboid domain containing 2 -1.40 *** 
XR_028604 LOC508226 similar to CDC42-binding protein kinase 
beta 
-1.40 *** 
NM_001038110 VASP vasodilator-stimulated phosphoprotein -1.40 *** 
NM_001014961 FAM110A family with sequence similarity 110, 
member A 
-1.40 *** 
NM_201528 SLC2A8 solute carrier family 2 (facilitated glucose 
transporter), member 8 
-1.40 *** 
XR_028087 LOC516155 similar to Mannosyl-oligosaccharide 
glucosidase (Processing A-glucosidase I) 
-1.40 *** 
NM_001035326 CTSA cathepsin A -1.40 *** 
XM_867034 ELAC2 elaC homolog 2 (E. coli) -1.40 *** 
NM_001078079 AIF1L allograft inflammatory factor 1-like -1.41 *** 
XM_001252568 NA NA -1.41 *** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
XM_614021 DHX57 DEAH (Asp-Glu-Ala-Asp/His) box 
polypeptide 57 
-1.41 ** 
NM_001034231 ID2 inhibitor of DNA binding 2, dominant 
negative helix-loop-helix protein 
-1.41 ** 
NM_001101306 TNFRSF6B tumor necrosis factor receptor superfamily, 
member 6b, decoy 
-1.41 ** 
NM_001076053 FAM73B hypothetical protein LOC535315 -1.41 *** 
NM_001076219 YIPF3 Yip1 domain family, member 3 -1.41 ** 
NM_001035108 CNDP2 CNDP dipeptidase 2 (metallopeptidase M20 
family) 
-1.41 ** 
NM_001075656 JUNB jun B proto-oncogene -1.41 ** 
NM_001083439 SUPT5H suppressor of Ty 5 homolog (S. cerevisiae) -1.41 *** 
NM_001098968 TAF10 TAF10 RNA polymerase II, TATA box 
binding protein (TBP)-associated factor, 
30kDa 
-1.41 *** 
NM_001076237 SLC39A7 solute carrier family 39 (zinc transporter), 
member 7 
-1.41 *** 
NM_174703 TNXB tenascin XB -1.41 ** 
NM_001038029 TBC1D20 TBC1 domain family, member 20 -1.41 *** 
XM_590408 GPIHBP1 glycosylphosphatidylinositol anchored high 
density lipoprotein binding protein 1 
-1.41 *** 
NM_001015592 PFN1 profilin 1 -1.41 ** 
XM_580667 GAS6 growth arrest-specific 6 -1.42 ** 
NM_001034282 SHMT2 serine hydroxymethyltransferase 2 
(mitochondrial) 
-1.42 *** 
NM_001075340 MFSD5 major facilitator superfamily domain 
containing 5 
-1.42 *** 
NM_001045879 PDIA4 protein disulfide isomerase family A, 
member 4 
-1.42 ** 
NM_001103245 EFHD2 EF-hand domain family, member D2 -1.42 *** 
NM_001076272 ZFPL1 zinc finger protein-like 1 -1.42 *** 
NM_001046615 VPS4A vacuolar protein sorting 4 homolog A (S. 
cerevisiae) 
-1.42 *** 
NM_001076405 RNF167 ring finger protein 167 -1.42 *** 
NM_001101899 SYVN1 synovial apoptosis inhibitor 1, synoviolin -1.42 ** 
XM_614120 ATP13A1 ATPase type 13A1 -1.42 *** 
NM_205801 CLDN3 claudin 3 -1.42 *** 
NM_001040486 SLC38A3 solute carrier family 38, member 3 -1.42 ** 
NM_001077943 FAM62A family with sequence similarity 62 (C2 
domain containing), member A 
-1.42 *** 
XM_001253241 NA NA -1.42 *** 
NM_001097575 RTEL regulator of telomere elongation helicase 1 -1.43 *** 
NM_001101915 ALDOA aldolase A, fructose-bisphosphate -1.43 *** 
NM_001105489 NPDC1 neural proliferation, differentiation and 
control, 1 
-1.43 ** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
XM_588361 TSEN54 tRNA splicing endonuclease 54 homolog 
(S. cerevisiae) 
-1.43 *** 
NM_001014939 TBCB tubulin folding cofactor B -1.43 *** 
NM_001046008 PXMP2 peroxisomal membrane protein 2, 22kDa -1.43 ** 
NM_001046190 ABCD1 ATP-binding cassette, sub-family D (ALD), 
member 1 
-1.43 *** 
NM_001102006 SSH3 slingshot homolog 3 (Drosophila) -1.43 *** 
XM_870452 FXR2 fragile X mental retardation, autosomal 
homolog 2 
-1.43 *** 
NM_001082602 DDX41 DEAD (Asp-Glu-Ala-Asp) box polypeptide 
41 
-1.44 *** 
NM_001034473 ZNF205 zinc finger protein 205 -1.44 *** 
NM_174625 TXNRD1 thioredoxin reductase 1 -1.44 *** 
XM_612111 NA NA -1.44 ** 
XM_581459 EHD4 EH-domain containing 4 -1.44 *** 
XR_027523 LOC506239 similar to Spectrin beta chain, brain 2 
(Spectrin, non-erythroid beta chain 2) 
(Beta-III spectrin) 
-1.44 *** 
NM_001102356 EIF3B eukaryotic translation initiation factor 3, 
subunit B 
-1.44 *** 
NM_174216 VEGFA vascular endothelial growth factor A -1.44 ** 
NM_001076496 SCN1B sodium channel, voltage-gated, type I, beta -1.44 *** 
NM_001034246 STAP2 signal transducing adaptor family member 2 -1.44 *** 
NM_001046340 H2AFY H2A histone family, member Y -1.44 *** 
XM_589863 FKBP8 FK506 binding protein 8, 38kDa -1.44 ** 
NM_176670 ATP5D ATP synthase, H+ transporting, 
mitochondrial F1 complex, delta subunit 
-1.45 *** 
NM_001079612 SLC35A4 solute carrier family 35, member A4 -1.45 *** 
XM_001250904 NA NA -1.45 *** 
NM_001110446 DGCR6L DiGeorge syndrome critical region gene 6-
like 
-1.45 *** 
NM_001034627 GSN gelsolin (amyloidosis, Finnish type) -1.45 ** 
NM_001113284 GSN gelsolin (amyloidosis, Finnish type) -1.45 ** 
XM_582618 EVL Enah/Vasp-like -1.45 *** 
NM_173885 ACK1 activated p21cdc42Hs kinase -1.45 *** 
NM_001078101 ZYX zyxin -1.46 ** 
NM_001046402 ALKBH7 alkB, alkylation repair homolog 7 (E. coli) -1.46 *** 
XM_606600 NA NA -1.46 *** 
NM_001075600 EXOC3 exocyst complex component 3 -1.46 ** 
NM_001076184 PAK4 p21 protein (Cdc42/Rac)-activated kinase 4 -1.46 *** 
XM_605214 LOC526838 similar to transcriptional adaptor 2 (ADA2 
homolog, yeast)-beta 
-1.46 *** 
NM_177432 IRF1 interferon regulatory factor 1 -1.46 ** 
XM_001253779 NA NA -1.46 *** 
XM_599078 NA NA -1.46 *** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_174383 LOXL1 lysyl oxidase-like 1 -1.46 * 
NR_003958 H19 H19, imprinted maternally expressed 
untranslated mRNA 
-1.46 * 
XM_611412 NA NA -1.46 * 
XR_028883 NA NA -1.46 ** 
NM_180998 LTF lactotransferrin -1.46 ** 
NM_001035471 SMS spermine synthase -1.46 ** 
XM_001255494 AKR7A2 aldo-keto reductase family 7, member A2 
(aflatoxin aldehyde reductase) 
-1.46 ** 
NM_174078 GUK1 guanylate kinase 1 -1.46 *** 
NM_173892 ASS1 argininosuccinate synthetase 1 -1.46 ** 
NM_001038507 GLTSCR2 glioma tumor suppressor candidate region 
gene 2 
-1.46 *** 
NM_001034775 BCL7B B-cell CLL/lymphoma 7B -1.46 *** 
NM_001079587 ZFYVE21 zinc finger, FYVE domain containing 21 -1.47 *** 
XM_001255790 NA NA -1.47 *** 
NM_001045888 PCOLCE procollagen C-endopeptidase enhancer -1.47 ** 
NM_174277 CLTLB clathrin, light polypeptide B (light chain B) -1.47 *** 
XM_610785 NA NA -1.47 ** 
XM_873294 SYT17 synaptotagmin XVII -1.47 ** 
NM_174837 CYB561 cytochrome b-561 -1.47 *** 
NM_001024485 POMGNT1 protein O-linked mannose beta1,2-N-
acetylglucosaminyltransferase 
-1.47 *** 
XM_589552 MAP7D1 MAP7 domain containing 1 -1.47 *** 
NM_001075718 TPP1 tripeptidyl peptidase I -1.47 *** 
NM_001046435 CALCOCO
1 
calcium binding and coiled-coil domain 1 -1.47 *** 
NM_001046411 KRT7 keratin 7 -1.48 ** 
AFFX-
Bt_GST_3 
NA NA -1.48 *** 
NM_001035354 GPD1 glycerol-3-phosphate dehydrogenase 1 
(soluble) 
-1.48 * 
NM_174077 GPX3 glutathione peroxidase 3 (plasma) -1.48 * 
NM_001101841 RNPS1 RNA binding protein S1, serine-rich 
domain 
-1.48 *** 
XM_865331 SNRNP200 small nuclear ribonucleoprotein 200kDa 
(U5) 
-1.48 *** 
NM_001105339 ACSS2 acyl-CoA synthetase short-chain family 
member 2 
-1.48 * 
NM_001099137 SRD5A1 steroid-5-alpha-reductase, alpha 
polypeptide 1 (3-oxo-5 alpha-steroid delta 
4-dehydrogenase alpha 1) 
-1.48 * 
AFFX-
Bt_GST_M 
NA NA -1.48 *** 
XM_867318 STX10 syntaxin 10 -1.48 *** 
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Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_174201 TP53 tumor protein p53 -1.48 *** 
NM_001098029 FBLN1 fibulin 1 -1.48 * 
NM_001034763 SH3BGRL3 SH3 domain binding glutamic acid-rich 
protein like 3 
-1.48 *** 
NM_001113302 SREBF1 sterol regulatory element binding 
transcription factor 1 
-1.48 *** 
NM_174741 BCAM basal cell adhesion molecule (Lutheran 
blood group) 
-1.48 ** 
NM_001034477 ARFIP2 ADP-ribosylation factor interacting protein 
2 
-1.48 ** 
NM_182988 BANF1 barrier to autointegration factor 1 -1.48 *** 
XM_001250905 NA NA -1.48 *** 
XM_001250955 NA NA -1.48 *** 
NM_001017953 PDGFB platelet-derived growth factor beta 
polypeptide (simian sarcoma viral (v-sis) 
oncogene homolog) 
-1.48 *** 
XR_028669 LOC788643 similar to platelet-derived growth factor 
beta 
-1.48 *** 
NM_001040604 GADD45B growth arrest and DNA-damage-inducible, 
beta 
-1.49 ** 
NM_001035460 MGC12804
9 
hypothetical protein LOC615081 -1.49 *** 
NM_001075789 SOX18 SRY (sex determining region Y)-box 18 -1.49 *** 
XM_863839 ZMIZ2 zinc finger, MIZ-type containing 2 -1.49 *** 
NM_174537 FCER1G Fc fragment of IgE, high affinity I, receptor 
for ///  gamma polypeptide 
-1.49 ** 
NM_001017936 RAB25 RAB25, member RAS oncogene family -1.49 ** 
XM_614378 SPRYD3 SPRY domain containing 3 -1.49 *** 
NM_001077909 INSIG1 insulin induced gene 1 -1.49 ** 
XM_001249363 NA NA -1.49 ** 
XM_001249423 NA NA -1.49 ** 
XM_001251214 LOC782581 similar to DEXI -1.49 *** 
NM_001076337 MRPL14 mitochondrial ribosomal protein L14 -1.49 *** 
XM_001252338 LOC784449 similar to KIAA1324 -1.49 * 
NM_001046020 RARRES2 retinoic acid receptor responder (tazarotene 
induced) 2 
-1.49 ** 
NM_001078116 ABHD12 abhydrolase domain containing 12 -1.49 ** 
XM_866852 EIF4ENIF1 eukaryotic translation initiation factor 4E 
nuclear import factor 1 
-1.50 *** 
NM_001037477 PPP2R1A protein phosphatase 2 (formerly 2A), 
regulatory subunit A, alpha isoform 
-1.50 *** 
NM_001105376 IPO9 importin 9 -1.50 *** 
NM_001105390 IPO13 importin 13 -1.50 *** 
NM_174521 CORO1A coronin, actin binding protein, 1A -1.50 * 
NM_001083401 PRKCDBP protein kinase C, delta binding protein -1.50 *** 
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XM_001250004 PFN1 profilin 1 -1.50 ** 
XM_588401 IMPA2 inositol(myo)-1(or 4)-monophosphatase 2 -1.50 *** 
NM_174791 PTGDS prostaglandin D2 synthase 21kDa (brain) -1.51 * 
NM_001100300 C11H9ORF
142 
chromosome 9 open reading frame 142 
ortholog 
-1.51 *** 
NM_174821 SERPING1 serpin peptidase inhibitor, clade G (C1 
inhibitor), member 1 
-1.51 ** 
NM_001076995 AAMP angio-associated, migratory cell protein -1.51 *** 
NM_001046209 RAB26 RAB26, member RAS oncogene family -1.51 ** 
NM_001034424 MAF1 MAF1 homolog (S. cerevisiae) -1.51 *** 
NM_001101294 DUSP7 dual specificity phosphatase 7 -1.51 *** 
NM_001105491 TMEM9 transmembrane protein 9 -1.51 *** 
NM_001046173 PPP2R4 protein phosphatase 2A activator, 
regulatory subunit 4 
-1.51 *** 
NM_174261 CAPNS1 calpain, small subunit 1 -1.52 *** 
XR_028390 NA NA -1.52 * 
NM_001034810 SEPX1 selenoprotein X, 1 -1.52 *** 
NM_174674 TNFRSF1A tumor necrosis factor receptor superfamily, 
member 1A 
-1.52 *** 
XM_599833 LOC521568 similar to ATP-binding cassette, sub-family 
C, member 4 
-1.52 ** 
XM_590721 NUMA1 nuclear mitotic apparatus protein 1 -1.52 ** 
NM_001045951 CARHSP1 calcium regulated heat stable protein 1, 
24kDa 
-1.52 ** 
NM_001046005 PNPLA2 patatin-like phospholipase domain 
containing 2 
-1.52 ** 
NM_001038071 MAP2K2 mitogen-activated protein kinase kinase 2 -1.52 *** 
NM_001098862 LZTS2 leucine zipper, putative tumor suppressor 2 -1.52 *** 
NM_001046130 SH3GL1 SH3-domain GRB2-like 1 -1.53 *** 
NM_001079780 H2AFX H2A histone family, member X -1.53 *** 
NM_001046479 ERI3 exoribonuclease 3 -1.53 *** 
NM_174577 PI4KA phosphatidylinositol 4-kinase, catalytic, 
alpha 
-1.53 *** 
NM_001082445 MED25 mediator complex subunit 25 -1.53 *** 
XM_592305 CLSTN1 calsyntenin 1 -1.53 *** 
NM_001034445 NADK NAD kinase -1.53 *** 
XM_001256815 NA NA -1.53 *** 
XM_590469 RASAL1 RAS protein activator like 1 (GAP1 like) -1.53 *** 
XM_587533 PRSS22 protease, serine, 22 -1.53 * 
NM_001113243 CORO1B coronin, actin binding protein, 1B -1.53 *** 
XR_028308 LOC787905 similar to Lectin, galactoside-binding, 
soluble, 4 (galectin 4) 
-1.53 *** 
NM_001035353 PLVAP plasmalemma vesicle associated protein -1.53 *** 
NM_001076030 OGDH oxoglutarate (alpha-ketoglutarate) 
dehydrogenase (lipoamide) 
-1.53 *** 
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NM_001014941 BCAP31 B-cell receptor-associated protein 31 -1.54 *** 
NM_001013597 MOCS1 molybdenum cofactor synthesis 1 -1.54 *** 
NM_001076419 NENF neuron derived neurotrophic factor -1.54 ** 
NM_001097561 GNB2 guanine nucleotide binding protein (G 
protein), beta polypeptide 2 
-1.54 *** 
NM_001035313 TGFB1I1 transforming growth factor beta 1 induced 
transcript 1 
-1.54 *** 
NM_001046026 DULLARD dullard homolog (Xenopus laevis) -1.54 *** 
XM_587457 ATP2C2 ATPase, Ca++ transporting, type 2C, 
member 2 
-1.54 * 
NM_001077926 ABO ABO blood group (transferase A, alpha 1-3-
N-acetylgalactosaminyltransferase ///  
transferase B, alpha 1-3-
galactosyltransferase) 
-1.54 ** 
NM_001035500 MRPS34 mitochondrial ribosomal protein S34 -1.54 *** 
NM_001034225 OS9 osteosarcoma amplified 9, endoplasmic 
reticulum associated protein 
-1.54 ** 
NM_001082443 SIGIRR single immunoglobulin and toll-interleukin 
1 receptor (TIR) domain 
-1.54 *** 
NM_001075166 STUB1 STIP1 homology and U-box containing 
protein 1 
-1.55 *** 
NM_001102242 PYGO2 pygopus homolog 2 (Drosophila) -1.55 *** 
XM_001256288 NA NA -1.55 *** 
NM_001076418 TPRG1L tumor protein p63 regulated 1-like -1.55 *** 
NM_001083655 PCDH1 protocadherin 1 -1.55 *** 
NM_001075246 METTL2B methyltransferase like 2B -1.55 *** 
NM_001038688 RRAS related RAS viral (r-ras) oncogene homolog -1.55 ** 
XM_583844 SERPINB1 serpin peptidase inhibitor, clade B 
(ovalbumin), member 1 
-1.55 ** 
NM_001034325 MGC12787
4 
hypothetical LOC508617 -1.56 *** 
NM_001034748 GPSN2 glycoprotein, synaptic 2 -1.56 *** 
NM_001077132 MGC13789
4 
hypothetical protein MGC137894 -1.56 *** 
NM_174329 GPR68 G protein-coupled receptor 68 -1.56 *** 
XM_001252015 LOC783399 similar to Equ c1 -1.56 * 
NM_183082 AIP aryl hydrocarbon receptor interacting 
protein 
-1.56 *** 
NM_001083432 TMEM214 transmembrane protein 214 -1.56 ** 
NM_001046139 TSTA3 tissue specific transplantation antigen P35B -1.56 ** 
NM_001040607 ASCL2 achaete-scute complex homolog 2 
(Drosophila) 
-1.56 ** 
NM_001110018 MAPK3 mitogen-activated protein kinase 3 -1.57 ** 
NM_001082471 BAG3 BCL2-associated athanogene 3 -1.57 ** 
NM_001001162 USF2 upstream transcription factor 2, c-fos 
interacting 
-1.57 ** 
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NM_001079511 C25H16orf
14 
chromosome 16 open reading frame 14 
ortholog 
-1.57 ** 
XM_001252534 NA NA -1.57 ** 
NM_001098139 SLC44A2 solute carrier family 44, member 2 -1.57 *** 
NM_001024510 CORO1B coronin, actin binding protein, 1B -1.57 *** 
NM_001014883 NR1H2 nuclear receptor subfamily 1, group H, 
member 2 
-1.57 *** 
NM_174617 STAT5B signal transducer and activator of 
transcription 5B 
-1.58 *** 
XM_001256223 LOC789476 similar to Signal transducer and activator of 
transcription 5B 
-1.58 *** 
XM_610839 FGFRL1 fibroblast growth factor receptor-like 1 -1.58 *** 
NM_001098864 ASNA1 arsA arsenite transporter, ATP-binding, 
homolog 1 (bacterial) 
-1.58 *** 
NM_001080726 CITED4 Cbp/p300-interacting transactivator, with 
Glu/Asp-rich carboxy-terminal domain, 4 
-1.58 ** 
NM_001045884 AP1M1 adaptor-related protein complex 1, mu 1 
subunit 
-1.58 *** 
NM_001102480 TMEM43 transmembrane protein 43 -1.58 *** 
NM_001077012 IFRD2 interferon-related developmental regulator 
2 
-1.58 *** 
NM_174202 TPSB1 tryptase beta 1 -1.58 *** 
NM_001081607 VIPR1 vasoactive intestinal peptide receptor 1 -1.58 *** 
XR_028159 NA NA -1.58 *** 
NM_175793 MAPK1 mitogen-activated protein kinase 1 -1.59 *** 
NM_001075960 CMTM7 CKLF-like MARVEL transmembrane 
domain containing 7 
-1.59 *** 
NM_001075190 LMF1 lipase maturation factor 1 -1.59 *** 
NM_001035009 NDRG1 N-myc downstream regulated 1 -1.60 *** 
NM_001105322 KRT17 keratin 17 -1.60 *** 
XM_001249839 NA NA -1.60 *** 
XM_001249888 NA NA -1.60 *** 
NM_001076352 LMO2 LIM domain only 2 (rhombotin-like 1) -1.60 *** 
XM_001256510 HDLBP high density lipoprotein binding protein -1.60 *** 
XM_869177 CLK2 CDC-like kinase 2 -1.60 *** 
NM_001034353 ERGIC3 ERGIC and golgi 3 -1.60 ** 
NM_001078066 ESAM endothelial cell adhesion molecule -1.60 *** 
XM_001255460 CENPB centromere protein B, 80kDa -1.60 *** 
NM_174611 SLC6A8 solute carrier family 6 (neurotransmitter 
transporter, creatine), member 8 
-1.60 *** 
NM_174064 GDI1 GDP dissociation inhibitor 1 -1.61 *** 
XM_866231 TMEM157 similar to transmembrane protein 157 -1.61 *** 
XM_591419 SPEN spen homolog, transcriptional regulator 
(Drosophila) 
-1.61 *** 
NM_001083434 AKT1S1 AKT1 substrate 1 (proline-rich) -1.61 *** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001113242 ERI3 exoribonuclease 3 -1.61 *** 
NM_001034768 LGALS4 lectin, galactoside-binding, soluble, 4 -1.62 *** 
XM_001251425 NA NA -1.62 * 
NM_001101908 TMEM120B transmembrane protein 120B -1.62 * 
NM_001046317 MPHOSPH
10 
M-phase phosphoprotein 10 (U3 small 
nucleolar ribonucleoprotein) 
-1.62 *** 
NM_001077065 SLC9A3R2 solute carrier family 9 (sodium/hydrogen 
exchanger), member 3 regulator 2 
-1.62 *** 
NM_175825 GSTM1 glutathione S-transferase M1 -1.62 *** 
XM_867316 GALE UDP-galactose-4-epimerase -1.63 *** 
NM_001034398 SLC29A1 solute carrier family 29 (nucleoside 
transporters), member 1 
-1.63 *** 
NM_173882 SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 1 
-1.63 ** 
NM_001102509 SURF4 surfeit 4 -1.63 *** 
NM_001014951 TMEM171 transmembrane protein 171 -1.63 *** 
NM_174161 PSAP prosaposin -1.63 *** 
NM_001024929 BHLHB2 basic helix-loop-helix domain containing, 
class B, 2 
-1.63 *** 
NM_001101305 LOC788925 hypothetical protein LOC788925 -1.64 *** 
NM_001034523 AP2M1 adaptor-related protein complex 2, mu 1 
subunit 
-1.64 *** 
XR_028269 LOC785503 similar to adaptor-related protein complex 
2, mu 1 subunit 
-1.64 *** 
NM_174396 MYO1C myosin IC -1.64 *** 
XM_001256191 LOC789436 similar to Vigilin (High density lipoprotein-
binding protein) (HDL-binding protein) 
-1.64 *** 
XM_593707 NA NA -1.65 *** 
NM_001083466 HNRNPUL
1 
heterogeneous nuclear ribonucleoprotein U-
like 1 
-1.65 *** 
NM_174442 PTBP1 polypyrimidine tract binding protein 1 -1.65 *** 
NM_174008 CD14 CD14 molecule -1.65 ** 
NM_173991 APOE apolipoprotein E -1.65 * 
NM_001038534 RNASEH2A ribonuclease H2, subunit A -1.65 *** 
XM_610753 RFNG RFNG O-fucosylpeptide 3-beta-N-
acetylglucosaminyltransferase 
-1.66 *** 
XR_028440 NA NA -1.66 *** 
NM_001034511 AP1M2 adaptor-related protein complex 1, mu 2 
subunit 
-1.66 *** 
NM_001034629 EPHX1 epoxide hydrolase 1, microsomal 
(xenobiotic) 
-1.66 *** 
NM_001097984 ALDOC aldolase C, fructose-bisphosphate -1.66 *** 
XR_027442 LOC533435 similar to BTB (POZ) domain containing 2 -1.66 *** 
NM_001034456 MLF2 myeloid leukemia factor 2 -1.66 *** 
NM_001076812 LOC507340 hypothetical LOC507340 -1.67 *** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_174629 UQCRC1 UQCRC1 protein -1.67 *** 
NM_001102121 TAPBPL TAP binding protein-like -1.67 *** 
NM_174443 PTGES prostaglandin E synthase -1.67 *** 
NM_001035081 RAB7A RAB7A, member RAS oncogene family -1.67 *** 
NM_001078078 PMEPA1 prostate transmembrane protein, androgen 
induced 1 
-1.68 *** 
NM_001101271 LOC618094 hypothetical LOC618094 -1.68 *** 
NM_001046387 MRI1 methylthioribose-1-phosphate isomerase 
homolog (S. cerevisiae) 
-1.68 *** 
NM_001046138 RHOC ras homolog gene family, member C -1.69 *** 
NM_001046431 EHD2 EH-domain containing 2 -1.69 *** 
NM_001075651 PDXK pyridoxal (pyridoxine, vitamin B6) kinase -1.69 ** 
NM_001037483 POLR2J polymerase (RNA) II (DNA directed) 
polypeptide J, 13.3kDa 
-1.70 *** 
NM_001105481 RAB8A RAB8A, member RAS oncogene family -1.71 *** 
NM_001035420 CNN2 calponin 2 -1.71 *** 
NM_001105441 ABHD14B abhydrolase domain containing 14B -1.72 *** 
NM_001040469 C3 complement component 3 -1.72 *** 
NM_001099053 LOXL2 lysyl oxidase-like 2 -1.72 *** 
NM_001034053 LMNA lamin A/C -1.72 *** 
NM_001034054 PGAM1 phosphoglycerate mutase 1 (brain) -1.73 *** 
NM_001075122 SRPR signal recognition particle receptor 
(docking protein) 
-1.74 *** 
NM_001079649 CRIP2 cysteine-rich protein 2 -1.74 *** 
NM_001103250 CYB5R3 cytochrome b5 reductase 3 -1.74 *** 
XM_001256604 LOC790007 similar to EH domain-containing protein 4 
(Hepatocellular carcinoma-associated 
protein 10/11) 
-1.74 *** 
NM_001046124 HM13 histocompatibility (minor) 13 -1.75 *** 
NM_001040554 HLA-A major histocompatibility complex, class I, 
A 
-1.75 *** 
NM_174194 TBCD tubulin folding cofactor D -1.75 *** 
XM_614220 LRP5 low density lipoprotein receptor-related 
protein 5 
-1.76 *** 
XR_027372 LOC534416 similar to WW domain-binding protein 11 
(WBP-11) (SH3 domain-binding protein 
SNP70) (Npw38-binding protein) (NpwBP) 
-1.76 *** 
NM_001077852 SLC9A3R1 solute carrier family 9 (sodium/hydrogen 
exchanger), member 3 regulator 1 
-1.77 *** 
XM_001254012 NA NA -1.77 *** 
NM_001099376 MINK1 misshapen-like kinase 1 (zebrafish) -1.77 *** 
NM_001083804 SCLY selenocysteine lyase -1.77 *** 
XR_028267 NA NA -1.77 *** 
XR_027440 NA NA -1.77 *** 
NM_176662 PRKCSH protein kinase C substrate 80K-H -1.77 *** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001075452 ROGDI rogdi homolog (Drosophila) -1.78 *** 
XM_876020 CNTFR ciliary neurotrophic factor receptor -1.78 *** 
XM_586851 LIPG lipase, endothelial -1.79 *** 
NM_001015571 ARF3 ADP-ribosylation factor 3 -1.80 *** 
NM_001034802 RAB24 RAB24, member RAS oncogene family -1.80 ** 
XM_001254705 IGK Ig kappa chain -1.80 ** 
NM_001099705 PCDHGA8 protocadherin gamma subfamily A, 8 -1.80 *** 
NM_001102513 PCDHGB4 protocadherin gamma subfamily B, 4 -1.80 *** 
NM_001103334 PCDHGC3 protocadherin gamma subfamily C, 3 -1.80 *** 
NM_001114080 PCDHGC3 protocadherin gamma subfamily C, 3 -1.80 *** 
XR_028187 NA NA -1.80 *** 
XM_001250641 SAMD1 sterile alpha motif domain containing 1 -1.80 *** 
NM_001099706 ECM1 extracellular matrix protein 1 -1.80 *** 
NM_001015630 GSS glutathione synthetase -1.81 ** 
NM_001046129 WIPI2 WD repeat domain, phosphoinositide 
interacting 2 
-1.81 *** 
XM_863846 SULF2 sulfatase 2 -1.81 *** 
XM_614520 LOC534672 similar to family with sequence similarity 
20, member C 
-1.81 *** 
XM_882308 TINAGL1 tubulointerstitial nephritis antigen-like 1 -1.82 *** 
XM_583785 TNFSF10 tumor necrosis factor (ligand) superfamily, 
member 10 
-1.82 *** 
NM_001075473 LOC510860 C4b-binding protein alpha-like -1.82 *** 
NM_001034632 PIN1 peptidylprolyl cis/trans isomerase, NIMA-
interacting 1 
-1.82 *** 
NM_001046367 SPINT1 serine peptidase inhibitor, Kunitz type 1 -1.83 *** 
NM_001099138 C1QTNF5 C1q and tumor necrosis factor related 
protein 5 
-1.83 *** 
NM_001034039 COL1A1 collagen, type I, alpha 1 -1.84 *** 
NM_001034452 TRABD TraB domain containing -1.84 *** 
NM_001114855 BoLA major histocompatibility complex, class I, 
A 
-1.85 *** 
XM_001251326 NA NA -1.85 *** 
NM_001014957 PYCR1 pyrroline-5-carboxylate reductase 1 -1.85 *** 
XM_001254365 NA NA -1.85 *** 
XR_028526 NA NA -1.86 *** 
NM_001046613 CLPTM1 cleft lip and palate associated 
transmembrane protein 1 
-1.86 *** 
NM_001099002 ORAI1 ORAI calcium release-activated calcium 
modulator 1 
-1.87 *** 
XM_603601 ATXN7L3 ataxin 7-like 3 -1.88 *** 
NM_001046509 MACROD1 MACRO domain containing 1 -1.88 *** 
XM_867430 GGT1 gamma-glutamyltransferase 1 -1.88 *** 
XM_881439 GSTM2 glutathione S-transferase M2 -1.90 *** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001034735 CD74 CD74 molecule, major histocompatibility 
complex, class II invariant chain 
-1.91 *** 
NM_001078041 PLD3 phospholipase D family, member 3 -1.91 *** 
XM_001253549 DUSP28 dual specificity phosphatase 28 -1.91 *** 
NM_001046358 CMTM8 CKLF-like MARVEL transmembrane 
domain containing 8 
-1.92 *** 
NM_001105051 RING1 ring finger protein 1 -1.93 *** 
XM_001249906 NA NA -1.95 *** 
NM_177518 AGPAT1 1-acylglycerol-3-phosphate O-
acyltransferase 1 (lysophosphatidic acid 
acyltransferase, alpha) 
-1.96 *** 
NM_001080246 PKN1 protein kinase N1 -1.97 *** 
NM_173986 AKT1 v-akt murine thymoma viral oncogene 
homolog 1 
-1.99 *** 
NM_001101056 CSNK1G2 casein kinase 1, gamma 2 -1.99 *** 
NM_174710 ADRBK1 adrenergic, beta, receptor kinase 1 -2.00 *** 
NM_001035319 RNH1 ribonuclease/angiogenin inhibitor 1 -2.00 *** 
XM_001249950 NA NA -2.01 *** 
NM_001013599 TAGLN2 transgelin 2 -2.02 *** 
NM_001077125 KLHL12 kelch-like 12 (Drosophila) -2.02 *** 
XM_584919 PLXNB2 plexin B2 -2.04 *** 
NM_001035087 HMOX2 heme oxygenase (decycling) 2 -2.04 *** 
NM_001076205 RBM42 RNA binding motif protein 42 -2.05 *** 
NM_001076026 LIN37 lin-37 homolog (C. elegans) -2.05 *** 
NM_001004024 JUP junction plakoglobin -2.06 *** 
NM_174493 ZFP36 zinc finger protein 36, C3H type, homolog 
(mouse) 
-2.07 *** 
NM_176650 ARHGDIA Rho GDP dissociation inhibitor (GDI) 
alpha 
-2.08 *** 
XM_001249809 LOC784095 similar to Rho GDP-dissociation inhibitor 1 
(Rho GDI 1) (Rho-GDI alpha) (GDI-1) 
-2.08 *** 
NM_001040480 PSMB8 proteasome (prosome, macropain) subunit, 
beta type, 8 (large multifunctional peptidase 
7) 
-2.08 *** 
NM_174224 ACACA acetyl-coenzyme A carboxylase alpha -2.10 *** 
XM_001255074 LOC787813 similar to acetyl-CoA-carboxylase -2.10 *** 
NM_001077871 SLC25A29 solute carrier family 25, member 29 -2.12 *** 
XM_001250445 NA NA -2.12 *** 
XM_001253132 NA NA -2.12 *** 
NM_001083371 C7H19ORF
43 
chromosome 19 open reading frame 43 
ortholog 
-2.12 *** 
NM_001015655 CFL1 cofilin 1 (non-muscle) -2.15 *** 
XM_001249857 NA NA -2.15 *** 
NM_001035285 SERINC2 serine incorporator 2 -2.16 *** 
XM_592497 TGFB1 transforming growth factor, beta 1 -2.17 *** 
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Table S4. Continued. 
Unigene ID Symbol Gene title FC1 FDR qvalue2 
NM_001075210 PVRL2 poliovirus receptor-related 2 (herpesvirus 
entry mediator B) 
-2.20 *** 
NM_001075495 CDC42EP1 CDC42 effector protein (Rho GTPase 
binding) 1 
-2.23 *** 
NM_174561 MAN2B1 mannosidase, alpha, class 2B, member 1 -2.24 *** 
NM_001083800 IGLL1 immunoglobulin lambda-like polypeptide 1 -2.25 *** 
NM_001080241 HPN hepsin -2.28 *** 
XM_001254640 LOC787164 similar to hepsin (transmembrane protease, 
serine 1) 
-2.28 *** 
XM_590109 PKM2 pyruvate kinase, muscle -2.31 *** 
XR_028808 LOC519422 similar to Transcription intermediary factor 
1-beta (TIF1-beta) (Tripartite motif-
containing protein 28) (Nuclear corepressor 
KAP-1) (KRAB-associated protein 1) 
(KAP-1) (KRAB-interacting protein 1) 
(KRIP-1) (RING finger protein 96) 
-2.35 *** 
NM_174656 SLC25A1 solute carrier family 25 (mitochondrial 
carrier ///  citrate transporter), member 1 
-2.35 *** 
NM_001076397 ENG endoglin -2.83 *** 
NM_174598 SCNN1A sodium channel, nonvoltage-gated 1 alpha -2.84 *** 
XM_610582 AKAP1 A kinase (PRKA) anchor protein 1 -2.99 *** 
XR_028125 NA NA -2.99 *** 
NM_001033608 MIF macrophage migration inhibitory factor 
(glycosylation-inhibiting factor) 
-3.61 *** 
XM_871314 LOC404062 immunoglobin light chain VJ region -5.93 *** 
1
 FC = Fold change were calculated considering gene expression when cows were fed with 
UFA-enriched-diet compared with the same cows fed control diet.  
2
 FDR q-value = effect of UFA supplementation; *, **, *** levels of significance indicate 
P < 0.05, P < 0.01 and P < 0.001, respectively. 
 
 
Table S5. Results for qPCR assays and correlation with microarray data when comparing 
dairy cows supplemented with unprotected unsaturated fatty acids (UFA) relative to the 
same cows fed control diet. 
Gene 
Symbol 
qPCR 
Fold Change 
Array 
Fold Change Correlation 
P-value of 
correlation1 
FASN -1.16 -1.17 0.70 * 
FADS3 -1.27 -1.27 0.71 * 
FADS1 1.37 1.39 0.73 ** 
SCD1 -1.27 -1.28 0.71 ** 
1
 P-value = *, **, *** levels of significance indicate P < 0.05, P < 0.01 and P < 0.001, 
respectively. 
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Table S6. Global transcriptional profiles based on cellular component, molecular functions 
and biological processes by Gene Ontology (GO) annotation determined in Erminj analysis 
in the mammary gland when comparing dairy cows supplemented with unprotected 
unsaturated fatty acids (UFA) relative to the same cows fed control diet. 
Name ID Probes Genes Raw Score 
FDR 
q-value1 
Cellular component 
Ribosome GO:0005840 122 121 2.26 *** 
Respiratory chain GO:0070469 45 45 3.06 *** 
Mitochondrial membrane part GO:0044455 60 60 3.05 *** 
Proton-transporting ATP synthase 
complex 
GO:0045259 17 17 3.52 ** 
Lysosome GO:0005764 66 65 2.13 ** 
Mitochondrial matrix GO:0005759 80 79 2.00 ** 
Mitochondrial lumen GO:0031980 80 78 2.02 ** 
Golgi apparatus part GO:0044431 112 107 1.82 ** 
Cell projection GO:0042995 121 118 1.78 ** 
Proton-transporting two-sector ATPase 
complex 
GO:0016469 38 37 2.43 ** 
Pigment granule GO:0048770 49 47 2.24 ** 
Vacuole GO:0005773 75 74 1.97 ** 
Golgi membrane GO:0000139 99 94 1.85 ** 
Ribosomal subunit GO:0033279 30 30 2.59 ** 
Microtubule cytoskeleton GO:0015630 121 119 1.67 * 
Endosome GO:0005768 67 67 1.93 * 
Proteasome complex GO:0000502 22 22 2.86 * 
Nuclear periphery GO:0034399 12 12 3.68 * 
Cell fraction GO:0000267 126 125 1.65 * 
Chromosome GO:0005694 89 88 1.79 * 
Mitochondrial ribosome GO:0005761 15 15 2.89 * 
Coated membrane GO:0048475 37 36 2.19 * 
External side of plasma membrane GO:0009897 40 40 2.11 * 
Organellar large ribosomal subunit GO:0000315 11 11 3.20 * 
Chromosomal part GO:0044427 73 72 1.80 * 
Cytosolic part GO:0044445 27 27 2.25 * 
Cell surface GO:0009986 56 56 1.88 * 
Nuclear matrix GO:0016363 10 10 3.59 * 
Cell junction GO:0030054 123 122 1.61 * 
Large ribosomal subunit GO:0015934 18 18 2.74 * 
Anchoring junction GO:0070161 25 25 2.29 * 
Nuclear envelope GO:0005635 55 54 1.86 * 
Nucleolus GO:0005730 64 63 1.77 * 
Nuclear membrane GO:0031965 24 23 2.28 * 
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Table S6. Continued. 
Name  ID Probes Genes Raw Score 
FDR 
q-value1 
Basolateral plasma membrane GO:0016323 38 37 1.96 * 
Insoluble fraction GO:0005626 117 116 1.59 * 
Clathrin coat GO:0030118 19 18 2.58 * 
Focal adhesion GO:0005925 16 16 2.71 * 
Late endosome GO:0005770 21 21 2.28 * 
Membrane fraction GO:0005624 112 111 1.55 * 
Coated pit GO:0005905 14 13 2.66 * 
Mitochondrial large ribosomal subunit GO:0005762 12 12 2.98 * 
Proton-transporting two-sector ATPase 
complex 
GO:0033177 18 18 2.55 * 
DNA-directed RNA polymerase II, 
holoenzyme 
GO:0016591 12 11 2.77 * 
      
Molecular functions 
Structural constituent of ribosome GO:0003735 97 96 2.29 *** 
Phosphatase activity GO:0016791 95 92 2.12 *** 
Phosphoric ester hydrolase activity GO:0042578 124 121 2.02 *** 
Inorganic cation transmembrane 
transporter activity 
GO:0022890 69 68 2.31 ** 
Hydrogen ion transmembrane transporter 
activity 
GO:0015078 57 56 2.51 ** 
Monovalent inorganic cation 
transmembrane transporter activity 
GO:0015077 60 59 2.44 ** 
Oxidoreductase activity, acting on NADH 
or NADPH 
GO:0016651 33 33 2.79 ** 
Protein dimerization activity GO:0046983 113 109 1.89 ** 
Protein serine/threonine kinase activity GO:0004674 123 121 1.75 * 
Cofactor binding GO:0048037 116 116 1.79 * 
Enzyme activator activity GO:0008047 62 61 1.96 * 
Threonine-type endopeptidase activity GO:0004298 16 16 3.30 * 
Phosphoprotein phosphatase activity GO:0004721 55 52 2.10 * 
Vitamin binding GO:0019842 62 62 2.00 * 
Active transmembrane transporter activity GO:0022804 121 117 1.68 * 
NADH dehydrogenase activity GO:0003954 15 15 3.05 * 
Magnesium ion binding GO:0000287 117 114 1.70 * 
Actin binding GO:0003779 88 85 1.79 * 
Transferase activity, transferring acyl 
groups 
GO:0016746 83 80 1.84 * 
Ligase activity, forming carbon-nitrogen 
bonds 
GO:0016879 75 71 1.87 * 
Enzyme binding GO:0019899 66 65 1.91 * 
Nucleoside-triphosphatase regulator 
activity 
GO:0060589 109 106 1.73 * 
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Table S6. Continued. 
Name ID Probes Genes Raw Score 
FDR 
q-value1 
NADH dehydrogenase (ubiquinone) 
activity 
GO:0008137 13 13 3.16 * 
Antioxidant activity GO:0016209 29 29 2.35 * 
Oxidoreductase activity, acting on sulfur 
group of donors 
GO:0016667 22 19 2.70 * 
Acyltransferase activity GO:0008415 72 70 1.86 * 
Protein homodimerization activity GO:0042803 61 58 1.94 * 
Isomerase activity GO:0016853 63 62 1.93 * 
Lyase activity GO:0016829 83 81 1.75 * 
GTPase regulator activity GO:0030695 104 101 1.68 * 
Small GTPase regulator activity GO:0005083 70 68 1.85 * 
Transferase activity, transferring acyl 
groups other than amino-acyl groups 
GO:0016747 74 72 1.81 * 
Electron carrier activity GO:0009055 95 93 1.68 * 
GTPase activator activity GO:0005096 51 50 1.98 * 
Acid-amino acid ligase activity GO:0016881 59 55 1.87 * 
ATPase activity GO:0016887 107 105 1.62 * 
G-protein coupled receptor activity GO:0004930 115 114 1.64 * 
Peptidase inhibitor activity GO:0030414 65 62 1.83 * 
Sodium ion binding GO:0031402 25 25 2.30 * 
Small conjugating protein ligase activity GO:0019787 41 39 2.01 * 
Metallopeptidase activity GO:0008237 78 70 1.78 * 
Endopeptidase inhibitor activity GO:0004866 62 59 1.80 * 
      
Biological Processes 
Electron transport chain GO:0022900 67 67 2.78 *** 
Intracellular protein transport GO:0006886 127 123 1.98 ** 
Oxidative phosphorylation GO:0006119 45 44 2.78 ** 
Negative regulation of metabolic process GO:0009892 123 117 1.91 ** 
Negative regulation of cellular metabolic 
process 
GO:0031324 114 109 1.96 ** 
Lipid biosynthetic process GO:0008610 104 103 2.03 ** 
Small GTPase mediated signal 
transduction 
GO:0007264 87 85 2.06 ** 
Energy derivation by oxidation of organic 
compounds 
GO:0015980 46 45 2.48 ** 
Regulation of protein metabolic process GO:0051246 126 123 1.81 ** 
Cell redox homeostasis GO:0045454 33 33 2.67 ** 
Monovalent inorganic cation transport GO:0015672 101 99 1.91 ** 
Cytoskeleton organization GO:0007010 76 75 2.11 ** 
Mitochondrial ATP synthesis coupled 
electron transport 
GO:0042775 8 8 5.69 ** 
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Table S6. Continued. 
Name ID Probes Genes Raw Score 
FDR 
q-value1 
Cellular amine metabolic process GO:0044106 126 125 1.77 ** 
Negative regulation of macromolecule 
metabolic proces 
GO:0010605 114 109 1.86 ** 
Nucleotide biosynthetic process GO:0009165 109 103 1.89 ** 
Purine nucleotide metabolic process GO:0006163 91 87 1.97 ** 
ATP synthesis coupled electron transport GO:0042773 10 10 5.02 ** 
Ribonucleotide metabolic process GO:0009259 79 76 2.05 ** 
Cellular homeostasis GO:0019725 114 111 1.81 ** 
Purine ribonucleotide metabolic process GO:0009150 75 72 2.05 ** 
Respiratory electron transport chain GO:0022904 12 12 4.33 ** 
Ribonucleotide biosynthetic process GO:0009260 76 73 1.99 * 
Purine nucleotide biosynthetic process GO:0006164 82 79 1.95 * 
Purine ribonucleotide biosynthetic 
process 
GO:0009152 72 69 2.00 * 
Regulation of cellular component 
organization 
GO:0051128 89 84 1.94 * 
Cellular respiration GO:0045333 31 30 2.70 * 
Organophosphate metabolic process GO:0019637 59 57 2.07 * 
Defense response GO:0006952 136 125 1.70 * 
Actin cytoskeleton organization GO:0030036 45 44 2.31 * 
Death GO:0016265 121 120 1.74 * 
Phospholipid metabolic process GO:0006644 54 52 2.14 * 
Actin filament-based process GO:0030029 45 44 2.25 * 
Negative regulation of biosynthetic 
process 
GO:0009890 84 79 1.86 * 
Nucleoside triphosphate metabolic 
process 
GO:0009141 70 67 1.93 * 
Cellular amino acid metabolic process GO:0006520 100 99 1.76 * 
Response to DNA damage stimulus GO:0006974 78 75 1.88 * 
Negative regulation of macromolecule 
biosynthetic process 
GO:0010558 79 75 1.88 * 
Negative regulation of cellular 
biosynthetic process 
GO:0031327 81 77 1.88 * 
Regulation of cellular protein metabolic 
process 
GO:0032268 100 98 1.77 * 
Purine ribonucleoside triphosphate 
metabolic process 
GO:0009205 66 63 1.94 * 
Cell death GO:0008219 117 116 1.72 * 
Regulation of leukocyte activation GO:0002694 41 41 2.16 * 
Negative regulation of developmental 
process 
GO:0051093 110 110 1.72 * 
Regulation of hydrolase activity GO:0051336 75 75 1.84 * 
Membrane organization GO:0016044 77 74 1.89 * 
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Table S6. Continued. 
Name ID Probes Genes Raw Score 
FDR 
q-value1 
Hexose metabolic process GO:0019318 71 70 1.92 * 
Monosaccharide metabolic process GO:0005996 77 76 1.85 * 
Purine nucleoside triphosphate metabolic 
process 
GO:0009144 67 64 1.94 * 
Regulation of cell activation GO:0050865 42 42 2.16 * 
Protein amino acid dephosphorylation GO:0006470 45 42 2.18 * 
Glucose metabolic process GO:0006006 54 54 2.01 * 
Regulation of organelle organization GO:0033043 46 45 2.06 * 
ATP metabolic process GO:0046034 57 56 2.00 * 
Negative regulation of apoptosis GO:0043066 75 75 1.82 * 
Negative regulation of nucleobase, 
nucleoside, nucleotide and nucleic acid 
metabolic process 
GO:0045934 67 64 1.92 * 
Negative regulation of protein metabolic 
process 
GO:0051248 37 35 2.20 * 
Negative regulation of nitrogen 
compound metabolic process 
GO:0051172 69 66 1.88 * 
Regulation of cellular component 
biogenesis 
GO:0044087 34 33 2.22 * 
Proton transport GO:0015992 39 38 2.19 * 
Protein folding GO:0006457 69 68 1.85 * 
Glycerophospholipid metabolic process GO:0006650 30 29 2.32 * 
Nucleoside triphosphate biosynthetic 
process 
GO:0009142 64 61 1.87 * 
Sodium ion transport GO:0006814 36 36 2.24 * 
DNA repair GO:0006281 59 57 1.90 * 
Protein targeting GO:0006605 45 44 2.07 * 
ATP biosynthetic process GO:0006754 54 53 1.92 * 
Glucose metabolic process GO:0006006 54 54 2.01 * 
Regulation of organelle organization GO:0033043 46 45 2.06 * 
1
 FDR q-value = effect of UFA supplementation; *, **, *** levels of significance indicate 
P < 0.05, P < 0.01 and P < 0.001, respectively. 
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Table S7. Gene Set Enrichment Analysis (GSEA) for gene expression in the mammary 
gland when comparing dairy cows supplemented with unprotected unsaturated fatty acids 
(UFA) relative to the same cows fed control diet. 
Name Size NES FDR q-value1 
Oxidative phosphorilation 92 2.25 *** 
Ribosome 28 2.18 *** 
Electron transport chain 87 2.11 *** 
Sig IL4 Receptor in B Lymphocytes 16 -2.08 * 
St B cell antigen receptor 28 -2.07 * 
ERK1 ERK2 MAPK Signaling pathway 19 -2.05 * 
SIG CD40 Pathway map 28 -2.01 * 
HS Focal Adhesion Kegg 113 -1.94 * 
HS IL-6 NET pathway 18 76 -1.93 * 
MAPKINASE signaling pathway  50 -1.93 * 
ST FAS signaling pathway 45 -1.93 * 
FMLP induced chemokine gene expresión in HMC-1 cells 19 -1.92 * 
HS Integrin-mediated cell adhesión  68 -1.92 * 
Links between PYK2 and MAP Kinase 16 -1.90 * 
HS IL-9 NET pathway 20 16 -1.89 * 
SIG BCR signaling pathway 32 -1.89 * 
ST Integrin signaling pathway 49 -1.89 * 
ST GAQ pathway  19 -1.85 * 
HS S1P  signaling 19 -1.85 * 
VEGF signaling pathway 47 -1.81 * 
Ceramide signaling pathway 15 -1.80 * 
NRF2-Regulated genes combined 18 -1.80 * 
HS MAPK cascade 24 -1.80 * 
HS P38 MAPK signaling pathway 26 -1.77 * 
Bioactive peptide induced signaling pathway 19 -1.76 * 
HS IL-7 NET pathway19 40 -1.75 * 
Phospholipids as signalling intermediaries  15 -1.74 * 
HS MAPK signaling pathway 120 -1.74 * 
Apoptosis 52 -1.72 * 
Angiotensin II mediated activation of JNK pathway  
via PYK2 dependent signaling 
16 -1.71 * 
HS Regulation of actin cytoskeleton  95 -1.71 * 
1
 FDR q-value = effect of UFA supplementation; *, **, *** levels of significance indicate 
P < 0.05, P < 0.01 and P < 0.001, respectively. 
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Table S8. Expression (fluorescence units) of SCD1 and SCD5 in the mammary gland tissue 
when comparing dairy cows supplemented with unprotected unsaturated fatty acids (UFA) 
relative to the same cows fed control diet. 
 Control diet  UFA-
enriched  P- value
1
 
Item      s.e.  
SCD1, fluorescence units 6058  5896 348.5 0.74 
SCD5, fluorescence units 59.38  84.53 3.03 *** 
1
 P-value = effect of UFA supplementation; *, **, *** levels of significance indicate P < 
0.05, P < 0.01 and P < 0.001, respectively. 
2
 Included n = 28 cows. 
 
 
 
 
Figure S1. Canonical signalling pathways significantly modulated in the mammary gland 
tissue when comparing dairy cows supplemented with unprotected unsaturated fatty acids 
(UFA) relative to the same cows fed control diet. Statistical significance of pathway 
modulation was calculated via a right tailed Fisher’s Exact test in Ingenuity Pathway and 
represented as –log (P-value): -log values exceeding 1.30 were significant false discovery 
rate (FDR) q-values < 0.05). 
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Figure S2. a) Canonical pathways involved in cellular growth, proliferation and 
development, and significantly modulated in the mammary gland tissue when comparing 
dairy cows supplemented with unprotected unsaturated fatty acids (UFA) relative to the 
same cows fed control diet. Statistical significance of pathway modulation was calculated 
via a right-tailed Fisher’s Exact test in Ingenuity Pathway and represented as –log (P 
value): -log values exceeding 1.30 were significant false discovery rate (FDR) q-values < 
0.05); b) The down-regulated and up-regulated genes for each molecular pathway are 
presented. The colour intensity indicates the expression of genes: red up-regulated, green 
down-regulated in animals supplemented with UFA relative to the same cows fed a control 
diet.  
a) 
b) 
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Figure S3. a) Canonical pathways involved in immune system response significantly 
modulated in the mammary gland tissue when comparing dairy cows supplemented with 
unsaturated fatty acids (UFA) relative to the same cows fed control diet. Statistical 
significance of pathway modulation was calculated via a right-tailed Fisher’s Exact test in 
Ingenuity Pathway and represented as –log (P value): -log values exceeding 1.30 were 
significant false discovery rate (FDR) q-values < 0.05); b) The down-regulated and up-
regulated genes for each molecular pathway are presented. The colour intensity indicates 
the expression of genes: red up-regulated, green down-regulated in animals supplemented 
with UFA relative to the same cows fed a control diet. 
a) 
b) 
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Abstract 
 
Stearoyl-CoA desaturase (SCD) is an important enzyme in the bovine mammary gland, 
where it inserts a cis-double bond at the ∆9 position in a wide range of fatty acids. 
Investigating SCD expression in the bovine mammary gland generally requires invasive 
biopsy to obtain mammary tissue. The aim of this study was to evaluate the use of milk 
somatic cells as a non-invasive alternative to biopsy for measuring mammary SCD 
expression in dairy cows. Both milk somatic cells and mammary tissue were collected from 
fourteen Holstein-Friesian cows and used for analysis of SCD expression by qRT-PCR. 
The SCD5 mRNA levels in mammary tissue compared with SCD1 were low, and for 
several milk somatic cell samples, SCD5 expression was even below the limit of detection. 
A significant relationship was found between SCD1 expression in milk somatic cells and in 
mammary tissue. In addition, SCD1 expression in milk somatic cells was significantly 
related to ∆9-desaturase indices in milk, which are commonly used as an indicator of SCD1 
activity within the mammary gland. Our study showed that milk somatic cells can be used 
as a source of mRNA to study SCD1 expression in dairy cows, offering a non-invasive 
alternative to mammary tissue samples obtained by biopsy.  
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Introduction 
 
Various studies in human subjects indicate that saturated fatty acids (SFA) increase the 
risk of cardiovascular disease and are involved in the development of the metabolic 
syndrome (Astrup et al., 2011). Altering the fatty acid (FA) composition of milk fat to be 
more in line with public health recommendations, would reduce SFA intake through milk. 
Reducing the SFA proportion of milk fat can be achieved by increasing the activity of 
stearoyl-CoA desaturase (SCD) in the mammary gland of dairy cows. Stearoyl-CoA 
desaturase is an enzyme that inserts a cis-double bond at the ∆9 position in a wide range of 
FA. The preferred substrates for SCD are stearic acid (C18:0) and palmitic acid (C16:0), 
generating oleic acid (C18:1 cis-9) and palmitoleic acid (C16:1 cis-9) respectively, but 
SCD can also convert other unsaturated FA, e.g. vaccenic acid (C18:1 trans-11) into 
rumenic acid (C18:2 cis-9, trans-11 CLA; Ntambi & Miyazaki, 2004). Several health 
benefits have been attributed to rumenic acid, including anticarcinogenic and 
antiatherogenic effects (Pariza et al., 2001; Wahle et al., 2004). In bovine, two isoforms of 
SCD, designated stearoyl-CoA desaturase 1 (SCD1) and stearoyl-CoA desaturase 5 
(SCD5), have been identified (Lengi & Corl, 2007). Stearoyl-CoA desaturase 1 is 
abundantly expressed in the mammary gland of lactating dairy cows and has a key role in 
milk fat synthesis (McDonald & Kinsella, 1973; Bernard et al., 2008; Bionaz & Loor, 
2008b). Conversely, the importance of the recently discovered isoform SCD5 in milk fat 
synthesis remains unclear. Contrary to SCD1, no relationship was observed between the 
relative low SCD5 mRNA abundance in bovine mammary tissue and ∆9-desaturation 
indices for milk, suggesting that SCD5 plays a minor role in the desaturation of milk FA 
(Jacobs et al., 2011).  
To assess SCD expression in the bovine mammary gland, mammary tissue is usually 
obtained by biopsy. However, this technique is costly and invasive and can potentially lead 
to infection of the mammary gland, with detrimental effects on animal welfare. In addition, 
this invasive method can influence the results of the experiment. Potentially, isolated milk 
somatic cells can be used as a non-invasive alternative, since these cells contain exfoliated 
secretory epithelial cells of the mammary gland. Previous studies have shown that milk 
provides a convenient and non-invasive source of viable mammary epithelial cells which 
can be used for gene expression studies in various species (Boutinaud & Jammes, 2002). In 
goats, Boutinoud et al. (2002) reported that the relative mRNA expression of α-S1, κ-casein 
and α-lactalbumin was identical in both milk somatic cells and mammary tissue. A similar 
effect was found for the expression of lipogenic genes (including acetyl-CoA carboxylase, 
fatty acid synthase and SCD1) in milk somatic cells and mammary tissue of beef cows 
(Murrieta et al., 2006). Two studies have examined mammary gene expression in dairy 
cows using milk somatic cells (Feng et al., 2007; Boutinaud et al., 2008). However, both 
studies did not compare the expression level of genes in milk somatic cells with those in the 
native mammary gland. Since milk somatic cells contain mainly leukocytes and only a 
small proportion of secretory epithelial cells, the quantification of mammary transcripts 
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could be imprecise. Therefore, the aim of this study was to evaluate the use of milk somatic 
cells as a non-invasive alternative to biopsy for measuring SCD expression in the mammary 
gland of dairy cows. To this end, we measured the expression levels of SCD in isolated 
milk somatic cells by quantitative RT-PCR and compared these with the levels in 
mammary tissue obtained by biopsy. In addition, SCD expression levels were compared 
with ∆9-desaturation indices calculated from milk FA, which are commonly used as an 
indicator of SCD activity in the mammary gland.  
 
Material and Methods 
 
Animals and Treatments 
The samples utilized in this study were collected from two separate experiments 
involving Holstein-Friesian cows, that evaluated the effects of linseed supplementation on 
performance and FA profile of milk. These two studies were chosen because it was 
anticipated that linseed supplementation would inhibit mammary SCD expression (Bernard 
et al., 2005a), thereby creating more variation in SCD expression. Samples from 
Experiment 1 were used to compare SCD expression in milk somatic cells and mammary 
tissue as well as to study the relationship between SCD expression and the ∆9-desaturation 
indices in milk. Samples from Experiment 2 were used to further investigate the 
relationship between SCD expression in milk somatic cells and the desaturation indices in 
milk. Experiment 1 was approved by the Institutional Animal Care and Ethics Committee 
of Wageningen UR Livestock Research (Lelystad, the Netherlands) and Experiment 2 by 
the Institutional Animal Care and Use Committee of Wageningen University (Wageningen, 
the Netherlands). 
 
Experiment 1 
Experiment 1 was conducted to study the effect of linseed supplementation on health 
and production of periparturient dairy cows. Fourteen Holstein-Friesian cows were paired 
according to parity, expected date of calving and milk performance in the previous 
lactation. Cows within each pair were randomly assigned to one of two treatment groups: 1) 
“Linseed”; or 2) “Control”. Cows in the Linseed group received a basal diet supplemented 
with a concentrate-mixture including linseed (4.8% of total diet on dry matter basis), 
whereas cows in the Control group received a basal diet supplemented with a concentrate 
mixture without linseed (Table 1). All cows received the basal diet ad libitum, which was a 
forage mixture that consisted of maize silage, wilted grass silage, grass seed straw, solvent 
extracted soybean meal and formaldehyde treated soybean meal (Mervobest™, Agrifirm, 
Apeldoorn, the Netherlands). This basal diet was supplemented with a concentrate mixture 
that was fed individually through automatic concentrate dispensers. Cows were group-
housed in a cubicle shed with continuous access to water and were milked twice daily at 
0600 and 1700h. Experimental treatments started 3 weeks before the expected calving date 
and lasted until 6 weeks after calving (Mach et al., unpublished). 
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Table 1. Ingredient composition of the treatment diets fed in Experiment 1 and 2. 
 Treatments 
 Experiment 1  Experiment 21 
Ingredient, % DM Control Linseed  CL EL FL DL 
        
 Grass silage 30.2 32.6  31.2 31.0 31.2 31.2 
 Maize silage 19.6 21.2  29.4 29.2 29.4 29.4 
 Grass seed straw 4.3 4.7  - - - - 
        
 Maize 13.8 12.9  5.2 4.5 6.0 5.4 
 Wheat 7.7 7.3  6.8 6.4 7.3 7.7 
 Soybean meal 6.9 3.7  4.9 4.7 5.0 4.9 
 Rapeseed meal - -  6.5 6.1 6.9 6.9 
 Soybean meal treated 4.5 5.3  - - - 0.2 
 Linseed - 4.8  - - - - 
 Crushed linseed - -  6.5 - - - 
 Extruded linseed - -  - 9.9 - - 
 Spray-dried linseed oil - -  - - 3.3 - 
 Linseed oil - -  - - - 2.1 
 DHA Gold2 - -  - - - 0.4 
 Others (inclusion <5%) 13.0 7.5  9.5 8.2 10.9 11.8 
1
 CL = crushed linseed; EL = extruded whole linseed; FL = formaldehyde treated spray-
dried linseed oil; DL = microalgae high in docosahexaenoic acid (DHA Gold®) in 
combination with linseed oil. 
2
 DHA Gold®, Martek Biosciences Corp., Columbia, MD. 
 
 
 
For the isolation of somatic cells, 1 L of milk was sampled from each cow on the last 
day of the experimental period (week 6) during the AM milking. This milk sample was kept 
on ice until somatic cell isolation, which was completed within 2 hours after milking. 
Simultaneously, individual milk samples were taken and stored at -20°C until FA analysis. 
Within 2 hours after milking, a mammary biopsy was taken from each cow. Approximately 
0.7 to 1.0 g of mammary tissue was obtained by surgical biopsy from the midpoint section 
of a rear quarter, according to the method of Farr et al. (1996) as described by Jacobs et al. 
(2011). Collected tissue was immediately snap-frozen in liquid nitrogen and stored at -80°C 
until total RNA extraction. 
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Experiment 2  
Experiment 2 was conducted to study the effect of different sources of linseed on 
performance and milk FA profile of dairy cows. Four multiparous Holstein-Friesian dairy 
cows in early lactation (mean days in milk: 52 ± 22) fitted with a ruminal cannula (10 cm 
i.d.; Bar Diamond Inc., Parma, ID) were fed diets with differently processed linseed 
according to a 4 x 4 Latin square design. Experimental periods were 21 d in length. Cows 
were housed in individual tie-stalls with continuous access to water and milked twice daily 
at 0630 and 1700h. Dietary treatments consisted of a basal diet (a mixture of grass silage 
and maize silage) and concentrates, which were supplemented with either 1) crushed 
linseed (CL), 2) extruded whole linseed (EL), 3) formaldehyde-treated spray dried linseed 
oil (FL), and 4) microalgae high in docosahexaenoic acid (DHA Gold®; Martek Biosciences 
Corp., Columbia, MD) in combination with linseed oil (DL; Table 1) and were designed to 
provide equal amounts of C18:3n3. Treatments were chosen based on an in vitro study 
aimed at decreasing ruminal biohydrogenation of C18:3n3 applying several chemically or 
technologically treated linseed products (Sterk et al. 2010). The basal diet, concentrates and 
linseed products were thoroughly mixed immediately before feeding. Diets were offered as 
two equal meals just before milking. After day 7, diets were fed at 95% of ad libitum intake 
to prevent variation in feed intake and C18:3n3 intake between treatments. Detailed 
information about this experiment has been described by Sterk (2011).  
For the isolation of somatic cells, 1 L of milk was sampled from each cow on the last 
day of each experimental period during the AM milking, including the week before the 
experiment (as control). This milk sample was kept on ice until somatic cell isolation, 
which was completed within 2 hours after milk sampling. In addition, individual milk 
samples were taken and stored at -20°C until FA analysis.  
 
Fatty Acid Analysis 
Fatty acid composition of the milk samples of Experiment 1 was analysed as described 
by Jacobs et al. (2011) and those of Experiment 2 were analysed as follows. Total lipids 
were extracted from the milk samples with diethyl ether and petroleum ether according to 
the Rose-Gottlieb method (AOAC, 1990). Fatty acids from milk lipids were methylated 
with 2.0 N of methanolic NaOCH3, neutralized with NaHSO4 and dried with Na2SO4. Fatty 
acid methyl esters (FAME) were recovered in 1 mL of hexane. 
The FAME were quantified using gas chromatography (Trace GC UltraTM, Thermo 
Fisher Scientific, Waltham, MA, USA) with a fused silica capillary column (100 m x 0.250 
mm and 0.2 µm film thickness; Supelco; SP2560, Bellefonte PA, USA). The carrier gas 
was helium at a constant flow of 1.5 mL/min. The flame ionization detector was set at 
280ºC. The time-temperature program used, started with an initial temperature of 70ºC for 
4 min, increased with 1ºC/min to 165ºC for 20 min, increased with 2ºC/min to 170ºC for 10 
min, and increased with 4ºC/min to a final temperature of 215ºC for 20 min. The FAME 
were identified using external standards (S37, Supelco, Bellefonte PA, USA; odd and 
branched chain fatty acids, trans-11-C18:1, cis-9,trans-11-C18:2, trans-10,cis-12-C18:2, 
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Larodan Fine Chemicals AB, Malmö, Sweden). Fatty acids trans-6+7+8-C18:1, trans-10-
C18:1, trans-12-C18:1, trans-13+14-C18:1, cis-12-C18:1, cis-13-C18:1, cis-14+trans-16-
C18:1, cis-15-C18:1, trans-11,cis-15-C18:2 were identified according to the elution 
sequence reported by Loor et al. (2004) and Shingfield et al. (2006). 
 
Somatic Cell Isolation 
Milk somatic cells were isolated according to the method described by Feng et al. 
(2007), with some minor modifications. Fresh milk samples of 1 L were transferred to 10 
sterile 100-mL conical tubes and, to limit formation of casein micelles, 100 µL of 0.5 M 
ethylenediaminetetraacetic acid (EDTA) in phosphate buffered saline (PBS) was added to 
each tube. Somatic cells were pelleted by centrifugation at 2,700 x g for 10 min at 4°C. 
Then, the cream layer was removed with a spatula and skim milk was discarded. The cell 
pellet was washed twice in 25 mL of ice-cold PBS (pH = 7.2) containing 0.5 mM EDTA, 
followed by centrifugation at 2,700 x g for 15 min at 4°C. The supernatant was discarded 
and the remaining cell pellet was resuspend in 1 mL of Trizol® reagent (Invitrogen, Breda, 
the Netherlands) and stored at -80°C until total RNA isolation. 
 
RNA Isolation and Real-Time PCR 
Frozen mammary tissue samples were homogenized in liquid nitrogen using a mortar 
and pestle. Total RNA from milk somatic cells and mammary tissue was isolated using 
Trizol® reagent (Invitrogen, Breda, the Netherlands), according to the manufacturer’s 
instructions. Total RNA was treated with DNAse I and column purified using the 
PureLink™ Micro-to-Midi Total RNA Purification System kit (Invitrogen, Breda, the 
Netherlands). To assess RNA quality, samples were analysed on a RNA 6000 NanoChip® 
(Agilent Technologies, Amstelveen, the Netherlands) using the Agilent 2100 bioanalyzer® 
(Agilent Technologies, Amstelveen, the Netherlands) according to the manufacturer’s 
instructions. The Agilent 2100 expert software was used to calculate the RNA Integrity 
Number (RIN), as a measure for the state of RNA intactness (Schroeder et al., 2006). First-
strand cDNA synthesis and quantitative real-time PCR was performed as described 
previously (Jacobs et al., 2011). The following gene-specific primers were used: for SCD1, 
forward primer 5’-GGCGTTCCAGAATGACGTTT-3’ and reverse primer 5’-
AAAGCCACGTCGGGAATTG -3’; for SCD5, 5’-GGCACCGGCAGGACATC-3’ 
(forward) and 5’-GAGCAGTCAGGAGGAAGCAGAA-3’ (reverse). Cytokeratin 8 
(KRT8) or beta-actin (ACTB) was used as internal standard. For KRT8, we used the 
forward primer 5’-ATTTGCCTCCTTCATCGACAA-3’ and reverse primer 5’-
GCTCCGGGCAGTCTTCTG-3’. For ACTB, 5’-GCCCTGAGGCTCTCTTCCA-3’ 
(forward) and 5’-CGGATGTCGACGTCACACTT-3’ (reverse). Templates were amplified 
after a preincubation for 10 min at 95 ºC, followed by amplification for 40 cycles (10 s at 
95 ºC, 5 s at 60 ºC, 5 s at 72 ºC). All reactions revealed a single product as determined by 
melting curve analysis. Specificity of the primer sets were verified by sequencing of the 
generated amplicons. PCR efficiencies for the genes were established to be at least 86%. 
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Relative mRNA expression for each gene of interest (I) was calculated using the formula: 
(1 + E[I]) -Ct[I] / (1 + E[H]) -Ct[H], where E = amplification efficiency and H = housekeeping 
gene.  
 
Statistical Analysis 
The regression procedure (PROC REG) of SAS (version 9.2, SAS Institute Inc.) was 
used to analyse relationships between relative abundance of SCD mRNA in milk somatic 
cells and mammary tissue, as well as the various desaturase indices calculated from milk 
FA. The various desaturase indices (i.e., C14, C16, C17 and C18 index) were calculated 
from milk FA as the ratio between the ∆9-desaturase product and the sum of the product 
and the substrate FA of SCD, e.g. C14:1 cis-9 / (C14:1 cis-9 + C14:0). To evaluate the 
effect of dietary linseed supplementation on the relative abundance of SCD mRNA and the 
various desaturation indices, analyses were carried out by ANOVA using the PROC 
MIXED procedure of SAS with treatment as fixed effect. Differences were considered 
significant at a probability of P < 0.05, and as a trend at a probability of 0.05 < P < 0.10. 
 
Results 
 
Total RNA Yield and Quality 
Total RNA yield was 181.4 µg (SEM = 13.1 µg) per mammary tissue sample of 0.15 to 
0.20 g obtained from biopsy (Experiment 1). Total RNA yield from milk somatic cells was 
6.0 µg per sample (SEM = 1.9 µg) in Experiment 1 and 4.2 µg per sample (SEM = 0.6 µg) 
in Experiment 2, obtained with 1 L milk samples. After DNAse treatment and column 
purification, the A260/A280 ratio was > 1.90 in all samples, indicating that protein 
contamination was negligible. Several milk somatic cell samples did not yield sufficient 
RNA (< 2 µg per sample) and therefore, four samples of Experiment 1 (n = 10 remaining) 
and five samples of Experiment 2 (n=15 remaining) were excluded from further analysis. 
The average RNA integrity number (RIN) was 7.1 (SEM = 0.30) for mammary tissue 
samples and 7.6 (SEM = 0.21) for milk somatic cell samples.  
 
Relationship Between SCD Expression in Milk Somatic Cells and in 
Mammary Tissue 
In Experiment 1, both SCD1 and SCD5 expression were measured by qRT-PCR 
analysis in milk somatic cells as well as mammary tissue. For four out of ten milk somatic 
cell samples SCD5 mRNA level was below the limit of detection and therefore, only the 
results for SCD1 expression are presented (Figure 1). As internal controls we used either 
ACTB, known to be expressed in virtually all mammalian cells, or KRT8, which is 
characteristic of mammary luminal cells (Moll et al., 1982; Abd El-Rehim et al., 2004).  
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Figure 1. Relationship between relative abundance of SCD1 mRNA in mammary tissue 
and milk somatic cells (Experiment 1; n = 10). SCD1 expression in milk somatic cells = 
0.332 (± 0.020) + 0.155 (± 0.0450) x SCD1 expression in mammary tissue; r2 = 0.60; P < 
0.01. 
 
 
When KRT8 was used as endogenous control gene instead of ACTB, relationship between 
SCD1 expression in mammary tissue and milk somatic cells was significantly improved (r2 
= 0.60; P < 0.01 for KRT8 (Figure 1) versus r2 = 0.26; P = 0.17 for ACTB). Therefore, 
KRT8 was used as endogenous control gene in the results presented.  
 
Relationship between SCD1 expression and ∆9-desaturase indices 
Experiment 1 
Figure 2a shows the relationship between SCD1 expression in mammary tissue and the 
C14 desaturation index (r2 = 0.34; P = 0.08). The r2 values of the relationship between 
mammary SCD1 expression and the C16, C17 and C18 indices were 0.36 (P = 0.04), 0.38 
(P = 0.02) and 0.22 (P = 0.14), respectively. Figure 2b shows the relationship between 
SCD1 expression in milk somatic cells and the C14 desaturation index (r2 = 0.52; P = 0.02). 
The r2 values of the relationship between SCD1 expression in milk somatic cells and the 
C16, C17 and C18 indices were 0.45 (P = 0.03), 0.47 (P = 0.09) and 0.32 (P = 0.18), 
respectively.  
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Figure 2. Relationship between the C14 desaturase index and the relative abundance of 
SCD1 mRNA in mammary tissue (a) as well as milk somatic cells (b) of the same cows 
(Experiment 1; n=10). For mammary tissue: C14 index = 0.046 (± 0.009) + 0.043 (± 0.021) 
x SCD1 mRNA; r2 = 0.34; P = 0.08 and for milk somatic cells: C14 index = -0.040 (± 
0.036) + 0.261 (± 0.089) x SCD1 mRNA; r2 = 0.52; P = 0.02.  
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Experiment 2 
A significant relationship was observed between relative abundance of SCD1 
expression in milk somatic cells and the C14 desaturation index (C14 index = -0.032 (± 
0.021) + 0.247 (± 0.047) x SCD1 expression milk somatic cells; r2 = 0.70; P < 0.01). The r2 
values of the relationship between SCD1 expression in milk somatic cells and the C16, C17 
and C18 indices were 0.77 (P < 0.001), 0.65 (P < 0.001) and 0.44 (P < 0.01), respectively. 
 
Figure 3a shows the relationship between SCD1 expression in milk somatic cells and 
the C14 desaturation index of experiment 1 and 2 combined (r2 = 0.70; P < 0.001). Figure 
3b shows the relationship between SCD1 expression in milk somatic cells and the C16 
desaturation index of experiment 1 and 2 combined (r2 = 0.63; P < 0.001). When the 
highest value was removed, the r2 values of the C14 and C16 index changed to 0.32 and 
0.34, respectively. The r2 values of the relationship between SCD1 expression in milk 
somatic cells and the C17 and C18 indices were 0.37 (P < 0.01) and 0.35 (P < 0.01), 
respectively. 
 
Effect of linseed supplementation on SCD1 expression 
In experiment 1, relative expression of SCD1 in milk somatic cells was not different    
(P = 0.12) between cows on the control diet (0.44 ± 0.021) and cows on the linseed 
supplemented diet (0.40 ± 0.018). Similarly, relative expression of SCD1 in mammary 
tissue was not different (P = 0.26) between cows on the control diet (0.49 ± 0.070) and 
cows on the linseed supplemented diet (0.39 ± 0.057). In addition, the C14 desaturation 
index was not affected (P = 0.19) by linseed supplementation and was 0.07 ± 0.005 and 
0.06 ± 0.004 for cows on the control and linseed supplemented diet, respectively.  
In experiment 2, relative expression of SCD1 in milk somatic cells was not affected    
(P = 0.84) by the different linseed treatments and was 0.45 ± 0.13, 0.41 ± 0.02, 0.42 ± 0.05, 
0.39 ± 0.02 and 0.47 ± 0.19 for the control, CL, EL, FL and DL treatment, respectively. In 
addition, the C14 desaturation index was not affected (P = 0.37) by the different linseed 
treatments and was 0.07 ± 0.02, 0.06 ± 0.01, 0.08 ± 0.02, 0.06 ± 0.01 and 0.10 ± 0.06 for 
the control, CL, EL, FL and DL treatment, respectively. 
 
Discussion 
 
The aim of this study was to evaluate the use of milk somatic cells for quantitative 
analysis of SCD mRNA, as a non-invasive alternative to mammary biopsy. Milk somatic 
cells have been previously used to study gene expression levels in humans (Lindquist et al., 
1994; Alcorn et al., 2002), goats (Boutinaud et al., 2002) beef cows (Murrieta et al., 2006) 
and dairy cows (Feng et al., 2007; Boutinaud et al., 2008). Whether the use of bovine milk 
somatic cells as an alternative source of SCD mRNA is valid, depends on several criteria. 
We used the following three criteria: 1) harvest of sufficient quantity of mRNA from milk  
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Figure 3. Relationship between the relative abundance of SCD1 mRNA in milk somatic 
cells and the C14 desaturase index (a) as well as the C16 desaturase index (b) of cows in 
Experiment 1 (n = 10) and Experiment 2 (n = 15). C14 index = -0.035 (± 0.015) + 0.252 (± 
0.035) x SCD1 mRNA; r2 = 0.70; P < 0.001 and C16 index = -0.016 (± 0.013) + 0.188 (± 
0.030) x SCD1 mRNA; r2 = 0.63; P < 0.001. 
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somatic cells; 2) satisfactory relationship between SCD expression in mammary tissue and 
in somatic cells; 3) relationship between SCD expression in somatic cells and ∆9-
desaturation indices to be at least as good as the relationship between SCD expression in 
mammary tissue and desaturation indices.  
 
Total RNA Yield and Quality 
In order for milk somatic cells to be considered a suitable alternative to mammary 
tissue, it is essential that each sample yields sufficient RNA of good quality. Total RNA 
extracted from milk somatic cells was low (range: 1.6 to 14.3 µg per 1 L milk sample) 
compared with the study of Feng et al. (2007) (range: 3.3 to 26.9 µg per 1 L milk sample). 
Feng et al. (2007) showed that total RNA yield is directly related to the amount of viable 
somatic cells. In our study, several milk samples did not yield sufficient RNA and were 
therefore not used in subsequent analysis. Collecting a larger quantity of milk would 
obviously increase the amount of somatic cells, thereby increasing RNA yield. In addition, 
time of milk sampling can influence total somatic cell count as well as the proportion of 
mammary epithelial cells. In goats, total and epithelial cell count were substantially higher 
in post-milk samples compared with samples taken during milking (Boutinaud et al., 2002). 
Another issue, which can hamper RNA isolation from milk somatic cells, is the formation 
of casein micelles. In the present study, EDTA was used to prevent the formation of casein 
micelles, but this prevention may have been incomplete. Techniques that limit the 
formation of casein micelles could therefore increase RNA yield from milk somatic cells. 
The RIN values in our study show that the quality of the RNA isolated from milk somatic 
cells was comparable to that of mammary tissue. 
 
Relationship Between SCD Expression in Milk Somatic Cells and in 
Mammary Tissue 
The bovine mammary gland expresses both SCD1 and SCD5 (Gervais et al., 2009; 
Jacobs et al., 2011), although the mRNA abundance of SCD5 is substantially lower than 
that of SCD1 (Jacobs et al., 2011). Correspondingly, in this study we found low SCD5 
expression levels in mammary tissue compared with SCD1 as determined by qRT-PCR. 
For several milk somatic cell samples, SCD5 expression was even below the limit of 
detection and therefore, SCD5 results are not presented. This was most likely caused by the 
low and variable proportion of mammary epithelial cells of total somatic cells in bovine 
milk and indicates that the use of milk somatic cells might not be suitable for measuring 
genes with low levels of mRNA. 
There are substantial differences in amount and cell type distribution of somatic cells 
between species, due to differences in milk secretion, milk volume and immune defence 
mechanisms (Boutinaud and Jammes, 2002). The major cell type in somatic cells from 
bovine milk is leukocytes, including macrophages, lymphocytes and polymorphonuclear 
neutrophils (Boutinaud and Jammes, 2002). Consequently, mammary epithelial cells only 
represent a small proportion (± 2%) of total somatic cells in bovine milk, and variation is 
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substantial (Feng et al., 2007; Boutinaud et al., 2008). This low and variable amount of 
epithelial cells is a concern for quantification of mammary transcripts by using a 
housekeeping gene that is expressed in leukocytes as well, since the expression of such a 
housekeeping gene does not reflect the proportion of mammary epithelial cells (Boutinaud 
et al., 2008). Besides the ubiquitously expressed ACTB, we tested whether KRT8, which is 
characteristic to mammary epithelial cells (Moll et al., 1982; Abd El-Rehim et al., 2004), 
could be used as endogenous control gene to correct for the differences in proportion of 
epithelial cells in total milk somatic cells. Cytokeratin 8, which is expressed as cytoplasmic 
as well as cell-surface protein, has been successfully used to isolate living mammary 
epithelial cells from somatic milk cells by immunopurification (Boutinaud et al., 2008). In 
addition, epithelial keratins are relatively abundant and stable (Hudson, 2002), which is 
essential for housekeeping genes. Compared with ACTB, the use of KRT8 as endogenous 
control gene significantly improved the relationship between SCD1 expression in 
mammary tissue and milk somatic cells, (r2 = 0.60; P < 0.01 for KRT8 versus r2 = 0.26; P = 
0.17 for ACTB).  
Parallel to our results, Boutinaud et al. (2002) found that in goats, the relative amount of 
milk protein mRNA was identical in both milk somatic cells and mammary tissue samples. 
Also, in beef cows a positive correlation was found between expression of lipogenic genes 
in milk somatic cells and mammary tissue (Murrieta et al., 2006). Taken together, this 
indicates that milk somatic cells can be used as a representative source of mRNA to analyse 
mammary SCD1 expression, since results are comparable to those obtained from mammary 
tissue. 
 
Relationship Between SCD1 Expression and ∆9-desaturase Indices 
Substrate-product relationships from several pairs of milk FA are commonly used as an 
indicator of ∆9-desaturase activity within the mammary gland. The C14 desaturase index is 
considered the best indicator of SCD activity, since generally almost all C14:0 and C14:1 
cis-9 originate from de novo synthesis in the mammary gland (Bernard et al., 2008; Heck et 
al., 2009; Jacobs et al., 2011). In this study, a positive relationship between SCD1 mRNA 
expression in mammary tissue and the C14 desaturase index was found (r2 = 0.34; P = 
0.08), which was comparable to a previous study (r2 = 0.35; P = 0.002; Jacobs et al., 2011). 
Similarly, Bernard et al. (2005a) reported positive, although again not strong, relationships 
between mRNA levels of SCD and milk proxy ratios.  
We found positive relationships between SCD1 expression in milk somatic cells and the 
C14 index in both experiments, indicating that SCD1 expression in milk somatic cells 
provides a reasonable estimation of SCD activity in the mammary gland. A similar 
conclusion was drawn by Feng et al. (2007) who reported a significant relationship between 
the C14 desaturase index and relative abundance of SCD1 mRNA in milk somatic cells. 
Interestingly, the relationship between the various desaturation indices and SCD1 
expression in milk somatic cells was somewhat better compared to the relationship between 
these indices and SCD1 expression in mammary tissue. This suggests that SCD1 mRNA 
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expression in milk somatic cells provides a better reflection of SCD1 activity in the 
mammary gland, compared with the expression measured in mammary tissue obtained from 
biopsy. This could be due to the fact that mammary tissue provides a “snapshot” of SCD1 
expression, while milk somatic cells are accumulated over a period of time, thereby 
averaging out possible diurnal variation in SCD1 expression. 
 
Conclusions 
 
Our results show that using milk somatic cells as a source of mRNA to examine SCD1 
expression in dairy cows yields results comparable with mammary tissue. In addition, 
mRNA abundance of SCD1 measured in milk somatic cells was significantly related to ∆9-
desaturase indices in milk. The mRNA expression of SCD5 in both mammary tissue and in 
milk somatic cells was low. The yield of total RNA from milk of dairy cows is rather low 
and further investigation is needed to improve the yield of RNA from milk. This study 
showed that milk somatic cells can be used as a source of mRNA to study SCD1 expression 
in dairy cows, offering a non-invasive alternative to mammary tissue samples obtained by 
biopsy. 
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Abstract 
 
Stearoyl-CoA desaturase (SCD) is an important enzyme in the bovine mammary gland 
since it introduces a cis-double bond at the ∆9 position in a wide range of fatty acids. 
Several long-chain polyunsaturated fatty acids inhibit expression of SCD, but information 
on the effect of short-chain fatty acids on mammary SCD expression is scarce. We used a 
bovine mammary cell line (MAC-T) to assess the effect of acetic acid (Ac) and β-
hydroxybutyric acid (BHBA) on the mRNA expression of SCD via qRT-PCR, and 
compared this to the effect of various long-chain fatty acids on SCD expression as well as 
expression of acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS). In addition, 
expression of sterol regulatory binding protein 1 (SREBP-1), insulin-induced gene 1 protein 
(INSIG-1) and peroxisome proliferator-activated receptors (PPARs) were measured to 
examine if these transcription factors are involved in the regulation of SCD expression in 
bovine mammary epithelial cells. MAC-T cells were treated for 12 h without fatty acid 
additions (CON) or with either 5 mM Ac, 5 mM BHBA, a combination of 5 mM Ac + 5 
mM BHBA, 100 µM palmitic acid (PA), 100 µM stearic acid (SA), 100 µM oleic acid 
(OA), 100 µM trans-vaccenic acid (TVA), 100 µM linoleic acid (LA) or 100 µM α-
linolenic acid (ALA). Treatment incubations were performed in triplicate. In comparison 
with CON, expression of SCD1 was increased by Ac (+61%) and reduced by OA (-61%), 
LA (-84%) and ALA (-88%). Contrary to SCD1, MAC-T cells did not express SCD5 
mRNA. Expression of ACC was also increased by Ac (+44%) and reduced by LA (-48%) 
and ALA (-49%). Compared with control, FAS expression was not significantly affected by 
the treatments. The mRNA level of SREBP-1 was not affected by Ac or BHBA, but was 
reduced by OA (-44%), TVA (-42%), LA (-62%) and ALA (-68%) compared with control. 
Expression of INSIG-1 was down-regulated by SA (-37%), OA (-63%), TVA (-53%), LA 
(-81%) and ALA (-91%). Both PPARα and PPARδ expression was not significantly 
affected by the treatments. These results show that acetate up-regulates expression of SCD1 
and ACC in MAC-T cells, which indicates that acetate may increase desaturation and de 
novo synthesis of fatty acids in the bovine mammary gland. Furthermore, the results 
strengthen the support for the role of SREBP-1 and INSIG-1 as central regulators of 
lipogenesis in the bovine mammary gland. 
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Introduction 
 
Stearoyl-CoA desaturase (SCD) is a key enzyme in mammary lipid metabolism since it 
introduces a cis-double bond at the ∆9 position in a wide range of fatty acids (FA). The 
preferred substrates of SCD are C18:0 and, to a lesser extent, C16:0, which are converted to 
C18:1 cis-9 and C16:1 cis-9, respectively (Ntambi & Miyazaki, 2004). Since C18:1 cis-9 
has a considerable lower melting point than C18:0, SCD plays a critical role in maintaining 
fluidity of cell membranes as well as milk fat. In addition, SCD is responsible for the 
conversion of C18:1 trans-11 into C18:2 cis-9, trans-11 (CLA), which has been associated 
with several health benefits, including anticarcinogenic and antiatherogenic effects 
(Bhattacharya et al, 2006; Reynolds & Roche, 2010). 
It is well-known that in rodents, polyunsaturated fatty acids (PUFA) inhibit SCD 
expression in both liver and adipose tissue, whereas saturated fatty acids and 
monounsaturated fatty acids have little effect (Ntambi, 1999). In addition, it was shown that 
feeding mice a diet high in C18:1 cis-9 or C18:2 cis-9,12 inhibits both mRNA expression 
and activity of SCD in the mammary gland (Singh et al., 2004). Conversely, in ruminants 
only a few studies investigated the effect of FA on mammary SCD expression. Kadegowda 
et al. (2009a) reported that addition of C16:0, but not C18:0, increased expression of SCD 
in a bovine mammary cell line (MAC-T), whereas C18:1 cis-9, C18:1 trans-10, C18:2 
trans-10, cis-12 and C20:5 all decreased expression of SCD. In addition, it was shown in 
the same cell line that promoter activity of bovine SCD could be inhibited by C18:1 cis-9, 
whereas C18:0, C18:1 trans-11, C18:2 and C18:3 had no effect (Keating et al., 2006).  
Signalling mechanisms involved in the regulation of lipogenic genes, including SCD, 
have been comprehensively described in rodent liver and adipose tissue, but relatively little 
is known about these signalling mechanisms in the mammary gland of ruminants (Bernard 
et al., 2008). In rodents, transcriptional mechanisms are responsible for changes in mRNA 
expression of various lipogenic genes (Foufelle & Ferre, 2002) and critical transcription 
factors involved in the regulation of SCD include sterol regulatory binding protein 1 
(SREBP-1) and peroxisome proliferator-activated receptors (PPARs) (Paton & Ntambi, 
2009; Han et al., 2010). The SREBP family consist of transcription factors controlling the 
expression of a range of enzymes required for endogenous cholesterol, FA, triacylglycerol 
and phospholipid synthesis (Eberlé et al., 2004). In addition, insulin-induced gene 1 protein 
(INSIG-1) mediates negative feedback control of SREBP-1 (Horton et al., 2002; Dong & 
Tang, 2010). Similarly to rodents, it has been reported that SREBP-1 plays a pivotal role in 
FA synthesis in the bovine mammary gland (Peterson et al., 2004; Harvatine & Bauman, 
2006; Bauman et al., 2011). Peroxisome proliferator-activated receptors are a group of 
nuclear receptor proteins that function as ligand-activated transcription factors regulating 
the expression of genes involved in metabolism, cellular differentiation and development 
(Michalik et al., 2006). Three isoforms of PPAR are known, designated PPARα, PPARδ 
and PPARγ, and these isoforms are involved in regulating SCD expression in rodents 
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(Paton & Ntambi, 2009). Correspondingly, it has been suggested that PPARγ activation 
regulates milk fat synthesis in bovine mammary epithelial cells (Kadegowda et al., 2009a).  
Contrary to long-chain fatty acids (LCFA), no information is available on the effect of 
short-chain fatty acids (SCFA) on mammary SCD expression. Acetic acid (Ac) and β-
hydroxybutyric acid (BHBA), which originate from ruminal fermentation, are the main 
precursors for de novo synthesis of FA in the bovine mammary gland (Chilliard et al., 
2000). The two main enzymes involved in de novo FA synthesis are acetyl-CoA 
carboxylase (ACC) and fatty acid synthase (FAS) (Chilliard et al., 2000). It is hypothesized 
that both Ac and BHBA could alter the mRNA expression of genes involved in mammary 
lipid metabolism, including SCD. In this study we used MAC-T bovine mammary 
epithelial cells as a model to investigate the effect of the SCFA Ac and BHBA and various 
LCFA including C16:0, C18:1 cis-9 and C18:2 cis-9,12 on the mRNA expression of SCD 
as well as ACC and FAS in the bovine mammary gland. In addition, expression of SREBP-
1, INSIG-1 and PPARs were measured to examine if these transcription factors are 
involved in the regulation of SCD expression in bovine mammary epithelial cells. 
Moreover, FA composition of the MAC-T cells was measured to examine whether this was 
affected by the different treatments. 
  
Material and Methods 
 
Reagents 
Sodium acetic acid (S5636), sodium DL-β-hydroxybutyric acid (H6501), bovine serum 
albumin (BSA, fatty acid free; A8806), bovine insulin (I0516), bovine apo-transferrin 
(T1428), hydrocortisone (H0888), progesterone (P8783) and phosphate buffered saline 
(PBS; pH = 7.4; P3813) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The 
LCFA palmitic acid (C16:0, N-16A), stearic acid (C18:0, N-18A), oleic acid (C18:1 cis-9, 
U-46A), trans-vaccenic acid (C18:1 trans-11, U-49A), linoleic acid (C18:2 cis-9,12, U-
59A) and linolenic acid (C18:3 cis-9,12,15, U-62A) were obtained from Nu-Chek Prep Inc. 
(Elysian, MN, USA). Dulbecco’s modified eagle’s medium F-12 (DMEM/F-12), fetal 
bovine serum (FBS, 10091-148), penicillin/streptomycin (15070-063) and TRIzol® reagent 
(15596-026) were purchased from Invitrogen (Carlsbad, CA, USA). Bovine prolactin 
(AFP710E) was obtained from the National Hormone & Peptide Program (NHPP), 
NIDDK, and Dr. A. F. Parlow (Harbor-UCLA Medical Center, Torrance, CA, USA). 
 
Cell Culture and Treatments 
This study was performed using an established clonal cell line produced from primary 
bovine mammary alveolar cells (MAC-T) by stable transfection with SV-40 large T-antigen 
(Huynh et al., 1991). Cells were cultured in DMEM/F-12 supplemented with 10% (v/v) 
FBS and 1% penicillin/streptomycin (5,000 units of penicillin and 5,000 µg of streptomycin 
per mL) at 37ºC in a humidified atmosphere of 5% CO2. The MAC-T cells were seeded in 
vented 75 cm2 flasks (Corning Inc., Corning, NY, USA) and grown to  
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Table 1. Primer sequences of genes selected for quantitative polymerase chain reaction 
analysis. 
Gene1 Primer sequence 
SCD1 F    5’-GGCGTTCCAGAATGACGTTT-3’ 
 R    5’-AAAGCCACGTCGGGAATTG -3’ 
ACC F    5’-CATCTTGTCCGAAACGTCGAT-3’ 
 R    5’-CCCTTCGAACATACACCTCCA-3’ 
FAS F    5’-ACCTCGTGAAGGCTGTGACTCA-3’ 
 R    5’-TGAGTCGAGGCCAAGGTCTGAA-3’ 
18S F    5’-AGAAACGGCTACCACATCCAA-3’ 
 R    5’-GGGTCGGGAGTGGGTAATTT-3’ 
ACTB F    5’-GCCCTGAGGCTCTCTTCCA-3’ 
 R    5’-CGGATGTCGACGTCACACTT-3’ 
MRPL39 F    5’-AGGTTCTCTTTTGTTGGCATCC-3’ 
 R    5’-TTGGTCAGAGCCCCAGAAGT-3’ 
SREBP-1 F    5’-GGTTTCCAGAGGGACCTGAGT-3’ 
 R    5’-TGGCCCCTGCCATCAGT-3’ 
INSIG-1 F    5’-GCATCGACAGTCACCTTGGA-3’ 
 R    5’-TGTCAAGGAGAGCTGAACGTTATT-3’ 
PPARα F    5’-GGATGTCCCATAACGCGATT-3’ 
 R    5’-GGTCATGCTCACACGTAAGGATT-3’ 
PPARδ F    5’-TGTGGCAGCCTCAATATGGA-3’ 
 R    5’-GACGGAAGAAGCCCTTGCA-3’ 
1
 SCD1 = stearoyl-coenzyme A desaturase 1; ACC = acetyl coenzyme A carboxylase; FAS 
= fatty acid synthase; 18S = 18S ribosomal RNA; ACTB = β-actin; MRPL39 = 
mitochondrial ribosomal protein L39; SREBP-1 = sterol regulatory element-binding 
protein 1; INSIG-1 = insulin induced gene 1; PPARα = peroxisome proliferator-activated 
receptor alpha; PPARδ = peroxisome proliferator-activated receptor delta. 
 
 
approximately 90% confluency in DMEM/F-12 supplemented with 10% FBS and 1% 
penicillin/streptomycin for 24 h. Subsequently, the cell monolayer was rinsed twice with 10 
mL PBS and incubated in a lactogenic media (adapted from Kadegowda et al., 2009a) 
comprised of DMEM/F-12 supplemented with 1% penicillin/streptomycin, 1 g/L BSA, 5 
mg/L bovine insulin, 5 mg/L bovine apo-transferrin, 2.5 mg/L bovine prolactin, 1 mg/L 
hydrocortisone, and 1 mg/L progesterone. This lactogenic media was refreshed after 24 h 
and cells were cultured for 48 h at 37ºC in the lactogenic media before treatment with FA. 
Before addition to the MAC-T cells, the LCFA were complexed with BSA as sodium salts 
as described by Sørensen et al. (2008) with modifications. First, 0.1 mmol FA was 
dissolved in 1 ml hexane:isopropanol (3:2) followed by addition of 10 mL 0.1 N sodium 
hydroxide. This solution was then mixed and the hexane:isopropanol layer was evaporated 
using nitrogen gas. Subsequently, 1 mL of this solution was slowly added to 2 ml of 5% 
(w/v) BSA, and the resulting FA-BSA solution was stored overnight at 4 ºC, followed by 
storage at -20 ºC until use. 
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Treatments were performed in the presence of lactogenic media at 37 ºC. For LCFA 
treatment, cells were treated with 100 µM FA-BSA solution and for SCFA treatment with 
either 5 mM Ac, 5 mM BHBA or a mixture of Ac and BHBA (5 mM each). In order to keep 
the amount of BSA similar among all treatment groups, BSA was applied to the control, Ac 
and BHBA treatments as well. Treatments were performed in triplicate and cells were 
harvested after 12 h of incubation for subsequent analysis of gene expression and FA 
composition. 
 
RNA Extraction and Real Time PCR 
Total RNA was isolated using ice-cold TRIzol® reagent, according to the 
manufacturer’s instructions, as described previously (Jacobs et al., 2011). SYBR® Green 
qRT-PCR was performed with a ABI 7500 Real-Time PCR System (Applied Biosystems, 
Foster City, CA, USA) utilizing the SYBR® Green PCR Master Mix (Applied Biosystems). 
PCR conditions were as follows: denaturation at 95°C for 10 min followed by amplification 
of 40 cycles of 15s at 95°C and 1 min at 60°C. Oligonucleotide primers used are presented 
in Table 1. PCR efficiencies for the genes were established to be at least 91%. Melting 
curve analysis was carried out to determine primer specificity. Relative mRNA expression 
for each gene of interest (I) was calculated using the formula: (1 + E[I]) -Ct[I] / (1 + 
E[GMH]) -Ct[GMH], where E = amplification efficiency and GMH = geometric mean of the 
three housekeeping genes (ACTB, 18S and MRPL39). Each sample was run in duplicate. 
 
Lipid Extraction and FA Analysis 
The MAC-T cells were collected, pelleted by centrifugation (1000 x g for 10 min. at 
4°C), and washed twice with PBS. Total lipids were extracted using methanol and 
chloroform according to Bligh & Dyer (1959). Extracted lipids were trans-esterified using 
potassium hydroxide in methanol (0.5 N) followed by boron trifluoride in methanol (10% 
w/w) at 100°C for ten minutes each. Fatty acid methyl esters (FAME) were dissolved in n-
hexanes and quantified using a GC-2010 Plus gas chromatograph (Shimadzu, Kyoto, 
Japan) using a CP-Sil 88 WCOT fused silica column (100 m x 0.25 mm i.d. x 0.2 µm film 
thickness; Varian Inc., Lake Forest, CA, USA) according to our previous published 
methods (Caldari-Torres et al., 2011). The FAME were identified by comparison of 
retention times with known FAME standards (Caldari-Torres et al., 2011). 
 
Statistical Analysis 
Statistical analyses were carried out by ANOVA using the PROC MIXED procedure of 
SAS (version 9.2, SAS Institute Inc.) to evaluate the effects of the treatments on mRNA 
abundance of genes and FA composition of the cells. The model included treatment as 
fixed effect and to test pair-wise comparisons, post hoc analyses were carried out on the 
least square means adjusted for multiple comparisons using the Tukey-Kramer test. 
Differences were considered significant at a probability of P < 0.05, and as a trend at a 
probability of 0.05 < P < 0.10. The regression procedure (PROC REG) of SAS was used  
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Figure 1. Relative mRNA abundance of SCD1 in MAC-T cells treated with either 5 mM 
acetate or 100 µM palmitic acid (C16:0) after increasing incubation time. Vertical lines 
represent the standard error of the mean, and time points within treatment without a 
common letter differ (P < 0.05). 
 
 
to analyse relationships between relative abundance of the different genes as well as 
relationships between mRNA abundance of SCD1 and the desaturase indices. Relationships 
between SCD1 mRNA abundance and the desaturase indices were calculated without the 
treatments that involved substrates and products of that particular desaturase index. Results 
presented are expressed as mean ± SEM. 
 
Results 
 
Expression of Lipogenic Genes 
A preliminary time response study showed that the maximal effect of Ac and C16:0 on 
SCD1 expression was reached after 12 h of incubation (Figure 1). Therefore, MAC-T 
bovine mammary epithelial cells were treated for 12 h with Ac, BHBA or various LCFA, 
after which the mRNA expression of the lipogenic enzymes SCD1, ACC and FAS was 
determined by qRT-PCR. As shown in Figure 2, the transcript of SCD1 was increased by  
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Figure 2. Relative mRNA abundance of SCD1 in MAC-T cells after treatment (12h) with 
either: 5 mM acetate (Ac), 5 mM β-hydroxybutyrate (BHBA), combination of Ac and 
BHBA (Ac+BHBA), or 100 µM of the following LCFA: palmitic acid (C16:0), stearic acid 
(C18:0), oleic acid (C18:1 c9), trans-vaccenic acid (C18:1 t11), linoleic acid (C18:2) or 
linolenic acid (C18:3). Vertical lines represent the standard error of the mean, and 
treatments without a common letter differ (P < 0.05). 
 
 
Ac (+61%) and reduced by C18:1 cis-9 (-61%), C18:2 cis-9,12 (-84%) and C18:3 cis-
9,12,15 (-88%) compared with control cells. Contrary to SCD1, MAC-T cells did not 
express SCD5 mRNA (Figure 3). Expression of ACC was also increased by Ac (+44%) and 
reduced by C18:2 cis-9,12 (-48%) and C18:3 cis-9,12,15 (-49%) compared with control 
cells (Figure 4a). Compared with control, FAS expression was not significantly affected by 
the treatments (Figure 4b). However, FAS expression was lower for the C18:2 cis-9,12 and 
C18:3 cis-9,12,15 treatment compared with Ac or BHBA and for the C18:1 cis-9 treatment 
compared with BHBA.  
 
Expression of Transcription Factors 
The mRNA level of SREBP-1 was reduced by C18:1 cis-9 (-44%), C18:1 trans-11 (-
42%), C18:2 cis-9,12 (-62%) and C18:3 cis-9,12,15 (-68%) compared with control (Figure 
5a). Expression of INSIG-1 was down-regulated by C18:0 (-37%), C18:1 cis-9 (-63%), 
C18:1 trans-11 (-53%), C18:2 cis-9,12 (-81%) and C18:3 cis-9,12,15 (-91%) compared 
with control (Figure 5b). Both PPARα (Figure 6a) and PPARδ (Figure 6b) expression were 
not significantly affected by the treatments, and PPARγ was not expressed in the MAC-T  
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Figure 3. Detection of SCD1 and SCD5 in native and immortalized (MAC-T) bovine 
mammary epithelial cells (0.8% agarose gel stained with ethidium bromide). Native 
mammary tissue was collected via biopsy. Total RNA was converted to cDNA in the 
presence of reverse transcriptase (+RT) or absence of reverse transcriptase (-RT; negative 
control). PCR conditions were as follows: denaturation at 94°C for 2 min followed by 
amplification of 40 cycles of 30s at 94°C, 45s at 30°C and 2 min at 72°C, followed by 8 
min at 72°C. Primers used for SCD1 were:  CTACACAACCACCACCACCA (forward), 
CAGGGCACCCATCAGATAGT (reverse) and for SCD5: 
CTTCCTCCTGACTGCTCTGG (forward) and GTGGGGACTACGAAGCACAT 
(reverse).  
 
 
cells (data not shown). Correlations between the relative mRNA abundance of the lipogenic 
genes SCD1, ACC and FAS and the transcription factors SREBP-1, INSIG-1, PPARα and 
PPARδ are shown in Table 2.  
 
Fatty Acid Composition 
Table 3 shows the FA composition of total lipids extracted from the MAC-T cells. As 
expected, application of the various LCFA resulted in an increased proportion of the 
corresponding FA in the cells. C18:1 trans-11 as well as C18:2 cis-9, trans-11 CLA were 
only detected in cells treated with C18:1 trans-11. The C16 and C18 desaturase indices 
were significantly affected by the different treatments. As predicted, the C18 index was 
significantly higher upon addition of C18:1 cis-9, which is the desaturase product itself. 
There was a significant relationship between the C18 desaturase index and relative SCD1 
mRNA abundance (r2 = 0.42; P < 0.001). However there was no significant relationship 
between the C16 desaturase index and relative SCD1 mRNA abundance (r2 = 0.05; P = 
0.28).   
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Figure 4. Relative mRNA abundance of ACC (a) and FAS (b) in MAC-T cells after 
treatment (12h) with either: 5 mM acetate (Ac), 5 mM β-hydroxybutyrate (BHBA), 
combination of Ac and BHBA (Ac+BHBA), or 100 µM of the following LCFA: palmitic 
acid (C16:0), stearic acid (C18:0), oleic acid (C18:1 c9), trans-vaccenic acid (C18:1 t11), 
linoleic acid (C18:2) or linolenic acid (C18:3). Vertical lines represent the standard error of 
the mean, and treatments without a common letter differ (P < 0.05). 
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Table 2. Correlation (r2 values) between the relative mRNA abundance of the lipogenic 
genes: stearoyl-coenzyme A desaturase 1 (SCD1), acetyl coenzyme A carboxylase (ACC) 
and fatty acid synthase (FAS) and the transcription factors: sterol regulatory element-
binding protein 1 (SREBP-1), insulin induced gene 1 (INSIG-1), peroxisome proliferator-
activated receptor alpha (PPARα) and peroxisome proliferator-activated receptor delta 
(PPARδ). 
 SCD1 ACC FAS SREBP-1 INSIG-1 PPARα PPARδ 
SCD1    - 0.81** 0.72**   0.68** 0.86** 0.04 0.16# 
ACC 0.81**    - 0.76**   0.65** 0.72** 0.05 0.12 
FAS 0.72** 0.76**    -   0.49** 0.56** 0.08 0.16# 
SREBP-1 0.68** 0.65** 0.49**      - 0.85** 0.10 0.20# 
INSIG-1 0.86** 0.72** 0.56**   0.85**    - 0.08 0.18# 
PPARα 0.04 0.05 0.08   0.10 0.08    - 0.30* 
PPARδ 0.16# 0.12 0.16#   0.20# 0.18# 0.30*    - 
# = P < 0.05 
* = P < 0.01 
** = P < 0.001 
 
 
Discussion 
 
The aim of this study was to examine the effects of the SCFA Ac and BHBA as well as 
various LCFA on expression of several lipogenic genes and transcriptional regulators in 
bovine mammary epithelial cells. In addition, FA composition of the cells was analysed to 
investigate whether this was affected by the different treatments. The data on the FA 
composition of the cells demonstrate that the LCFA were taken up by the cells, rather than 
incomplete washing of the cells, since cis-9, trans-11 CLA was only detected in cells 
treated with C18:1 trans-11. Apparent desaturation of C18:1 trans-11 to cis-9, trans-11 
CLA was 26.5% of total C18:1 trans-11 taken up by the cells. This is in close agreement 
with the 25.7% reported by Mosley et al. (2006) in dairy cows using 13C labelled FA. 
The upregulation of ACC and SCD1 by Ac indicates that Ac may increase de novo 
synthesis and desaturation of FA in bovine mammary epithelial cells. In contrast with our 
results, Yonezawa et al. (2004) found that addition of Ac decreased activity of ACC in 
primary cultured bovine mammary epithelial cells. This discrepancy could be due to 
temporal differences since Yonezawa et al. (2004) treated the cells for 7 d opposed to 12 h  
  
Table 3. Fatty acid composition of total lipids extracted from MAC-T cells after treatment (12h) with either: 5 mM acetate (Ac), 5 mM β-
hydroxybutyrate (BHBA), combination of Ac and BHBA (Ac+BHBA), or 100 µM of the following LCFA: palmitic acid (C16:0), stearic acid 
(C18:0), oleic acid (C18:1 c9), trans-vaccenic acid (C18:1 t11), linoleic acid (C18:2) or linolenic acid (C18:3). 
a-f
 Means within a row without a common superscript differ (P < 0.05).  
Fatty acid 
(g/100g FA) 
 Treatments   
Control Ac BHBA Ac + 
BHBA C16:0 C18:0 
C18:1 
c9 
C18:1 
t11 C18:2 C18:3 SEM 
P-
value1 
C16:0 19.45b 19.55b 20.29b 19.62b 23.41a 16.81c 16.54c 16.03c 16.05c 15.93c 0.26 <0.001 
C16:1 c9 
  3.03bc 2.76bcd   3.18b 2.55bcd   4.95a 2.49bcd 2.33cd 2.35cd   2.07d   2.41cd 0.15 <0.001 
C18:0 
  5.74bc 5.92bc   6.21b 5.94bc   5.50bc 10.42a 5.11cd 4.58d   5.68bc   5.57bc 0.18 <0.001 
C18:1 c9 34.44b 35.69b 34.09b 35.26b 30.37c 36.79b 40.83a 30.91c 25.46d 26.28d 0.62 <0.001 
C18:1 c11 
  3.46ab 3.44ab   3.64a  3.38abc   3.93a 2.84cd  3.00bcd 2.97bcd   2.48d   2.46d 0.12 <0.001 
C18:1 t11 
-
2
 - - - - - - 8.12 - - - - 
CLA c9, t11 
- - - - - - - 2.89 - - - - 
C18:2 18.94b 17.17bc 16.77bc 18.28bc 17.99bc 17.26bc 16.84bc 14.78c 32.54a 17.08bc 0.83 <0.001 
C18:3 
  0.46b 0.39b   0.43b 0.42b   0.36b 0.40b 0.42b 0.45b   0.48b 16.10a 0.18 <0.001 
 
            
Others3 11.83ab 12.02ab 12.16ab  11.21ab 10.29b 10.11b 12.14ab 13.13a 12.02ab 10.77ab 0.57   0.03  
Unidentified 
  2.66 3.06   3.25 3.33   3.21 2.87 2.78 3.79   3.21   3.39 0.29   0.31 
 
            
∆9-desaturation 
indices4           
 
  C16:1 c9 
  0.13b 0.12b   0.14b 0.12b   0.17a 0.13b 0.12b 0.13b   0.11b   0.13b 0.01 <0.001 
  C18:1 c9 
  0.86b 0.86b   0.85bc 0.86b   0.85bc 0.78e 0.89a 0.87ab   0.82d   0.83cd 0.01 <0.001 
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Table 3. Continued. 
1
 Effect of treatment. 
2
 Not detected. 
3
 Sum of minor fatty acids: ∑ (C14:0, C14:1 c9, C15:0, C16:1 t9, C16:1 c7/c8, C16:1 c11, 
C17:0, C17:1 c9, C17:1 c10, C18:1 t6-8, C18:1 t9, C18:1 t10, C18:1 t12, C18:1 c12, 
C18:1 c13, C18:1 c14/t16, C20:0, C20:1 c8, C20:1 c9, C20:1 c11, CLA t10c12, C20:2 (n-
6), C20:3 (n-6), C20:3 (n-3), C20:4 (n-6), C20:5 (n-3), C22:0, C24:0, C24:1 c15, C22:4 
(n-6), C22:5 (n-3), C22:6 (n-3)). 
4
 ∆9-desaturase indices are calculated as: ∆9-desaturase product divided by the sum of the 
∆9-desaturase product and substrate. 
 
 
in our study. In addition, possible post-translational effects could result in differences 
between mRNA expression and activity of ACC. However, it has been shown that 
intraruminal infusion of either Ac or BHBA increases the amount of SCFA in the milk of 
dairy cows (Storry & Rook, 1965). This suggest that an increased availability of substrate, 
increases de novo fatty acid synthesis and/or decreases the incorporation of preformed 
LCFA in the bovine mammary gland. Although Ac upregulated ACC in our study, addition 
of Ac did not result in an increase of C16:0 in total lipids extracted from the cells. It has 
been speculated that mammary cells have a requirement for LCFA for lipid droplet 
formation, since upregulation of ACC and FAS, together with Ac availability, did not 
increase lipid droplet formation in MAC-T cells (Kadegowda et al., 2009a). In addition, the 
incubation of 12 h in our study, although appropriate for mRNA expression, might not have 
been sufficient to fully detect differences in FA composition of the cells. There was no 
significant effect of BHBA or the combination of Ac and BHBA on any of the genes 
measured, compared to the control treatment, although numerically these additions resulted 
in a similar response. This suggest that Ac has a more pronounced effect on lipogenic gene 
expression in bovine mammary epithelial cells compared to BHBA. 
C16:0 has been shown to upregulate SCD1 expression in MAC-T cells (Kadegowda et 
al., 2009a). However, we did not find a significant effect of C16:0 treatment on SCD1 
expression in MAC-T cells. This contradiction could be due to the fact that our MAC-T 
cells did not express PPARγ, since Kadegowda et al. (2009a) suggested that the effect of 
C16:0 on SCD1 expression was partly mediated through PPARγ. Addition of C18:0 to the 
MAC-T cells did also not affect SCD1 expression. This is in line with Kadegowda et al. 
(2009a) who also reported that C18:0 did not affect SCD1 expression in MAC-T cells. 
Moreover, Jayan & Herbein (2000) reported that SCD activity was not affected when C18:0 
was added to MAC-T cells.  
The main product of SCD is C18:1 cis-9 arising from desaturation of C18:0 (Ntambi, 
1999). Addition of this product to the MAC-T cells resulted in down-regulation of SCD1. 
This suggests that C18:1 cis-9 inhibits SCD1 expression in a negative feedback loop. This 
is in agreement with Keating et al. (2006), who showed that the SCD promoter activity was  
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Figure 5. Relative mRNA abundance of SREBP-1 (a) and INSIG-1 (b) in MAC-T cells 
after treatment (12h) with either: 5 mM acetate (Ac), 5 mM β-hydroxybutyrate (BHBA), 
combination of Ac and BHBA (Ac+BHBA), or 100 µM of the following LCFA: palmitic 
acid (C16:0), stearic acid (C18:0), oleic acid (C18:1 c9), trans-vaccenic acid (C18:1 t11), 
linoleic acid (C18:2) or linolenic acid (C18:3). Vertical lines represent the standard error of 
the mean, and treatments without a common letter differ (P < 0.05). 
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downregulated by C18:1 cis-9 in MAC-T cells. Similarly, it has been reported that C18:1 
cis-9 inhibits both SCD1 expression (Kadegowda et al., 2009a) and SCD1 activity (Jayan & 
Herbein, 2000) in MAC-T cells. These results are in line with the role of SCD as key 
regulator of cell membrane fluidity as well as milk fat fluidity, by maintaining a rather 
constant C18:0 / C18:1 cis-9 ratio.  
C18:1 trans-11 can be converted by SCD to cis-9, trans-11 CLA. When C18:1 trans-11 
was added to the MAC-T cells, we found no significant effect on expression of SCD1. 
Correspondingly, it was shown that the promoter activity of SCD1 was not altered in MAC-
T cells treated with C18:1 trans-11 (Keating et al., 2006). However, Jayan & Herbein 
(2000) reported that SCD activity was increased in MAC-T cells following the addition of 
C18:1 trans-11. This could suggest that C18:1 trans-11 has a direct effect on SCD activity 
without influencing the mRNA expression of SCD1. 
It is well-known that n-3 and n-6 PUFA inhibit hepatic SCD1 expression in rodents 
(Ntambi, 1999). Also it was shown that C18:2 cis-9,12 decreases SCD1 expression in 
mammary gland of mice (Singh et al., 2004). In our study SCD1 expression was decreased 
with both the C18:2 cis-9,12 and C18:3 cis-9,12,15 treatments. These results show that the 
PUFAs C18:2 cis-9,12 and C18:3 cis-9,12,15 downregulate SCD1 expression in bovine 
mammary epithelial cells, similarly to rodents. Keating et al. (2006) found no differences in 
promoter activity of SCD1 when MAC-T cells were treated with C18:2 cis-9,12 or C18:3 
cis-9,12,15, but they used a lower dose of FA (30 µM versus 100 µM in our study). We 
found recently that supplementing the diet of dairy cows with soybean oil (mainly C18:2 
cis-9,12) decreased SCD1 expression in the mammary gland compared with rapeseed oil 
(mainly C18:1 cis-9) or linseed oil (mainly C18:3 cis-9,12,15) (Jacobs et al., 2011). 
The C16 desaturase index was only affected by the C16:0 treatment, most likely due to 
the high addition of C16:0 to the cells. The C16 desaturase index was not related to the 
relative mRNA abundance of SCD1 (r2 = 0.05; P = 0.28). However, we observed a 
significant relationship between the C18 desaturase index and relative SCD1 mRNA 
abundance (r2 = 0.42; P < 0.001). This indicates that the C18 desaturase index is a better 
indicator of SCD activity compared to the C16 desaturase index, when calculated from total 
lipids extracted from bovine mammary epithelial cells. In biopsies of the bovine mammary 
gland, Jacobs et al. (2011) reported moderate correlations between SCD1 and C16 or C18 
index (r2 of 0.35 and 0.39, respectively), whereas Bionaz & Loor (2008b) and Invernizzi et 
al. (2010) concluded that desaturation indices were poor predictors of SCD activity. 
Similarly to SCD1, ACC expression was downregulated with both C18:2 cis-9,12 and 
C18:3 cis-9,12,15 addition. FAS expression displayed a similar trend as ACC but FAS 
expression was only numerically lower with addition of C18:2 cis-9,12 or C18:3 cis-
9,12,15 compared to control. In rodents it is known that PUFA supplementation inhibits 
expression of genes involved in de novo lipid synthesis, including ACC and FAS (Jump & 
Clarke, 1999). 
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Figure 6. Relative mRNA abundance of PPARα (a) and PPARδ (b) in MAC-T cells after 
treatment (12h) with either: 5 mM acetate (Ac), 5 mM β-hydroxybutyrate (BHBA), 
combination of Ac and BHBA (Ac+BHBA), or 100 µM of the following LCFA: palmitic 
acid (C16:0), stearic acid (C18:0), oleic acid (C18:1 c9), trans-vaccenic acid (C18:1 t11), 
linoleic acid (C18:2) or linolenic acid (C18:3). Vertical lines represent the standard error of 
the mean. No statistical differences (P < 0.05) between treatments in both PPARα and 
PPARδ expression were found. 
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The expression patterns across all treatments for ACC, FAS and SCD1 showed a quite 
similar trend. Furthermore, correlations between relative expression of the different 
lipogenic genes were rather high (range r2: 0.72 - 0.81; P < 0.001), which supports the idea 
that these lipogenic genes are regulated by common transcription factors. The SREBP 
family consist of several transcription factors that act as master regulators of lipid and 
cholesterol metabolism by controlling the expression of a range of enzymes required for 
endogenous cholesterol, FA, triacylglycerol and phospholipid synthesis (Eberlé et al., 
2004). It has been shown that trans-10, cis-12 CLA downregulates both SREBP-1 and 
INSIG-1 in MAC-T cells (Peterson et al., 2004) as well as in vivo in the bovine mammary 
gland (Harvatine & Bauman, 2006) providing strong support for SREBP-1 and INSIG-1 as 
a central signalling pathway regulating FA synthesis in the bovine mammary gland. In our 
study, SREBP-1 and INSIG-1 were expressed parallel to those of the lipogenic genes 
(SCD1, ACC and FAS) and correlations between both SREBP-1 and INSIG-1 and the 
lipogenic genes were moderate to high (range r2: 0.49 - 0.86; P < 0.001). This indicates that 
effect of FA on expression of SCD1, ACC and FAS in our study was, at least partly, 
mediated through SREBP-1 and INSIG-1. This strengthens the support for the role of 
SREBP-1 and INSIG-1 as central regulators of lipogenesis in the bovine mammary gland.  
In our study, PPARα and PPARδ were not affected by the treatments whereas PPARγ 
was not expressed by the MAC-T cells. It has been suggested that PPARγ activation 
regulates milk fat synthesis in bovine mammary epithelial cells (Kadegowda et al., 2009a). 
In our study, the addition of PUFA to the cells resulted in downregulation of ACC and 
SCD1 as expected, despite the fact that PPARγ was not expressed. This suggest that PPARγ 
expression is not a prerequisite for the inhibitory effect of PUFA on ACC and SCD1 
expression.  
 
Conclusions 
 
This study showed that Ac upregulates both SCD1 and ACC expression in bovine 
mammary epithelial cells, which indicates that Ac may increase de novo synthesis and 
desaturation of FA in the bovine mammary gland. In addition, both the PUFAs C18:2 cis-
9,12 and C18:3 cis-9,12,15 downregulate SCD1 and ACC expression. The effects of FA on 
the expression of the lipogenic genes SCD1, ACC and FAS appears to be, at least partly, 
regulated by the transcription factor SREBP-1 and INSIG-1, which strengthens the support 
for the role of SREBP-1 and INSIG-1 as central regulators of lipogenesis in the bovine 
mammary gland. 
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General Discussion 
 
Increasing the proportion of unsaturated fatty acids (UFA) in milk is believed to be 
beneficial in terms of human health, thereby increasing the nutritional quality of milk. In 
the Netherlands however, the content of even-chain, saturated fatty acids (SFA) in milk fat 
of raw bovine milk was higher in 2005 compared with 1992, which was related to changes 
in the composition of diets fed to dairy cows (Heck et al., 2009). The proportion of UFA in 
milk is mainly dependent on the proportion of UFA in the diet, the degree of 
biohydrogenation in the rumen, and on the activity of stearoyl-CoA desaturase (SCD) in the 
mammary gland. This thesis focuses on SCD in the mammary gland of dairy cows, and 
how SCD can be influenced by nutrition. More specifically, the effect of short- and long-
chain fatty acids (FA) on mRNA expression of SCD was investigated in the bovine 
mammary gland. In addition, a non-invasive alternative to mammary tissue for measuring 
SCD expression in the mammary gland of dairy cows was examined.  
Supplementing the diet of dairy cows with soybean oil (high in C18:2 cis-9,12) reduced 
stearoyl-CoA desaturase 1 (SCD1) expression in the mammary gland compared to rapeseed 
oil (high in C18:1 cis-9) or linseed oil (high in C18:3 cis-9,12,15), whereas stearoyl-CoA 
desaturase 5 (SCD5) expression was much smaller than SCD1 expression and did not differ 
between treatments (Chapter 2). Mammary tissue of cows in this study were also used for 
micro-array analysis to investigate the changes in genome-wide expression of genes in 
response to dietary UFA supplementation (Chapter 3). This analysis showed that 
supplementing the diet of dairy cows with UFA results in predominant downregulation of 
gene sets related to cell development and remodelling, apoptosis, nutrient metabolic 
process and immune system response in the mammary gland. A non-invasive, alternative 
source of mRNA was investigated (Chapter 4) in order to allow more routine evaluation of 
nutritional effects on mammary SCD expression. Results showed that using milk somatic 
cells as a source of mRNA to examine SCD1 expression in dairy cows, yields results 
comparable with mammary tissue and therefore, milk somatic cells can provide a non-
invasive alternative to mammary tissue samples obtained by biopsy to study effects on 
SCD1 expression. To further examine the effects of individual FA, in particular short-chain 
fatty acids (SCFA) on SCD expression, a bovine mammary epithelial cell line (MAC-T) 
was used (Chapter 5). Results of this study revealed that acetate (Ac) upregulates 
expression of both acetyl-CoA carboxylase (ACC) and SCD1 in MAC-T cells, indicating 
that Ac may increase de novo synthesis and desaturation of FA in the bovine mammary 
gland. Furthermore, expression of both sterol regulatory binding protein 1 (SREBP-1) and 
insulin-induced gene 1 (INSIG-1) was significantly related to the expression of the 
lipogenic genes, supporting the role of SREBP-1 and INSIG-1 as central regulators of 
lipogenesis in the bovine mammary gland. In this general discussion, SCD1 and its 
regulation, the role of SCD5 compared with SCD1, the use of desaturation indices as 
proxies of SCD activity, and non-nutritional factors affecting SCD activity are discussed.  
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Stearoyl-CoA Desaturase 1 
Until recently it was thought that only one isoform of SCD (i.e. SCD1) was present in 
bovine species and is therefore commonly referred to as just simply SCD. In 2007, Lengi & 
Corl (2007) identified a novel SCD isoform in bovine, designated SCD5 (see paragraph 
6.3) Consequently, most of the research and available literature on SCD in dairy cows 
involves the SCD1 isoform. In lactating ruminants, the highest activity of SCD is found 
within the mammary gland (McDonald & Kinsella, 1972). During lactation, SCD1 is 
markedly upregulated and SCD1 is one of the most abundantly expressed genes in the 
lactating mammary gland (Bionaz & Loor, 2008b). Furthermore, it has been proposed that 
SCD plays a central role in milk fat synthesis by providing endogenous C18:1 cis-9 for 
mammary triacylglyceride synthesis (Bionaz & Loor, 2008b). Based on arterio-venous 
differences in the SCD products and substrates, desaturation of C18:0 to C18:1 cis-9 in 
dairy cows was estimated to be 52% (Enjalbert et al., 1998). Using 13C-labelled FA, Mosley 
& McGuire (2007) reported that desaturation of C14:0, C16:0 and C18:0 in the mammary 
gland of dairy cows was estimated to be 7.0%, 2.5% and 48.7% respectively, resulting in 
92%, 56% and 43% of C14:1 cis-9, C16:1 cis-9 and C18:1 cis-9 in milk originating from 
substrate desaturation. In addition, it has been shown that desaturation of C18:1 trans-11 is 
the major source of cis-9, trans-11 CLA in milk of dairy cows. Studies using sterculic oil to 
inhibit SCD activity have shown that 78 to 91% of total cis-9, trans-11 CLA in milk 
originates from desaturation of C18: trans-11 by SCD (Corl et al., 2001; Kay et al., 2004). 
From the study reported in Chapter 5, it was calculated that 26.5% of the C18:1 trans-11 
taken up by the mammary epithelial cells (MAC-T) was desaturated to cis-9, trans-11 
CLA. This is in close agreement with the 25.7% reported by Mosley et al. (2006) in dairy 
cows using 13C labelled FA.  
 
Regulation of Stearoyl-CoA Desaturase 1 
Knowledge about the nutritional regulation of bovine SCD is limited compared to 
rodents. The nuclear transcription factor SREBP-1 is known to be an important regulator of 
SCD in rodents (Bernard et al., 2008). The SREBP family consists of several transcription 
factors that act as master regulators of lipid and cholesterol metabolism by controlling the 
expression of a range of enzymes required for endogenous cholesterol, FA, triacylglycerol 
and phospholipid synthesis (Eberlé et al., 2004). Results from the study reported in Chapter 
5 showed that the expression of the lipogenic genes ACC, FAS and SCD1 was significantly 
correlated with the expression of SREBP-1 as well as INSIG-1 in bovine mammary 
epithelial cells (Figure 1). This indicates that the expression of these lipogenic genes are, at 
least partially, coordinated through the SREBP-1 mechanism. Similar results have been 
presented by other in vitro studies investigating lipogenic gene expression in bovine 
mammary epithelial cells. Peterson et al. (2004) reported that supplementing trans-10, cis-
12 CLA to bovine mammary epithelial cells (MAC-T), downregulated ACC, FAS and 
SCD1 expression and this coincided with a reduction in proteolytic activation of SREBP-1. 
In addition, SREBP-1 expression was downregulated by trans-10, cis-12 CLA in  
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Figure 1. Relationship between relative mRNA abundance of SCD1 and SREBP-1 (a) as 
well as SCD1 and INSIG-1 (b) in MAC-T cells treated with various FA (n = 30; Chapter 
5). SREBP-1 expression = 0.064 (±0.009) + 1.51 (±0.163) x SCD1 expression; r2 = 0.75, P 
< 0.001. INSIG-1 expression = 0.024 (±0.009) + 2.64 (±0.171) x SCD1 expression; r2 = 
0.90, P < 0.001.  
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MAC-T cells parallel to the downregulation of lipogenic genes, including ACC, FAS and 
SCD1 (Kadegowda et al., 2009a). These results are supported by the fact that the promoter 
of SCD1 contains a region designated as SCD transcriptional enhancer element (STE) to 
which SREBP is predicted to bind (Keating et al., 2006).  
Micro-array analysis of mammary tissue in the study reported in Chapter 3 showed that 
UFA supplementation downregulated expression of numerous genes involved in lipid 
metabolism, including ACC, which concurred with reduction of SREBP-1 as well as 
INSIG-1 expression. This is analogous with the in vitro results of Chapter 5 where C18:2 
cis-9,12 and C18:3 cis,9,12,15 caused a reduction in ACC and SCD1 expression coupled 
with a downregulation of SREPB-1 and INSIG-1. These results are also in line with other 
studies examining expression of genes involved in lipid metabolism in the bovine 
mammary gland. It has been shown that either a low forage/high concentrate diet or 
abomasal infusion of trans-10, cis-12 CLA caused an inhibition of lipogenic gene 
expression, including ACC and FAS, which coincided with a downregulation of SREBP-1 
as well as INSIG-1 in the mammary gland of dairy cows (Harvatine & Bauman, 2006; 
Gervais et al., 2009). Overall, the results from Chapter 3 and 5 strengthen the support for 
the central role of SREBP-1 in the regulation of lipogenesis in the bovine mammary gland. 
The peroxisome proliferator-activated receptor (PPAR) family consists of three 
subtypes (PPARα, PPARδ and PPARγ) which are nuclear receptors that function as ligand-
activated transcription factors regulating the expression of genes involved in metabolism, 
cellular differentiation and development (Michalik et al., 2006). In rodents, the PPARγ 
agonist rosiglitazone upregulates SCD1 (Way et al., 2001), indicating that SCD1 is a target 
of PPARγ. Correspondingly, Kadegowda et al. (2009a) reported that several lipogenic 
genes, including ACC, FAS, DGAT1, SREBP-1 and INSIG-1, are putative PPARγ target 
genes in bovine mammary epithelial cells. In addition, it has been shown that PPARγ and 
its target genes were markedly upregulated in mammary tissue of dairy cows during onset 
of lactation, suggesting a role of this nuclear receptor in milk fat synthesis (Bionaz & Loor, 
2008b). Neither PPARα or PPARδ expression was affected by FA treatments in MAC-T 
cells (Chapter 5). Remarkably, PPARγ was not expressed by the MAC-T cells used. 
Nevertheless, the addition of the poly unsaturated fatty acid (PUFA) C18:2 cis-9,12 or 
C18:3 cis-9,12,15 to the MAC-T cells resulted in downregulation of ACC and SCD1 as 
expected, indicating that PPARγ expression is not a prerequisite for the inhibitory effect of 
PUFA on ACC and SCD1 expression in bovine mammary epithelial cells. 
 
Stearoyl-CoA Desaturase 5 
Recently, a novel bovine isoform of SCD was identified, designated SCD5, which 
appears to be primarily expressed in brain (Lengi & Corl, 2007). This new bovine 
desaturase gene seems to be an ortholog of the recently described human SCD5 gene, rather 
than a homolog of bovine SCD1 or any of the described murine SCD isoforms (Lengi & 
Corl, 2007). One of the reasons for the presence of multiple isoforms of SCD might be 
tissue-specific expression and/or substrate preference of the different isoforms. Although 
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SCD5 appears to be predominantly expressed in brain and pancreas (Wang et al., 2005; 
Lengi & Corl, 2007), it is also expressed in bovine mammary tissue (Gervais et al., 2009). 
In contrast to SCD1, mammary expression of SCD5 was not affected by supplementing the 
diet of dairy cows with various plant oils (Chapter 2). In addition, mRNA abundance of 
SCD5 in the mammary gland was much lower (<103) than that of SCD1. Similarly, in the 
study reported in Chapter 4, mRNA abundance of SCD5 was substantially lower than that 
of SCD1, indicating that SCD5 is less imperative regarding ∆9-desaturation of FA 
compared with SCD1. This is supported by the fact that the desaturation indices calculated 
from milk FA, which are frequently used to estimate mammary SCD activity, showed no 
relationship with relative mRNA abundance of SCD5 (e.g., C14 index: r2 = 0.02; P = 0.57), 
while there was a significant relationship with SCD1 (r2 = 0.35; P = 0.002; Chapter 2). 
However, SCD5 lacks N-terminal PEST sequences typically found in SCD1 (Lengi & Corl, 
2007), which are considered to be a signal for protein degradation (Reichsteiner & Rogers, 
1996), suggesting that protein stability is higher for SCD5 compared with SCD1. The 
results reported in Chapter 3 indicate that expression of SCD5 is less sensitive to changes in 
FA supply compared with SCD1 and that regulation of SCD5 differs from that of SCD1. 
One other study investigated SCD5 expression in the bovine mammary gland (Gervais et 
al., 2009), showing that intravenous infusion of trans-10, cis-12 CLA tended to reduce 
SCD1 expression in the mammary gland, whereas SCD5 expression was not affected. This 
again indicates that regulation of SCD5 differs from that of SCD1. Nevertheless, further 
research is necessary to determine the significance of SCD5 regarding ∆9-desaturation of 
FA in the bovine mammary gland. 
 
Desaturase Indices 
Several ratios of milk FA, referred to as desaturase indices, are frequently used as 
proxies to estimate SCD activity within the mammary gland. These desaturase indices are 
calculated as the ratio between the product and the sum of the product and substrate FA, 
e.g. C14:1 cis-9 / (C14:1 cis-9 + C14:0). Various desaturase indices are used, though the 
C14 index is considered the best indicator of SCD activity, since virtually all C14:0 and 
C14:1 cis-9 originate from de novo FA synthesis within the mammary gland (Lock & 
Garnsworthy, 2003; Bernard et al., 2008). In Chapter 2, the C14 desaturase index was 
positively, although not strongly, related to mRNA levels of SCD1 (r2 = 0.35; P = 0.002), 
indicating that this desaturase index can be used to estimate SCD activity in the mammary 
gland. Furthermore, the relationships between the different desaturase indices were high 
(range r2: 0.66 – 0.87; P < 0.001; Figure 2). Two observations were somewhat higher 
compared to the other data points and when these values were removed from the analysis, 
the r2 changed from 0.87 and 0.75 to 0.75 and 0.63 for the C14 index compared with the 
C16 index or the C18 index, respectively. Correspondingly, a similar positive relationship 
was found between the C14 desaturase index and expression of SCD1 in mammary tissue 
(r2 = 0.34; P = 0.08) as well as milk somatic cells (r2 = 0.52; P = 0.02) in Chapter 3.  
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Figure 2. Relationship between the C14 and C16 desaturase index (a) as well as the C14 
and C18 desaturase index (b) ( n = 28; Chapter 2). C16 index = 0.016 (±0.004) + 0.48 
(±0.038) x C14 index; r2 = 0.87, P < 0.001. C18 index = 0.57 (±0.015) + 1.14 (±0.13) x 
C14 index; r2 = 0.75, P < 0.001. 
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Other studies also found moderate relationships between desaturase indices and mRNA 
levels of SCD1 in dairy cows (Feng et al., 2007) and goats (Bernard et al., 2005a). 
Overall these results indicate that desaturase indices can be used as a convenient tool to 
estimate SCD activity within the mammary gland. However, it has been reported that 
desaturase indices do not always reflect actual SCD activity in bovine adipose tissue 
(Archibeque et al., 2005) or in the bovine mammary gland (Bionaz & Loor, 2008b; 
Invernizzi et al., 2010). Particularly, when the entire lactation cycle is considered, 
desaturase indices appear to be poorly associated with SCD1 mRNA levels in the 
mammary gland (Bionaz & Loor, 2008b). The lack of correlation between the various 
desaturase indices in the latter study, especially in the beginning of lactation, indicates that 
additional factors influence the amount of milk FA used for the calculation of these indices. 
Possible factors include the varying contribution of mobilized FA from body reserves, 
selective uptake of FA by the mammary gland, and varying contribution of de novo 
synthesised FA to total milk FA. In addition, substrate preference of SCD1 and selective 
use of FA for milk triglyceride synthesis could influence the various desaturase indices as 
well. 
 
Milk Fat Depression and SCD 
Assessing the effect of dietary FA on mammary gene expression in ruminants is 
complex since microbes in the rumen can alter the dietary FA. This so-called 
biohydrogenation results in saturation of FA, i.e. removal of double bonds, and in 
isomerization of the double bonds, i.e. shift from cis to trans configuration. Fatty acid 
analysis of blood plasma as well as milk in the study reported in Chapter 2, revealed that 
dietary oil supplementation most likely increased the amount of trans FA produced in the 
rumen. It has been shown that trans FA can affect expression of lipogenic genes, including 
SCD1, in the mammary gland. In particular trans-10, cis-12 CLA has been identified as one 
of the key ruminal biohydrogenation intermediates responsible for the inhibition of milk fat 
synthesis, often referred to as milk fat depression (MFD) (Shingfield & Griinari, 2007). 
Indeed, trans-10, cis-12 CLA in milk was positively correlated with milk fat % in Chapter 
2 (Figure 3). Diets that cause MFD include highly fermentable diets (low forage / high 
concentrate) and diets supplemented with plant or fish oil (high PUFA; Bauman & Griinari, 
2003). Feeding cows diets that cause MFD has been shown to inhibit expression of key 
lipogenic genes, including SCD1, in the mammary gland (Peterson et al., 2003; Harvatine 
& Bauman, 2006). In addition, abomasal infusion of trans-10, cis-12 CLA also inhibits 
lipogenic gene expression, including SCD1 (Baumgard et al., 2002; Harvatine & Bauman, 
2006). 
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Figure 3. Relationship between concentration of trans-10, cis-12 CLA in milk and milk fat 
% (n = 28; Chapter 2). Milk fat % = 4.48 (±0.20) + -44.4 (±8.64) x t10c12 CLA; r2 = 0.54, 
P < 0.001. 
 
 
Milk Fat Fluidity and SCD  
Milk fat fluidity is an important prerequisite for the secretion of milk by the mammary 
gland. Since the milk fat globule needs to be liquid, most of the FA have to be esterified to 
triacylglycerols in combinations that have a melting point at or below 39°C, the body 
temperature of the cow (Timmen & Patton, 1988). Since both C16:0 and C18:0 are solid at 
body temperature, there is a physiological need to convert a portion of each to C16:1 cis-9 
and C18:1 cis-9, respectively, that are liquid (Garnsworthy et al., 2010). It is believed that 
incorporating FA with a relative low melting point, i.e. C18:1 cis-9 or C4:0 to C10:0, in the 
final step of triglyceride synthesis is the main mechanism by which milk fluidity is 
regulated (Timmen & Patton, 1988). Since SCD1 controls the synthesis of C18:1 cis-9, 
SCD1 is thought to be essential in regulating milk fluidity. Dietary supplementation of fish 
oil or marine algae rich in C20:5n-3 or C22:6n-3 results in MFD and a pronounced 
decrease in C18:0 supply to the mammary gland since especially the last step in the 
biohydrogenation process in the rumen is inhibited and trans-10 rather than trans-11 
intermediates are formed (Boeckaert et al., 2008; Sterk et al., 2010). It has been suggested 
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reduce the ability of the mammary gland to maintain the required milk fluidity and 
therefore inhibit milk fat synthesis (Loor et al., 2005; Gama et al., 2008). However, 
abomasal infusion of sterculic oil, which is a source of cyclopropene FA that strongly 
inhibit the activity of the SCD1 enzyme, does not inhibit milk fat synthesis despite severely 
reduced SCD1 activity in the mammary gland (Griinari et al., 2000; Corl et al., 2001). This 
indicates that the mammary gland has a remarkable ability to maintain milk fat secretion 
over a substantial range in FA profile (Harvatine et al., 2009).  
  
Other Factors Influencing SCD Activity 
Several studies have demonstrated a substantial variation in desaturase indices in milk 
of dairy cows on a similar diet (Lock & Garnsworthy 2002; Kelsey et al., 2003; Lock & 
Garnsworthy 2003). Moreover, when switched between diets, the ranking of cows for 
desaturase indices remains consistent (Peterson et al., 2002b; Lock & Garnsworthy 2003), 
suggesting that genetic variation in SCD activity could play a role. Several studies used 
desaturase indices to estimate heritability of SCD in dairy cows. Moderate heritabilities for 
the C14 desaturase index were reported by Soyeurt et al. (2008; h2 = 0.20), Mele et al. 
(2009; h2 = 0.27), Stoop et al. (2009; h2 = 0.45) and Garnsworthy et al. (2010; h2 = 0.38). In 
addition to genetic variation within breed, variation in desaturase indices between different 
breeds has also been reported (Morales et al., 2000; Kelsey et al., 2003; Soyeurt et al., 
2006), suggesting genetic variation between breeds. However, the variation in heritability 
of SCD between the different studies is rather high, which might be partly related to 
differences in phenotypic variation between studies (i.e., low phenotypic variation related 
to high heritability and vice versa). For example, the highest heritability of SCD was 
obtained in a study in which all animals were heifers and in which all animals received a 
winter ration based on silage in February or March. This could mean that in practice (i.e., 
large phenotypic variation), heritability of SCD activity might be relatively low. Negative 
genetic correlations between desaturation indices and milk fat percentage have been 
reported (Schennink et al., 2008; Soyeurt et al., 2008), indicating that genetic selection on 
desaturation indices could have negative effects on milk fat percentage. In addition, it was 
shown that the SCD1 polymorphism A293V has a significant effect on individual 
desaturation indices, but not on the overall desaturation index, suggesting an effect of this 
polymorphism on substrate specificity of SCD (Schennink et al., 2008). 
Seasonal variation in desaturation indices has also been reported (Lock & Garnsworthy, 
2003; Heck et al., 2009). In the study of Heck et al. (2009), all desaturation indices showed 
the lowest values in spring (March - June) and the highest values in autumn (October), 
indicating lower SCD activity in spring compared with autumn. However, these data are 
not in line with results of Lock & Garnsworthy (2003), who showed that desaturation 
indices were highest in May/June (C14 index) and July (C16 and CLA index). It seems that 
differences in diet throughout the season (i.e., fresh grass in summer, more silage and 
concentrate in winter) affect the desaturation indices by changes in the supply of FA to the 
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mammary gland. Therefore, differences in feeding strategies between the two studies could 
play a role in the contradictory results of apparent SCD activity throughout the season.  
The effect of production variables (e.g., stage of lactation, milk yield and milk fat 
content) on desaturation indices (i.e., apparent SCD activity) has been examined (Kelsey et 
al., 2003; Lock et al., 2005). Kelsey et al. (2003) reported that cis-9, trans-11 CLA content 
in milk as well as the CLA index varied over 3-fold among individual cows on the same 
diet. Small or no relationships between the CLA index and parity or days in milk were 
observed, indicating little effect of these variables on SCD activity and suggesting genetic 
variation in rumen outflow of C18:1 trans-11 and/or tissue SCD activity. In addition, cis-9, 
trans-11 CLA content in milk fat and the CLA desaturase index were essentially 
independent of milk yield, milk fat percentage, and milk fat yield (Kelsey et al., 2003). 
These results are in agreement with Lock et al. (2005) who found that under normal 
conditions, the cis-9, trans-11 CLA content of milk and SCD activity in the mammary 
gland are independent of stage of lactation, milk yield, milk fat content, and milk fat yield.  
 
Implications and Future Research 
The main objective of the research described in this thesis was to investigate the effect 
of FA on SCD expression in the mammary gland of dairy cows. The purpose of this 
investigation was to find nutritional strategies that increase mammary SCD activity, thereby 
increasing MUFA as well as cis-9, trans-11 CLA content in milk, which would improve the 
nutritional quality of milk. In addition, a non-invasive alternative to biopsy for measuring 
SCD expression in the mammary gland of dairy cows was examined. 
Overall, it can be concluded that saturated LCFA have little or no effect on SCD1 
expression in the bovine mammary gland, whereas unsaturated LCFA inhibit mammary 
SCD1 expression. The inhibitory effect of unsaturated LCFA on mammary SCD1 
expression appears to increase proportionally with the amount of double bonds in the 
LCFA (i.e., more double bonds results in higher inhibition of SCD1 expression). Therefore, 
it seems difficult to enhance SCD1 expression in the mammary gland by supply of LCFA. 
In order to limit inhibition of mammary SCD1 expression, supply of PUFA to the 
mammary gland should be restricted. The regulation of SCD1 in the bovine mammary 
gland by LCFA appears to be, at least partly, regulated by the transcription factors SREBP-
1 and INSIG-1. Further research is needed to elucidate the role of these transcription factors 
and to identify possible additional genes that are involved in the regulation of SCD1 in the 
bovine mammary gland. Understanding the regulation of SCD1 in the bovine mammary 
gland could facilitate the search for nutritional strategies that could increase the activity of 
SCD in the mammary gland. Further research on the effect of SCFA on mammary SCD 
expression is needed to verify if SCFA can induce SCD1 expression in the bovine 
mammary gland. The recently discovered isoform SCD5 is expressed in bovine mammary 
tissue, although contribution to ∆9-desaturation of FA appears to be quite low. Additional 
research is required to elucidate the role of SCD5 in the mammary gland and examine its 
contribution to ∆9-desaturation of FA. Milk somatic cells can be used as a source of mRNA 
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to examine SCD1 expression in dairy cows, as a non-invasive alternative to mammary 
tissue samples obtained by biopsy. However, the rather low yield of RNA from milk 
somatic cells requires further research for improvement. 
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Summary 
 
Increasing the proportion of unsaturated fatty acids (UFA) in milk is believed to be 
beneficial in terms of human health, thereby increasing the nutritional quality of milk. In 
the Netherlands however, the proportion of UFA in milk decreased in the last decade, 
which is most likely related to changes in composition of diets fed to dairy cows. These 
changes include a lower proportion of fresh grass, reduced crude protein and fat content of 
grass and grass silage, and increased proportion of maize silage. The proportion of UFA in 
milk is mainly dependent on the proportion of UFA in the diet, the degree of 
biohydrogenation of UFA in the rumen, and on activity of the stearoyl-CoA desaturase 
(SCD) enzyme in the mammary gland. The SCD enzyme creates a double bond at the ∆9 
position in a wide range of fatty acids (FA), thereby making these FA unsaturated. This 
thesis focuses on SCD in the mammary gland of dairy cows, and how SCD can be 
influenced by nutrition. More specifically, the effect of short- and long-chain fatty acids on 
mRNA expression of SCD was investigated in the bovine mammary gland. The purpose of 
this research was to explore nutritional strategies that could increase the activity of SCD in 
the mammary gland of dairy cows, thereby improving the FA profile of milk. In addition, a 
non-invasive alternative to mammary tissue for measuring SCD expression in the 
mammary gland of dairy cows was examined.  
The objective of the first experiment (Chapter 2) was to compare the effects of various 
FA typically present in dairy cow rations, on the expression of both SCD1 and SCD5 (the 
two known bovine isoforms of SCD) in the mammary gland of dairy cows. Twenty-eight 
Holstein-Friesian cows were randomly assigned to one of the four dietary treatments being 
a basal diet supplemented (DM basis) with either 2.7% rapeseed oil as a source of C18:1 
cis-9, 2.7% soybean oil as a source of C18:2 cis-9,12, 2.7% linseed oil as a source of C18:3 
cis-9,12,15 or 2.7% of a 1:1:1 mixture of the three oils. After the treatment period of 23 
days, all cows were switched to a control diet for an additional 28 days. At the end of both 
the treatment period and the control period, tissue from the mammary gland was taken by 
biopsy and analysed for mRNA expression of SCD1 and SCD5 by using quantitative real-
time polymerase chain reaction (qRT-PCR). Milk yield as well as milk protein and fat 
content did not differ between the four dietary treatments. Mammary SCD1 expression was 
significantly down-regulated in dairy cows by feeding soybean oil compared with rapeseed 
oil or linseed oil, and this was partially reflected by the lower desaturase indices in the 
milk, which are frequently used as proxies for mammary SCD activity. In contrast, SCD5 
expression in the mammary gland was much lower (<103) than that of SCD1 and did not 
differ amongst the four treatments, indicating that mammary expression of SCD5 is less 
sensitive to changes in FA supply compared with SCD1.  
 
 
 
Summary 
  
 
 
161 
To study the changes in genome-wide expression of genes in response to dietary UFA 
supplementation, mammary tissue samples of experiment 1 were also used for micro-array 
analysis (Chapter 3). In this study, expression of the entire genome was compared between 
the four UFA diets and the control (no UFA supplementation). Compared to control, milk 
yield was higher but concentrations of milk fat and protein were lower when UFA were 
included in the diet. Furthermore, the proportion of de novo synthesised FA in milk was 
reduced, whereas that of long-chain fatty acids (LCFA) increased. Applying a statistical 
cut-off of false discovery rate of q-values < 0.05 together with an absolute fold change of 
1.3, a total of 972 genes were found to be significantly affected through UFA 
supplementation, indicating that large transcriptional adaptations occurred in the mammary 
gland when diets of dairy cows were supplemented with unprotected dietary UFA. Gene 
sets related to cell development and remodelling, apoptosis, nutrient metabolic process, as 
well as immune system response were predominantly downregulated during UFA 
supplementation.  
Since biopsy of the mammary gland is an invasive and costly method which presents a 
risk of udder infection, the use of milk somatic cells as a non-invasive, alternative source of 
mRNA was investigated in experiment 2 (Chapter 4). Both milk somatic cells and 
mammary tissue were collected from fourteen Holstein-Friesian cows fed diets with or 
without linseed and used for analysis of SCD expression by qRT-PCR. Expression of SCD5 
in mammary tissue was low compared with SCD1. A significant relationship (r2 = 0.60; P < 
0.01) was found between SCD1 expression in milk somatic cells and in mammary tissue. In 
addition, SCD1 expression in milk somatic cells was significantly related to ∆9-desaturase 
indices in milk (r2 between 0.32 and 0.52), which are commonly used as an indicator of 
SCD activity within the mammary gland. This relationship was better than the relationship 
between SCD1 expression in mammary tissue and ∆9-desaturase indices in milk (r2 
between 0.22 and 0.38). The yield of total RNA from milk of dairy cows was rather low, 
and further investigation is needed to improve the yield of RNA from milk. In conclusion, 
this study showed that milk somatic cells can be used as a source of mRNA to study SCD1 
expression in dairy cows, offering a non-invasive alternative to mammary tissue samples 
obtained by biopsy. 
Acetic acid (Ac) and β-hydroxybutyric acid (BHBA) are important precursors for de 
novo FA synthesis in the bovine mammary gland. However, contrary to LCFA, information 
on the effect of these short-chain FA on mammary SCD expression is scarce. Therefore, in 
experiment 3 (Chapter 5), a bovine mammary cell line (MAC-T) was used to assess the 
effect of Ac and BHBA on the mRNA expression of SCD via qRT-PCR, and to compare 
this to the effect of various LCFA on SCD expression, as well as expression of acetyl-CoA 
carboxylase (ACC) and fatty acid synthase (FAS). In addition, expression of sterol 
regulatory binding protein 1 (SREBP-1), insulin-induced gene 1 protein (INSIG-1) and 
peroxisome proliferator-activated receptors (PPARs) were measured to examine if these 
transcription factors are involved in the regulation of SCD expression in bovine mammary 
epithelial cells. MAC-T cells were treated for 12 h without FA additions (CON) or with 
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either 5 mM Ac, 5 mM BHBA, a combination of 5 mM Ac + 5 mM BHBA, 100 µM 
palmitic acid (PA), 100 µM stearic acid (SA), 100 µM oleic acid (OA), 100 µM trans-
vaccenic acid (TVA), 100 µM linoleic acid (LA) or 100 µM α-linolenic acid (ALA). In 
comparison with CON, expression of SCD1 was increased by Ac (+61%) and reduced by 
OA (-61%), LA (-84%) and ALA (-88%). Contrary to SCD1, MAC-T cells did not express 
SCD5 mRNA. Expression of ACC was also increased by Ac (+44%) and reduced by LA (-
48%) and ALA (-49%). Compared with CON, FAS expression was not significantly 
affected by the treatments. The mRNA level of SREBP-1 was not affected by Ac or BHBA, 
but was reduced by OA (-44%), TVA (-42%), LA (-62%) and ALA (-68%) compared with 
CON. Expression of INSIG-1 was down-regulated by SA (-37%), OA (-63%), TVA (-
53%), LA (-81%) and ALA (-91%). Both PPARα and PPARδ expression was not 
significantly affected by the treatments. These results show that Ac up-regulates expression 
of SCD1 and ACC in MAC-T cells, which indicates that Ac may increase desaturation and 
de novo synthesis of FA in the bovine mammary gland. Furthermore, the results strengthen 
the support for the role of SREBP-1 and INSIG-1 as central regulators of lipogenesis in the 
bovine mammary gland. 
Overall, it can be concluded that saturated LCFA have little or no effect on SCD1 
expression in the bovine mammary gland, whereas unsaturated LCFA inhibit mammary 
SCD1 expression. The inhibitory effect of unsaturated LCFA on mammary SCD1 
expression appears to increase proportionally with the amount of double bonds in the 
LCFA (i.e., more double bonds results in higher inhibition of SCD1 expression). Therefore, 
it seems difficult to enhance SCD1 expression in the mammary gland by supply of LCFA. 
In order to limit inhibition of mammary SCD1 expression, supply of poly unsaturated fatty 
acids (PUFA) to the mammary gland should be restricted. The regulation of SCD1 in the 
bovine mammary gland by LCFA appears to be, at least partly, regulated by the 
transcription factors SREBP-1 and INSIG-1. Based on the in vitro research it appears that 
short-chain FA, in particular Ac, upregulate mammary SCD1 expression, although further 
research is needed to verify if short-chain FA induce SCD1 expression in the bovine 
mammary gland. The recently discovered isoform SCD5 is expressed in bovine mammary 
tissue, although contribution to ∆9-desaturation of FA appears to be quite low.  
 
Samenvatting 
  
 
 
163 
Samenvatting 
 
Het verhogen van het aandeel onverzadigde vetzuren (UFA) in melk wordt over het 
algemeen als positief gezien wat betreft de gezondheid van de mens, en draagt daarmee bij 
aan het verhogen van de voedingskwaliteit van melk. In Nederland daarentegen, is het 
aandeel UFA in melk het laatste decennium juist afgenomen, wat waarschijnlijk gerelateerd 
is aan veranderingen in het rantsoen van melkkoeien. Deze veranderingen zijn o.a. een 
lager aandeel vers gras, verminderd ruw eiwit en vet gehalte van gras en graskuil, en een 
verhoogd aandeel maïskuil. Het aandeel UFA in melk wordt voornamelijk bepaald door het 
aandeel UFA in het rantsoen, de mate van biohydrogenatie van UFA in de pens, en door de 
activiteit van het stearoyl-CoA desaturase (SCD) enzym in het uier. Het SCD enzym creëert 
een dubbele binding op de ∆9 positie van uiteenlopende vetzuren (FA) en maakt deze 
daarbij dus onverzadigd. Dit proefschrift richt zich op SCD in het uier van melkkoeien en 
hoe SCD in het uier beïnvloed wordt door voeding van de melkkoe. In het bijzonder is het 
effect van kort- en langketen FA op mRNA expressie van SCD in het uier van melkkoeien 
onderzocht. Het doel van dit onderzoek was het verkennen van voedingsstrategieën die de 
activiteit van SCD in het uier kunnen verhogen, en zodoende leiden tot een verbeterd 
vetzuurprofiel van melk. Ook is onderzoek uitgevoerd naar een niet-invasieve methode om 
SCD expressie te meten in het uier van melkkoeien, als alternatief voor biopsie van het uier.  
Het doel van het eerste experiment (Hoofdstuk 2) was het onderzoeken van de effecten 
van verschillende FA op expressie van zowel SCD1 als SCD5 (de twee isovormen van 
SCD in het rund) in het uier van melkkoeien. In dit experiment werden 28 Holstein-Friesian 
koeien willekeurig toegewezen aan één van de vier rantsoenen bestaande uit een basis 
rantsoen gesupplementeerd (droge stof basis) met hetzij 2.7% raapzaadolie als een bron van 
C18:1 cis-9, of 2.7% sojaolie als een bron van C18:2 cis-9,12, of 2.7% lijnzaadolie als een 
bron van C18:3 cis-9,12,15, of 2.7% van een 1:1:1 mengsel van de drie oliën. Na de 
experimentele periode van 23 dagen werden alle koeien op een controle rantsoen gezet 
gedurende 28 dagen. Aan het einde van zowel de experimentele als de controle periode, 
werd uierweefsel verzameld door middel van biopsie waarin mRNA expressie van SCD1 
en SCD5 werd geanalyseerd met behulp van kwantitatieve real-time polymerase chain 
reaction (qRT-PCR). Melkproductie alsmede de gehalten aan melkvet, -eiwit en -lactose 
waren niet verschillend tussen de vier experimentele behandelingen. Expressie van SCD1 
in het uier was significant down-gereguleerd in melkkoeien in de sojaolie groep vergeleken 
met de raapzaadolie en lijnzaadolie groep. Dit was gedeeltelijk terug te vinden in de lagere 
∆9-desaturase indices in melk, die veelvuldig gebruikt worden als indicatoren voor SCD 
activiteit in het uier. De SCD5 expressie in het uier was echter veel lager (<103) dan de 
expressie van SCD1 en verschilde ook niet tussen de vier behandelingen, wat suggereert dat 
SCD5 expressie in het uier minder gevoelig is voor veranderingen in FA aanbod vergeleken 
met SCD1.  
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Om de veranderingen in genexpressie van het totale genoom als gevolg van UFA 
supplementatie van het rantsoen te bestuderen, is het uierweefsel van experiment 1 ook 
gebruikt voor micro-array analyse (Hoofdstuk 3). In deze studie werd expressie van het 
totale genoom vergeleken tussen de vier UFA rantsoenen en het controle rantsoen (geen 
UFA toevoeging). Vergeleken met de controle was de melkproductie hoger, maar waren de 
gehalten aan melkvet en -eiwit lager voor de koeien op het UFA rantsoen. Verder was het 
aandeel FA in melk afkomstig van de novo synthese gereduceerd, terwijl het aandeel 
langketen vetzuren (LCFA) toegenomen was. Het toepassen van een statistische limiet voor 
“false discovery rate” van q-waarde < 0.05 samen met een absolute “fold change” van 1.3, 
resulteerde in 972 genen waarvan de expressie significant veranderde als gevolg van UFA 
supplementatie. Dit suggereert dat aanzienlijke transcriptionele adaptatie plaatsvindt in het 
uier van melkkoeien wanneer onbeschermde UFA worden toegevoegd aan het rantsoen. 
Groepen van genen gerelateerd aan cel ontwikkeling en reorganisatie, apoptose, 
metabolische processen van nutriënten, en immuunsysteem respons waren voornamelijk 
down-gereguleerd als gevolg van UFA supplementatie.  
Aangezien biopsie van het uier een invasieve en dure methode is die bovendien een 
risico vormt voor uierinfectie, is in experiment 2 (Hoofdstuk 4) onderzocht of somatische 
cellen in melk gebruikt kunnen worden als niet-invasieve, alternatieve bron van mRNA 
voor het onderzoeken van SCD expressie in het uier. Hiervoor zijn zowel somatische cellen 
uit melk als uierweefsel verzameld van 14 Holstein-Friesian koeien, op een rantsoen met of 
zonder lijnzaad, en geanalyseerd op SCD expressie met behulp van qRT-PCR. Expressie 
van SCD5 in uierweefsel was laag vergeleken met SCD1. Er was een significante relatie  
(r2 = 0.60; P < 0.01) tussen SCD1 expressie in somatische cellen uit melk en in uierweefsel. 
Bovendien was SCD1 expressie in somatische cellen uit melk significant gerelateerd aan 
∆9-desaturase indices in melk (r2 tussen 0.32 en 0.52), die veelvuldig gebruikt worden als 
indicatoren voor SCD activiteit in het uier. Deze relatie was beter dan de relatie tussen 
SCD1 expressie in uierweefsel en ∆9-desaturase indices in melk (r2 tussen 0.22 en 0.38). 
De hoeveelheid totaal RNA geïsoleerd uit melk van koeien was laag en verder onderzoek is 
vereist om de RNA opbrengst uit melk te verhogen. Concluderend laat deze studie zien dat 
somatische cellen uit melk gebruikt kunnen worden als alternatieve bron van mRNA om 
SCD1 expressie te onderzoeken in melkkoeien, en zo een niet-invasief alternatief bieden 
voor uierweefsel via biopsie.  
Azijnzuur (Ac) en β-hydroxyboterzuur (BHBA) zijn belangrijke precursoren voor de 
novo synthese van FA in het uier van de melkkoe. Echter, in vergelijking met LCFA, is de 
informatie over de effecten van deze kortketen FA op de expressie van SCD en andere 
belangrijke genen voor de FA synthese in het uier schaars. Derhalve is in experiment 3 
(Hoofdstuk 5) een boviene uiercellijn (MAC-T) gebruikt om de effecten van Ac en BHBA 
op mRNA expressie van SCD te onderzoeken via qRT-PCR, en deze te vergelijken met het 
effect van verschillende LCFA op SCD expressie, evenals expressie van acetyl-CoA 
carboxylase (ACC) en fatty acid synthase (FAS). Bovendien werd de expressie van sterol 
regulatory binding protein 1 (SREBP-1), insulin-induced gene 1 protein (INSIG-1) en 
peroxisome proliferator-activated receptors (PPARs) gemeten om te onderzoeken of deze 
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transcriptiefactoren betrokken zijn bij de regulatie van SCD expressie in boviene uier 
epitheelcellen. MAC-T cellen werden gedurende 12 uur geïncubeerd zonder FA toevoeging 
(CON), of met toevoeging van 5 mM Ac, 5 mM BHBA, een combinatie van 5 mM Ac + 5 
mM BHBA, 100 µM palmitinezuur (PA), 100 µM stearinezuur (SA), 100 µM oliezuur 
(OA), 100 µM trans-vacceenzuur (TVA), 100 µM linolzuur (LA) of 100 µM α-linoleenzuur 
(ALA). In vergelijking met CON nam de expressie van SCD1 toe met Ac (+61%) en daalde 
deze met OA (-61%), LA (-84%) en ALA (-88%). In tegenstelling tot SCD1 werd geen 
SCD5 expressie waargenomen in de MAC-T cellen. De expressie van ACC nam toe met 
Ac (+44%) en daalde met LA (-48%) en ALA (-49%). Vergeleken met CON was FAS 
expressie niet significant beïnvloed door de verschillende behandelingen. Het mRNA 
niveau van SREBP-1 werd niet beïnvloed door Ac of BHBA, maar nam af met OA (-44%), 
TVA (-42%), LA (-62%) en ALA (-68%) vergeleken met CON. De expressie van INSIG-1 
was down-gereguleerd met SA (-37%), OA (-63%), TVA (-53%), LA (-81%) en ALA (-
91%). Zowel PPARα als PPARδ expressie was niet significant beïnvloed door de 
verschillende behandelingen. Deze resultaten laten zien dat expressie van SCD1 en ACC 
wordt up-gereguleerd door Ac in MAC-T cellen, wat suggereert dat Ac de desaturatie en de 
novo synthese van FA kan verhogen in het uier van melkkoeien. Bovendien versterken deze 
resultaten de rol van SREBP-1 en INSIG-1 als centrale regulatoren van lipogenese in het 
uier van melkkoeien.  
Allesomvattende kan geconcludeerd worden dat verzadigde LCFA weinig of geen 
effect hebben op SCD1 expressie in het uier van melkkoeien, terwijl onverzadigde LCFA 
de SCD1 expressie verminderen. Het remmende effect van onverzadigde LCFA op SCD1 
expressie in het uier lijkt proportioneel toe te nemen met het aantal dubbele bindingen in de 
onverzadigde LCFA (d.w.z. meer dubbele bindingen resulteert in een hogere remming van 
SCD1 expressie). Daardoor lijkt het moeilijk om SCD1 expressie in het uier significant te 
verhogen door het aanbieden van LCFA. Om remming van SCD1 expressie in het uier te 
beperken, zou het aanbod van meervoudig onverzadigde vetzuren (PUFA) naar het uier 
beperkt moeten worden. De regulatie van SCD1 in het uier van melkkoeien door LCFA 
lijkt, ten minste gedeeltelijk, gereguleerd door de transcriptiefactoren SREBP-1 en INSIG-
1. Gebaseerd op het in vitro onderzoek lijken kortketen FA, in het bijzonder Ac, SCD1 
expressie te up-reguleren, hoewel verder onderzoek noodzakelijk is om te verifiëren of 
kortketen FA de SCD1 expressie kunnen verhogen in het uier van melkkoeien. De recent 
ontdekte isovorm SCD5 komt tot expressie in het uier van melkkoeien, maar de bijdrage 
aan ∆9-desaturatie van FA lijkt vrij laag. 
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